KR800000089B1 - Method for preparing 2-acyl-4-oxo-hexahydro-4H-pyrazino [2, 1-a] isoquinoline derivative - Google Patents
Method for preparing 2-acyl-4-oxo-hexahydro-4H-pyrazino [2, 1-a] isoquinoline derivative Download PDFInfo
- Publication number
- KR800000089B1 KR800000089B1 KR7404234A KR740004234A KR800000089B1 KR 800000089 B1 KR800000089 B1 KR 800000089B1 KR 7404234 A KR7404234 A KR 7404234A KR 740004234 A KR740004234 A KR 740004234A KR 800000089 B1 KR800000089 B1 KR 800000089B1
- Authority
- KR
- South Korea
- Prior art keywords
- hpi
- carbonyl
- melting point
- acid
- group
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 238000000034 method Methods 0.000 title description 16
- -1 methylsulfonyloxy Chemical group 0.000 claims description 702
- 150000001875 compounds Chemical class 0.000 claims description 100
- 125000004432 carbon atom Chemical group C* 0.000 claims description 73
- 125000002252 acyl group Chemical group 0.000 claims description 13
- 239000000460 chlorine Chemical group 0.000 claims description 13
- 229910052801 chlorine Inorganic materials 0.000 claims description 13
- 229910052731 fluorine Inorganic materials 0.000 claims description 12
- 239000011737 fluorine Substances 0.000 claims description 12
- 239000003795 chemical substances by application Substances 0.000 claims description 9
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Chemical group BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 claims description 7
- 229910052794 bromium Inorganic materials 0.000 claims description 6
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 6
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical group [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 claims description 4
- 229910052740 iodine Chemical group 0.000 claims description 4
- GTRDOUXISKJZGL-UHFFFAOYSA-N 1,2,3,6,7,11b-hexahydropyrazino[2,1-a]isoquinolin-4-one Chemical compound C1=CC=C2C3CNCC(=O)N3CCC2=C1 GTRDOUXISKJZGL-UHFFFAOYSA-N 0.000 claims description 3
- 125000005279 aryl sulfonyloxy group Chemical group 0.000 claims description 3
- 125000001153 fluoro group Chemical group F* 0.000 claims description 3
- 238000004519 manufacturing process Methods 0.000 claims description 3
- NCXNXYJVFQGLHV-UHFFFAOYSA-N 4h-pyrazino[2,1-a]isoquinoline Chemical class C1=CC=C2C3=CN=CCN3C=CC2=C1 NCXNXYJVFQGLHV-UHFFFAOYSA-N 0.000 claims 1
- KZBUYRJDOAKODT-UHFFFAOYSA-N Chlorine Chemical group ClCl KZBUYRJDOAKODT-UHFFFAOYSA-N 0.000 claims 1
- 238000002844 melting Methods 0.000 description 180
- 230000008018 melting Effects 0.000 description 180
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 78
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 69
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 63
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 48
- 239000000243 solution Substances 0.000 description 44
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 41
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 39
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 36
- 239000002253 acid Substances 0.000 description 31
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 30
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 30
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 29
- 239000000203 mixture Substances 0.000 description 24
- 239000003054 catalyst Substances 0.000 description 23
- 238000006243 chemical reaction Methods 0.000 description 23
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 22
- 239000011541 reaction mixture Substances 0.000 description 21
- 239000002904 solvent Substances 0.000 description 20
- 125000000217 alkyl group Chemical group 0.000 description 19
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 18
- 241001465754 Metazoa Species 0.000 description 15
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 15
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 15
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 14
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 14
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 14
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 14
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 13
- PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 description 13
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 13
- YXFVVABEGXRONW-UHFFFAOYSA-N toluene Substances CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 13
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 12
- 229960000583 acetic acid Drugs 0.000 description 12
- 239000013543 active substance Substances 0.000 description 12
- 125000003545 alkoxy group Chemical group 0.000 description 12
- 230000000694 effects Effects 0.000 description 12
- 150000003839 salts Chemical class 0.000 description 12
- 229920006395 saturated elastomer Polymers 0.000 description 12
- 235000011054 acetic acid Nutrition 0.000 description 11
- 125000003277 amino group Chemical group 0.000 description 11
- 239000007864 aqueous solution Substances 0.000 description 11
- 239000011734 sodium Substances 0.000 description 11
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 11
- 241000242722 Cestoda Species 0.000 description 10
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 10
- CPELXLSAUQHCOX-UHFFFAOYSA-N Hydrogen bromide Chemical compound Br CPELXLSAUQHCOX-UHFFFAOYSA-N 0.000 description 10
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 10
- 239000002585 base Substances 0.000 description 10
- 125000000753 cycloalkyl group Chemical group 0.000 description 10
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 10
- 244000045947 parasite Species 0.000 description 10
- 229910052708 sodium Inorganic materials 0.000 description 10
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 9
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 9
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 9
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 9
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 9
- 150000001735 carboxylic acids Chemical class 0.000 description 9
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 9
- 239000007858 starting material Substances 0.000 description 9
- 125000001424 substituent group Chemical group 0.000 description 9
- 239000003826 tablet Substances 0.000 description 9
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 8
- 150000008064 anhydrides Chemical class 0.000 description 8
- 229910052799 carbon Inorganic materials 0.000 description 8
- IJGRMHOSHXDMSA-UHFFFAOYSA-O diazynium Chemical class [NH+]#N IJGRMHOSHXDMSA-UHFFFAOYSA-O 0.000 description 8
- 239000000706 filtrate Substances 0.000 description 8
- 238000005984 hydrogenation reaction Methods 0.000 description 8
- 239000012442 inert solvent Substances 0.000 description 8
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 7
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 7
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 7
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 7
- 239000004480 active ingredient Substances 0.000 description 7
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 7
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 7
- 239000003814 drug Substances 0.000 description 7
- 230000003287 optical effect Effects 0.000 description 7
- 238000002360 preparation method Methods 0.000 description 7
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 7
- 241000282472 Canis lupus familiaris Species 0.000 description 6
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 6
- 239000002262 Schiff base Substances 0.000 description 6
- 150000004753 Schiff bases Chemical class 0.000 description 6
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 6
- 150000007513 acids Chemical class 0.000 description 6
- 239000002671 adjuvant Substances 0.000 description 6
- 150000001298 alcohols Chemical class 0.000 description 6
- 125000003282 alkyl amino group Chemical group 0.000 description 6
- 125000003710 aryl alkyl group Chemical group 0.000 description 6
- 125000003118 aryl group Chemical group 0.000 description 6
- ILAHWRKJUDSMFH-UHFFFAOYSA-N boron tribromide Chemical compound BrB(Br)Br ILAHWRKJUDSMFH-UHFFFAOYSA-N 0.000 description 6
- 239000002775 capsule Substances 0.000 description 6
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 6
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 6
- 125000000031 ethylamino group Chemical group [H]C([H])([H])C([H])([H])N([H])[*] 0.000 description 6
- 125000000623 heterocyclic group Chemical group 0.000 description 6
- 125000000468 ketone group Chemical group 0.000 description 6
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 6
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 6
- 125000000250 methylamino group Chemical group [H]N(*)C([H])([H])[H] 0.000 description 6
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 6
- 229910052759 nickel Inorganic materials 0.000 description 6
- 125000003232 p-nitrobenzoyl group Chemical group [N+](=O)([O-])C1=CC=C(C(=O)*)C=C1 0.000 description 6
- 229910052763 palladium Inorganic materials 0.000 description 6
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 6
- 239000000741 silica gel Substances 0.000 description 6
- 229910002027 silica gel Inorganic materials 0.000 description 6
- 125000000020 sulfo group Chemical group O=S(=O)([*])O[H] 0.000 description 6
- 239000000725 suspension Substances 0.000 description 6
- 125000003816 2-hydroxybenzoyl group Chemical group OC1=C(C(=O)*)C=CC=C1 0.000 description 5
- 125000006325 2-propenyl amino group Chemical group [H]C([H])=C([H])C([H])([H])N([H])* 0.000 description 5
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 5
- 125000001999 4-Methoxybenzoyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1OC([H])([H])[H])C(*)=O 0.000 description 5
- CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 description 5
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical group [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 5
- 241000053763 Cystosoma Species 0.000 description 5
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 5
- 241000699670 Mus sp. Species 0.000 description 5
- DKGAVHZHDRPRBM-UHFFFAOYSA-N Tert-Butanol Chemical compound CC(C)(C)O DKGAVHZHDRPRBM-UHFFFAOYSA-N 0.000 description 5
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 5
- 229910052783 alkali metal Inorganic materials 0.000 description 5
- 229940024606 amino acid Drugs 0.000 description 5
- 235000001014 amino acid Nutrition 0.000 description 5
- 238000009876 asymmetric hydrogenation reaction Methods 0.000 description 5
- 238000009835 boiling Methods 0.000 description 5
- SXDBWCPKPHAZSM-UHFFFAOYSA-N bromic acid Chemical compound OBr(=O)=O SXDBWCPKPHAZSM-UHFFFAOYSA-N 0.000 description 5
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 5
- 238000000354 decomposition reaction Methods 0.000 description 5
- 125000004663 dialkyl amino group Chemical group 0.000 description 5
- 239000012954 diazonium Substances 0.000 description 5
- 235000019253 formic acid Nutrition 0.000 description 5
- 229910052739 hydrogen Inorganic materials 0.000 description 5
- 239000001257 hydrogen Substances 0.000 description 5
- 229910000042 hydrogen bromide Inorganic materials 0.000 description 5
- IXCSERBJSXMMFS-UHFFFAOYSA-N hydrogen chloride Substances Cl.Cl IXCSERBJSXMMFS-UHFFFAOYSA-N 0.000 description 5
- 229910000041 hydrogen chloride Inorganic materials 0.000 description 5
- XMBWDFGMSWQBCA-UHFFFAOYSA-N hydrogen iodide Chemical compound I XMBWDFGMSWQBCA-UHFFFAOYSA-N 0.000 description 5
- SUMDYPCJJOFFON-UHFFFAOYSA-N isethionic acid Chemical compound OCCS(O)(=O)=O SUMDYPCJJOFFON-UHFFFAOYSA-N 0.000 description 5
- 229910052751 metal Inorganic materials 0.000 description 5
- 239000002184 metal Substances 0.000 description 5
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 description 5
- 229910052757 nitrogen Inorganic materials 0.000 description 5
- 229910000029 sodium carbonate Inorganic materials 0.000 description 5
- 238000006467 substitution reaction Methods 0.000 description 5
- 235000000346 sugar Nutrition 0.000 description 5
- 238000012360 testing method Methods 0.000 description 5
- LSNNMFCWUKXFEE-UHFFFAOYSA-M Bisulfite Chemical compound OS([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-M 0.000 description 4
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 4
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 4
- 241000244160 Echinococcus Species 0.000 description 4
- KRHYYFGTRYWZRS-UHFFFAOYSA-N Fluorane Chemical compound F KRHYYFGTRYWZRS-UHFFFAOYSA-N 0.000 description 4
- OAKJQQAXSVQMHS-UHFFFAOYSA-N Hydrazine Chemical compound NN OAKJQQAXSVQMHS-UHFFFAOYSA-N 0.000 description 4
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 4
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 4
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 4
- 125000004423 acyloxy group Chemical group 0.000 description 4
- 150000003863 ammonium salts Chemical class 0.000 description 4
- HUMNYLRZRPPJDN-UHFFFAOYSA-N benzaldehyde Chemical compound O=CC1=CC=CC=C1 HUMNYLRZRPPJDN-UHFFFAOYSA-N 0.000 description 4
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 description 4
- 238000004587 chromatography analysis Methods 0.000 description 4
- 125000001316 cycloalkyl alkyl group Chemical group 0.000 description 4
- 150000001989 diazonium salts Chemical class 0.000 description 4
- 239000008298 dragée Substances 0.000 description 4
- 150000002170 ethers Chemical class 0.000 description 4
- 150000004820 halides Chemical class 0.000 description 4
- 229910052736 halogen Inorganic materials 0.000 description 4
- 150000002367 halogens Chemical class 0.000 description 4
- 238000010438 heat treatment Methods 0.000 description 4
- 208000015181 infectious disease Diseases 0.000 description 4
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 4
- 150000002576 ketones Chemical class 0.000 description 4
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 4
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 4
- 229910052697 platinum Inorganic materials 0.000 description 4
- 239000011591 potassium Substances 0.000 description 4
- 229910052700 potassium Inorganic materials 0.000 description 4
- 239000000843 powder Substances 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 150000003242 quaternary ammonium salts Chemical class 0.000 description 4
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 239000006188 syrup Substances 0.000 description 4
- 235000020357 syrup Nutrition 0.000 description 4
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 4
- 125000003396 thiol group Chemical group [H]S* 0.000 description 4
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 4
- QAEDZJGFFMLHHQ-UHFFFAOYSA-N trifluoroacetic anhydride Chemical compound FC(F)(F)C(=O)OC(=O)C(F)(F)F QAEDZJGFFMLHHQ-UHFFFAOYSA-N 0.000 description 4
- 229910052725 zinc Inorganic materials 0.000 description 4
- 239000011701 zinc Substances 0.000 description 4
- NHQDETIJWKXCTC-UHFFFAOYSA-N 3-chloroperbenzoic acid Chemical compound OOC(=O)C1=CC=CC(Cl)=C1 NHQDETIJWKXCTC-UHFFFAOYSA-N 0.000 description 3
- 125000000242 4-chlorobenzoyl group Chemical group ClC1=CC=C(C(=O)*)C=C1 0.000 description 3
- WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 description 3
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 3
- 241000282326 Felis catus Species 0.000 description 3
- 241000282412 Homo Species 0.000 description 3
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 3
- 150000001204 N-oxides Chemical class 0.000 description 3
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 3
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 3
- GLUUGHFHXGJENI-UHFFFAOYSA-N Piperazine Chemical class C1CNCCN1 GLUUGHFHXGJENI-UHFFFAOYSA-N 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 3
- 241000244155 Taenia Species 0.000 description 3
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 3
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 description 3
- 230000002378 acidificating effect Effects 0.000 description 3
- 238000005917 acylation reaction Methods 0.000 description 3
- 150000001340 alkali metals Chemical class 0.000 description 3
- 125000004414 alkyl thio group Chemical group 0.000 description 3
- 150000001408 amides Chemical class 0.000 description 3
- 150000001413 amino acids Chemical class 0.000 description 3
- 229910021529 ammonia Inorganic materials 0.000 description 3
- 239000007900 aqueous suspension Substances 0.000 description 3
- 125000003236 benzoyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C(*)=O 0.000 description 3
- 125000000440 benzylamino group Chemical group [H]N(*)C([H])([H])C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 description 3
- SXDBWCPKPHAZSM-UHFFFAOYSA-M bromate Inorganic materials [O-]Br(=O)=O SXDBWCPKPHAZSM-UHFFFAOYSA-M 0.000 description 3
- 150000001721 carbon Chemical group 0.000 description 3
- 239000000969 carrier Substances 0.000 description 3
- 150000001805 chlorine compounds Chemical class 0.000 description 3
- 125000001995 cyclobutyl group Chemical group [H]C1([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 3
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 3
- 125000001511 cyclopentyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 3
- 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 description 3
- 150000001991 dicarboxylic acids Chemical class 0.000 description 3
- VAYGXNSJCAHWJZ-UHFFFAOYSA-N dimethyl sulfate Chemical compound COS(=O)(=O)OC VAYGXNSJCAHWJZ-UHFFFAOYSA-N 0.000 description 3
- 239000003995 emulsifying agent Substances 0.000 description 3
- 125000003754 ethoxycarbonyl group Chemical group C(=O)(OCC)* 0.000 description 3
- 150000002222 fluorine compounds Chemical class 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- DMEGYFMYUHOHGS-UHFFFAOYSA-N heptamethylene Natural products C1CCCCCC1 DMEGYFMYUHOHGS-UHFFFAOYSA-N 0.000 description 3
- 230000007062 hydrolysis Effects 0.000 description 3
- 238000006460 hydrolysis reaction Methods 0.000 description 3
- 239000011630 iodine Substances 0.000 description 3
- INQOMBQAUSQDDS-UHFFFAOYSA-N iodomethane Chemical compound IC INQOMBQAUSQDDS-UHFFFAOYSA-N 0.000 description 3
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 3
- 150000002596 lactones Chemical class 0.000 description 3
- 239000008101 lactose Substances 0.000 description 3
- 235000019359 magnesium stearate Nutrition 0.000 description 3
- 150000002739 metals Chemical class 0.000 description 3
- 150000007522 mineralic acids Chemical class 0.000 description 3
- 229910017604 nitric acid Inorganic materials 0.000 description 3
- 150000002825 nitriles Chemical class 0.000 description 3
- 239000012044 organic layer Substances 0.000 description 3
- 239000003960 organic solvent Substances 0.000 description 3
- 239000003208 petroleum Substances 0.000 description 3
- 229910000027 potassium carbonate Inorganic materials 0.000 description 3
- 150000003141 primary amines Chemical class 0.000 description 3
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 3
- 238000007363 ring formation reaction Methods 0.000 description 3
- 125000002914 sec-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 3
- 150000003335 secondary amines Chemical class 0.000 description 3
- 125000000467 secondary amino group Chemical group [H]N([*:1])[*:2] 0.000 description 3
- 238000000926 separation method Methods 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- 229910052717 sulfur Inorganic materials 0.000 description 3
- 239000011593 sulfur Substances 0.000 description 3
- 239000000454 talc Substances 0.000 description 3
- 229910052623 talc Inorganic materials 0.000 description 3
- 239000011975 tartaric acid Substances 0.000 description 3
- 235000002906 tartaric acid Nutrition 0.000 description 3
- 125000000335 thiazolyl group Chemical group 0.000 description 3
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 3
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 2
- KEQGZUUPPQEDPF-UHFFFAOYSA-N 1,3-dichloro-5,5-dimethylimidazolidine-2,4-dione Chemical compound CC1(C)N(Cl)C(=O)N(Cl)C1=O KEQGZUUPPQEDPF-UHFFFAOYSA-N 0.000 description 2
- 125000000530 1-propynyl group Chemical group [H]C([H])([H])C#C* 0.000 description 2
- RAZNCTHEBQFYML-UHFFFAOYSA-N 2-(cyclohexanecarbonyl)-6,7-dihydro-3h-pyrazino[2,1-a]isoquinolin-4-one Chemical compound C1C(=O)N2CCC3=CC=CC=C3C2=CN1C(=O)C1CCCCC1 RAZNCTHEBQFYML-UHFFFAOYSA-N 0.000 description 2
- 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 description 2
- 125000004080 3-carboxypropanoyl group Chemical group O=C([*])C([H])([H])C([H])([H])C(O[H])=O 0.000 description 2
- 125000006201 3-phenylpropyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 2
- 125000003349 3-pyridyl group Chemical group N1=C([H])C([*])=C([H])C([H])=C1[H] 0.000 description 2
- VXEGSRKPIUDPQT-UHFFFAOYSA-N 4-[4-(4-methoxyphenyl)piperazin-1-yl]aniline Chemical compound C1=CC(OC)=CC=C1N1CCN(C=2C=CC(N)=CC=2)CC1 VXEGSRKPIUDPQT-UHFFFAOYSA-N 0.000 description 2
- IKHGUXGNUITLKF-UHFFFAOYSA-N Acetaldehyde Chemical compound CC=O IKHGUXGNUITLKF-UHFFFAOYSA-N 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 241000271566 Aves Species 0.000 description 2
- 241000283690 Bos taurus Species 0.000 description 2
- FERIUCNNQQJTOY-UHFFFAOYSA-N Butyric acid Chemical compound CCCC(O)=O FERIUCNNQQJTOY-UHFFFAOYSA-N 0.000 description 2
- 241000283707 Capra Species 0.000 description 2
- 241000282994 Cervidae Species 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 2
- VGCXGMAHQTYDJK-UHFFFAOYSA-N Chloroacetyl chloride Chemical compound ClCC(Cl)=O VGCXGMAHQTYDJK-UHFFFAOYSA-N 0.000 description 2
- RGSFGYAAUTVSQA-UHFFFAOYSA-N Cyclopentane Chemical compound C1CCCC1 RGSFGYAAUTVSQA-UHFFFAOYSA-N 0.000 description 2
- RGHNJXZEOKUKBD-SQOUGZDYSA-N D-gluconic acid Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O RGHNJXZEOKUKBD-SQOUGZDYSA-N 0.000 description 2
- YXHKONLOYHBTNS-UHFFFAOYSA-N Diazomethane Chemical compound C=[N+]=[N-] YXHKONLOYHBTNS-UHFFFAOYSA-N 0.000 description 2
- MDNWOSOZYLHTCG-UHFFFAOYSA-N Dichlorophen Chemical compound OC1=CC=C(Cl)C=C1CC1=CC(Cl)=CC=C1O MDNWOSOZYLHTCG-UHFFFAOYSA-N 0.000 description 2
- XTHFKEDIFFGKHM-UHFFFAOYSA-N Dimethoxyethane Chemical compound COCCOC XTHFKEDIFFGKHM-UHFFFAOYSA-N 0.000 description 2
- 241000283074 Equus asinus Species 0.000 description 2
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 2
- 108010010803 Gelatin Proteins 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- AVXURJPOCDRRFD-UHFFFAOYSA-N Hydroxylamine Chemical compound ON AVXURJPOCDRRFD-UHFFFAOYSA-N 0.000 description 2
- 241000244166 Hymenolepis diminuta Species 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 2
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 2
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 2
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 2
- 239000004472 Lysine Substances 0.000 description 2
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 2
- 241001137878 Moniezia Species 0.000 description 2
- 241000699666 Mus <mouse, genus> Species 0.000 description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
- MZRVEZGGRBJDDB-UHFFFAOYSA-N N-Butyllithium Chemical compound [Li]CCCC MZRVEZGGRBJDDB-UHFFFAOYSA-N 0.000 description 2
- 125000000815 N-oxide group Chemical group 0.000 description 2
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical group NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 description 2
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 2
- KFSLWBXXFJQRDL-UHFFFAOYSA-N Peracetic acid Chemical compound CC(=O)OO KFSLWBXXFJQRDL-UHFFFAOYSA-N 0.000 description 2
- YGYAWVDWMABLBF-UHFFFAOYSA-N Phosgene Chemical compound ClC(Cl)=O YGYAWVDWMABLBF-UHFFFAOYSA-N 0.000 description 2
- LGRFSURHDFAFJT-UHFFFAOYSA-N Phthalic anhydride Natural products C1=CC=C2C(=O)OC(=O)C2=C1 LGRFSURHDFAFJT-UHFFFAOYSA-N 0.000 description 2
- LOUPRKONTZGTKE-WZBLMQSHSA-N Quinine Chemical compound C([C@H]([C@H](C1)C=C)C2)C[N@@]1[C@@H]2[C@H](O)C1=CC=NC2=CC=C(OC)C=C21 LOUPRKONTZGTKE-WZBLMQSHSA-N 0.000 description 2
- 241000283984 Rodentia Species 0.000 description 2
- 241000282849 Ruminantia Species 0.000 description 2
- DWAQJAXMDSEUJJ-UHFFFAOYSA-M Sodium bisulfite Chemical compound [Na+].OS([O-])=O DWAQJAXMDSEUJJ-UHFFFAOYSA-M 0.000 description 2
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 2
- 241000356557 Taenia serialis Species 0.000 description 2
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 2
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical group OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 2
- WETWJCDKMRHUPV-UHFFFAOYSA-N acetyl chloride Chemical compound CC(Cl)=O WETWJCDKMRHUPV-UHFFFAOYSA-N 0.000 description 2
- 239000012346 acetyl chloride Substances 0.000 description 2
- 125000004442 acylamino group Chemical group 0.000 description 2
- 150000008044 alkali metal hydroxides Chemical class 0.000 description 2
- 239000012670 alkaline solution Substances 0.000 description 2
- 125000004453 alkoxycarbonyl group Chemical group 0.000 description 2
- 125000005138 alkoxysulfonyl group Chemical group 0.000 description 2
- 239000002168 alkylating agent Substances 0.000 description 2
- 229940100198 alkylating agent Drugs 0.000 description 2
- 238000005804 alkylation reaction Methods 0.000 description 2
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 2
- RDOXTESZEPMUJZ-UHFFFAOYSA-N anisole Chemical compound COC1=CC=CC=C1 RDOXTESZEPMUJZ-UHFFFAOYSA-N 0.000 description 2
- 230000002141 anti-parasite Effects 0.000 description 2
- 125000004104 aryloxy group Chemical group 0.000 description 2
- 150000001540 azides Chemical class 0.000 description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
- 210000000013 bile duct Anatomy 0.000 description 2
- ODWXUNBKCRECNW-UHFFFAOYSA-M bromocopper(1+) Chemical compound Br[Cu+] ODWXUNBKCRECNW-UHFFFAOYSA-M 0.000 description 2
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 2
- JHIWVOJDXOSYLW-UHFFFAOYSA-N butyl 2,2-difluorocyclopropane-1-carboxylate Chemical compound CCCCOC(=O)C1CC1(F)F JHIWVOJDXOSYLW-UHFFFAOYSA-N 0.000 description 2
- 229910000019 calcium carbonate Inorganic materials 0.000 description 2
- 150000001244 carboxylic acid anhydrides Chemical class 0.000 description 2
- MVPPADPHJFYWMZ-UHFFFAOYSA-N chlorobenzene Chemical compound ClC1=CC=CC=C1 MVPPADPHJFYWMZ-UHFFFAOYSA-N 0.000 description 2
- NEHMKBQYUWJMIP-UHFFFAOYSA-N chloromethane Chemical compound ClC NEHMKBQYUWJMIP-UHFFFAOYSA-N 0.000 description 2
- 125000004218 chloromethyl group Chemical group [H]C([H])(Cl)* 0.000 description 2
- XTHPWXDJESJLNJ-UHFFFAOYSA-N chlorosulfonic acid Substances OS(Cl)(=O)=O XTHPWXDJESJLNJ-UHFFFAOYSA-N 0.000 description 2
- LOUPRKONTZGTKE-UHFFFAOYSA-N cinchonine Natural products C1C(C(C2)C=C)CCN2C1C(O)C1=CC=NC2=CC=C(OC)C=C21 LOUPRKONTZGTKE-UHFFFAOYSA-N 0.000 description 2
- 235000015165 citric acid Nutrition 0.000 description 2
- 229910017052 cobalt Inorganic materials 0.000 description 2
- 239000010941 cobalt Substances 0.000 description 2
- GUTLYIVDDKVIGB-UHFFFAOYSA-N cobalt atom Chemical compound [Co] GUTLYIVDDKVIGB-UHFFFAOYSA-N 0.000 description 2
- 210000001072 colon Anatomy 0.000 description 2
- 239000003086 colorant Substances 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- ORTQZVOHEJQUHG-UHFFFAOYSA-L copper(II) chloride Chemical compound Cl[Cu]Cl ORTQZVOHEJQUHG-UHFFFAOYSA-L 0.000 description 2
- 239000007822 coupling agent Substances 0.000 description 2
- 125000004093 cyano group Chemical group *C#N 0.000 description 2
- 125000004122 cyclic group Chemical group 0.000 description 2
- 125000000582 cycloheptyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 2
- DIOQZVSQGTUSAI-UHFFFAOYSA-N decane Chemical compound CCCCCCCCCC DIOQZVSQGTUSAI-UHFFFAOYSA-N 0.000 description 2
- 238000006193 diazotization reaction Methods 0.000 description 2
- 125000002147 dimethylamino group Chemical group [H]C([H])([H])N(*)C([H])([H])[H] 0.000 description 2
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000007938 effervescent tablet Substances 0.000 description 2
- 125000001301 ethoxy group Chemical group [H]C([H])([H])C([H])([H])O* 0.000 description 2
- 238000001704 evaporation Methods 0.000 description 2
- 230000008020 evaporation Effects 0.000 description 2
- 239000000284 extract Substances 0.000 description 2
- 239000008098 formaldehyde solution Substances 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 125000002485 formyl group Chemical group [H]C(*)=O 0.000 description 2
- 229920000159 gelatin Polymers 0.000 description 2
- 239000008273 gelatin Substances 0.000 description 2
- 235000019322 gelatine Nutrition 0.000 description 2
- 235000011852 gelatine desserts Nutrition 0.000 description 2
- HHLFWLYXYJOTON-UHFFFAOYSA-N glyoxylic acid Chemical compound OC(=O)C=O HHLFWLYXYJOTON-UHFFFAOYSA-N 0.000 description 2
- 239000008187 granular material Substances 0.000 description 2
- 229940093915 gynecological organic acid Drugs 0.000 description 2
- 229910001385 heavy metal Inorganic materials 0.000 description 2
- 125000003104 hexanoyl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- 150000007857 hydrazones Chemical class 0.000 description 2
- 229930195733 hydrocarbon Natural products 0.000 description 2
- 150000002430 hydrocarbons Chemical class 0.000 description 2
- 150000002431 hydrogen Chemical class 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000000077 insect repellent Substances 0.000 description 2
- 239000000543 intermediate Substances 0.000 description 2
- 210000000936 intestine Anatomy 0.000 description 2
- PHTQWCKDNZKARW-UHFFFAOYSA-N isoamylol Chemical compound CC(C)CCO PHTQWCKDNZKARW-UHFFFAOYSA-N 0.000 description 2
- TWBYWOBDOCUKOW-UHFFFAOYSA-N isonicotinic acid Chemical compound OC(=O)C1=CC=NC=C1 TWBYWOBDOCUKOW-UHFFFAOYSA-N 0.000 description 2
- 125000002183 isoquinolinyl group Chemical class C1(=NC=CC2=CC=CC=C12)* 0.000 description 2
- 125000001786 isothiazolyl group Chemical group 0.000 description 2
- 125000000842 isoxazolyl group Chemical group 0.000 description 2
- 239000004310 lactic acid Substances 0.000 description 2
- 235000014655 lactic acid Nutrition 0.000 description 2
- 239000010410 layer Substances 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 244000144972 livestock Species 0.000 description 2
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 2
- 239000011976 maleic acid Substances 0.000 description 2
- 239000001630 malic acid Substances 0.000 description 2
- 235000011090 malic acid Nutrition 0.000 description 2
- NUJOXMJBOLGQSY-UHFFFAOYSA-N manganese dioxide Chemical compound O=[Mn]=O NUJOXMJBOLGQSY-UHFFFAOYSA-N 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical compound [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 description 2
- 229910052753 mercury Inorganic materials 0.000 description 2
- 229910052987 metal hydride Inorganic materials 0.000 description 2
- 125000001160 methoxycarbonyl group Chemical group [H]C([H])([H])OC(*)=O 0.000 description 2
- 229920000609 methyl cellulose Polymers 0.000 description 2
- 239000001923 methylcellulose Substances 0.000 description 2
- 235000010981 methylcellulose Nutrition 0.000 description 2
- BQJCRHHNABKAKU-KBQPJGBKSA-N morphine Chemical compound O([C@H]1[C@H](C=C[C@H]23)O)C4=C5[C@@]12CCN(C)[C@@H]3CC5=CC=C4O BQJCRHHNABKAKU-KBQPJGBKSA-N 0.000 description 2
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 description 2
- 125000004433 nitrogen atom Chemical group N* 0.000 description 2
- 229910000510 noble metal Inorganic materials 0.000 description 2
- 231100000252 nontoxic Toxicity 0.000 description 2
- 230000003000 nontoxic effect Effects 0.000 description 2
- 125000002801 octanoyl group Chemical group C(CCCCCCC)(=O)* 0.000 description 2
- 125000002811 oleoyl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])/C([H])=C([H])\C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- 150000007524 organic acids Chemical class 0.000 description 2
- 235000005985 organic acids Nutrition 0.000 description 2
- 150000007530 organic bases Chemical class 0.000 description 2
- 150000001451 organic peroxides Chemical class 0.000 description 2
- 125000002971 oxazolyl group Chemical group 0.000 description 2
- MUMZUERVLWJKNR-UHFFFAOYSA-N oxoplatinum Chemical compound [Pt]=O MUMZUERVLWJKNR-UHFFFAOYSA-N 0.000 description 2
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 2
- QNGNSVIICDLXHT-UHFFFAOYSA-N para-ethylbenzaldehyde Natural products CCC1=CC=C(C=O)C=C1 QNGNSVIICDLXHT-UHFFFAOYSA-N 0.000 description 2
- 230000000144 pharmacologic effect Effects 0.000 description 2
- 239000012071 phase Substances 0.000 description 2
- FAIAAWCVCHQXDN-UHFFFAOYSA-N phosphorus trichloride Chemical compound ClP(Cl)Cl FAIAAWCVCHQXDN-UHFFFAOYSA-N 0.000 description 2
- XHXFXVLFKHQFAL-UHFFFAOYSA-N phosphoryl trichloride Chemical compound ClP(Cl)(Cl)=O XHXFXVLFKHQFAL-UHFFFAOYSA-N 0.000 description 2
- XNGIFLGASWRNHJ-UHFFFAOYSA-N phthalic acid Chemical compound OC(=O)C1=CC=CC=C1C(O)=O XNGIFLGASWRNHJ-UHFFFAOYSA-N 0.000 description 2
- 125000001557 phthalyl group Chemical group C(=O)(O)C1=C(C(=O)*)C=CC=C1 0.000 description 2
- WLJVNTCWHIRURA-UHFFFAOYSA-N pimelic acid Chemical compound OC(=O)CCCCCC(O)=O WLJVNTCWHIRURA-UHFFFAOYSA-N 0.000 description 2
- 125000005936 piperidyl group Chemical group 0.000 description 2
- 229910003446 platinum oxide Inorganic materials 0.000 description 2
- FGIUAXJPYTZDNR-UHFFFAOYSA-N potassium nitrate Chemical compound [K+].[O-][N+]([O-])=O FGIUAXJPYTZDNR-UHFFFAOYSA-N 0.000 description 2
- 125000006239 protecting group Chemical group 0.000 description 2
- LOUPRKONTZGTKE-LHHVKLHASA-N quinidine Chemical compound C([C@H]([C@H](C1)C=C)C2)C[N@@]1[C@H]2[C@@H](O)C1=CC=NC2=CC=C(OC)C=C21 LOUPRKONTZGTKE-LHHVKLHASA-N 0.000 description 2
- 230000035484 reaction time Effects 0.000 description 2
- 238000001953 recrystallisation Methods 0.000 description 2
- 238000006722 reduction reaction Methods 0.000 description 2
- 229960004889 salicylic acid Drugs 0.000 description 2
- 201000004409 schistosomiasis Diseases 0.000 description 2
- 239000005049 silicon tetrachloride Substances 0.000 description 2
- 239000012279 sodium borohydride Substances 0.000 description 2
- 229910000033 sodium borohydride Inorganic materials 0.000 description 2
- 229910000104 sodium hydride Inorganic materials 0.000 description 2
- 235000010267 sodium hydrogen sulphite Nutrition 0.000 description 2
- LPXPTNMVRIOKMN-UHFFFAOYSA-M sodium nitrite Chemical compound [Na+].[O-]N=O LPXPTNMVRIOKMN-UHFFFAOYSA-M 0.000 description 2
- 229910052938 sodium sulfate Inorganic materials 0.000 description 2
- 235000011152 sodium sulphate Nutrition 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- 239000000375 suspending agent Substances 0.000 description 2
- 150000003512 tertiary amines Chemical class 0.000 description 2
- CIHOLLKRGTVIJN-UHFFFAOYSA-N tert‐butyl hydroperoxide Chemical compound CC(C)(C)OO CIHOLLKRGTVIJN-UHFFFAOYSA-N 0.000 description 2
- VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 description 2
- WJCNZQLZVWNLKY-UHFFFAOYSA-N thiabendazole Chemical compound S1C=NC(C=2NC3=CC=CC=C3N=2)=C1 WJCNZQLZVWNLKY-UHFFFAOYSA-N 0.000 description 2
- FYSNRJHAOHDILO-UHFFFAOYSA-N thionyl chloride Chemical compound ClS(Cl)=O FYSNRJHAOHDILO-UHFFFAOYSA-N 0.000 description 2
- HPGGPRDJHPYFRM-UHFFFAOYSA-J tin(iv) chloride Chemical compound Cl[Sn](Cl)(Cl)Cl HPGGPRDJHPYFRM-UHFFFAOYSA-J 0.000 description 2
- 125000005208 trialkylammonium group Chemical group 0.000 description 2
- 125000003774 valeryl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 2
- 239000008096 xylene Substances 0.000 description 2
- QBYIENPQHBMVBV-HFEGYEGKSA-N (2R)-2-hydroxy-2-phenylacetic acid Chemical compound O[C@@H](C(O)=O)c1ccccc1.O[C@@H](C(O)=O)c1ccccc1 QBYIENPQHBMVBV-HFEGYEGKSA-N 0.000 description 1
- LNAZSHAWQACDHT-XIYTZBAFSA-N (2r,3r,4s,5r,6s)-4,5-dimethoxy-2-(methoxymethyl)-3-[(2s,3r,4s,5r,6r)-3,4,5-trimethoxy-6-(methoxymethyl)oxan-2-yl]oxy-6-[(2r,3r,4s,5r,6r)-4,5,6-trimethoxy-2-(methoxymethyl)oxan-3-yl]oxyoxane Chemical compound CO[C@@H]1[C@@H](OC)[C@H](OC)[C@@H](COC)O[C@H]1O[C@H]1[C@H](OC)[C@@H](OC)[C@H](O[C@H]2[C@@H]([C@@H](OC)[C@H](OC)O[C@@H]2COC)OC)O[C@@H]1COC LNAZSHAWQACDHT-XIYTZBAFSA-N 0.000 description 1
- AAWZDTNXLSGCEK-LNVDRNJUSA-N (3r,5r)-1,3,4,5-tetrahydroxycyclohexane-1-carboxylic acid Chemical compound O[C@@H]1CC(O)(C(O)=O)C[C@@H](O)C1O AAWZDTNXLSGCEK-LNVDRNJUSA-N 0.000 description 1
- OZCAXVJMDCPLEO-UHFFFAOYSA-N 1,2,3,4-tetrahydroisoquinoline-1-carbonitrile Chemical compound C1=CC=C2C(C#N)NCCC2=C1 OZCAXVJMDCPLEO-UHFFFAOYSA-N 0.000 description 1
- 125000004529 1,2,3-triazinyl group Chemical group N1=NN=C(C=C1)* 0.000 description 1
- 125000004504 1,2,4-oxadiazolyl group Chemical group 0.000 description 1
- MFEVGQHCNVXMER-UHFFFAOYSA-L 1,3,2$l^{2}-dioxaplumbetan-4-one Chemical compound [Pb+2].[O-]C([O-])=O MFEVGQHCNVXMER-UHFFFAOYSA-L 0.000 description 1
- IGERFAHWSHDDHX-UHFFFAOYSA-N 1,3-dioxanyl Chemical group [CH]1OCCCO1 IGERFAHWSHDDHX-UHFFFAOYSA-N 0.000 description 1
- 125000005940 1,4-dioxanyl group Chemical group 0.000 description 1
- FRASJONUBLZVQX-UHFFFAOYSA-N 1,4-naphthoquinone Chemical compound C1=CC=C2C(=O)C=CC(=O)C2=C1 FRASJONUBLZVQX-UHFFFAOYSA-N 0.000 description 1
- 125000000183 1,4-thiazinyl group Chemical group S1C(C=NC=C1)* 0.000 description 1
- PVOAHINGSUIXLS-UHFFFAOYSA-N 1-Methylpiperazine Chemical compound CN1CCNCC1 PVOAHINGSUIXLS-UHFFFAOYSA-N 0.000 description 1
- WOXWUZCRWJWTRT-UHFFFAOYSA-N 1-amino-1-cyclohexanecarboxylic acid Chemical compound OC(=O)C1(N)CCCCC1 WOXWUZCRWJWTRT-UHFFFAOYSA-N 0.000 description 1
- RTBFRGCFXZNCOE-UHFFFAOYSA-N 1-methylsulfonylpiperidin-4-one Chemical compound CS(=O)(=O)N1CCC(=O)CC1 RTBFRGCFXZNCOE-UHFFFAOYSA-N 0.000 description 1
- 125000004343 1-phenylethyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])(*)C([H])([H])[H] 0.000 description 1
- RQEUFEKYXDPUSK-UHFFFAOYSA-N 1-phenylethylamine Chemical compound CC(N)C1=CC=CC=C1 RQEUFEKYXDPUSK-UHFFFAOYSA-N 0.000 description 1
- 125000006334 2,4-difluoro benzoyl group Chemical group [H]C1=C([H])C(C(*)=O)=C(F)C([H])=C1F 0.000 description 1
- RWMBKMMQEMUWEO-UHFFFAOYSA-N 2,4-dihydro-1h-pyrazin-3-one Chemical compound O=C1CNC=CN1 RWMBKMMQEMUWEO-UHFFFAOYSA-N 0.000 description 1
- DIBAKBGYJUCGDL-UHFFFAOYSA-N 2,6-diamino-n-[1-[(2-amino-2-oxoethyl)amino]-3-(1h-imidazol-5-yl)-1-oxopropan-2-yl]hexanamide Chemical compound NCCCCC(N)C(=O)NC(C(=O)NCC(N)=O)CC1=CN=CN1 DIBAKBGYJUCGDL-UHFFFAOYSA-N 0.000 description 1
- HIXDQWDOVZUNNA-UHFFFAOYSA-N 2-(3,4-dimethoxyphenyl)-5-hydroxy-7-methoxychromen-4-one Chemical compound C=1C(OC)=CC(O)=C(C(C=2)=O)C=1OC=2C1=CC=C(OC)C(OC)=C1 HIXDQWDOVZUNNA-UHFFFAOYSA-N 0.000 description 1
- ODULREKDLNYKAC-UHFFFAOYSA-N 2-(4-fluorobenzoyl)-1h-isoquinoline-1-carbonitrile Chemical compound C1=CC(F)=CC=C1C(=O)N1C(C#N)C2=CC=CC=C2C=C1 ODULREKDLNYKAC-UHFFFAOYSA-N 0.000 description 1
- FALRKNHUBBKYCC-UHFFFAOYSA-N 2-(chloromethyl)pyridine-3-carbonitrile Chemical compound ClCC1=NC=CC=C1C#N FALRKNHUBBKYCC-UHFFFAOYSA-N 0.000 description 1
- ZFFBIQMNKOJDJE-UHFFFAOYSA-N 2-bromo-1,2-diphenylethanone Chemical compound C=1C=CC=CC=1C(Br)C(=O)C1=CC=CC=C1 ZFFBIQMNKOJDJE-UHFFFAOYSA-N 0.000 description 1
- 125000004974 2-butenyl group Chemical group C(C=CC)* 0.000 description 1
- 125000003541 2-chlorobenzoyl group Chemical group ClC1=C(C(=O)*)C=CC=C1 0.000 description 1
- 125000002941 2-furyl group Chemical group O1C([*])=C([H])C([H])=C1[H] 0.000 description 1
- RUJHATQMIMUYKD-UHFFFAOYSA-N 2-naphthalen-1-ylethanamine Chemical compound C1=CC=C2C(CCN)=CC=CC2=C1 RUJHATQMIMUYKD-UHFFFAOYSA-N 0.000 description 1
- BWWHTIHDQBHTHP-UHFFFAOYSA-N 2-nitrobenzoyl chloride Chemical compound [O-][N+](=O)C1=CC=CC=C1C(Cl)=O BWWHTIHDQBHTHP-UHFFFAOYSA-N 0.000 description 1
- 125000003890 2-phenylbutyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])(C([H])([H])*)C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000000094 2-phenylethyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000001494 2-propynyl group Chemical group [H]C#CC([H])([H])* 0.000 description 1
- 125000004105 2-pyridyl group Chemical group N1=C([*])C([H])=C([H])C([H])=C1[H] 0.000 description 1
- 125000000175 2-thienyl group Chemical group S1C([*])=C([H])C([H])=C1[H] 0.000 description 1
- YNJSNEKCXVFDKW-UHFFFAOYSA-N 3-(5-amino-1h-indol-3-yl)-2-azaniumylpropanoate Chemical compound C1=C(N)C=C2C(CC(N)C(O)=O)=CNC2=C1 YNJSNEKCXVFDKW-UHFFFAOYSA-N 0.000 description 1
- LTHOSILCKUBBIS-UHFFFAOYSA-N 3-(trifluoromethyl)benzoyl fluoride Chemical compound FC(=O)C1=CC=CC(C(F)(F)F)=C1 LTHOSILCKUBBIS-UHFFFAOYSA-N 0.000 description 1
- 125000004975 3-butenyl group Chemical group C(CC=C)* 0.000 description 1
- 125000004179 3-chlorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C(Cl)=C1[H] 0.000 description 1
- NMNZZIMBGSGRPN-UHFFFAOYSA-N 3-oxabicyclo[3.2.0]heptane-2,4-dione Chemical compound O=C1OC(=O)C2CCC12 NMNZZIMBGSGRPN-UHFFFAOYSA-N 0.000 description 1
- XMIIGOLPHOKFCH-UHFFFAOYSA-N 3-phenylpropionic acid Chemical compound OC(=O)CCC1=CC=CC=C1 XMIIGOLPHOKFCH-UHFFFAOYSA-N 0.000 description 1
- NMSRALOLNIBERV-UHFFFAOYSA-N 4,5,6,6a-tetrahydro-3ah-cyclopenta[c]furan-1,3-dione Chemical compound C1CCC2C(=O)OC(=O)C21 NMSRALOLNIBERV-UHFFFAOYSA-N 0.000 description 1
- SDVIYPBSYKHGTP-UHFFFAOYSA-N 4,5,6,7,8,8a-hexahydro-3ah-cyclohepta[c]furan-1,3-dione Chemical compound C1CCCCC2C(=O)OC(=O)C21 SDVIYPBSYKHGTP-UHFFFAOYSA-N 0.000 description 1
- YEJRWHAVMIAJKC-UHFFFAOYSA-N 4-Butyrolactone Chemical compound O=C1CCCO1 YEJRWHAVMIAJKC-UHFFFAOYSA-N 0.000 description 1
- WIPRZHGCPZSPLJ-UHFFFAOYSA-N 4-aminotetrahydro-2H-thiopyran-4-carboxylic acid Chemical compound OC(=O)C1(N)CCSCC1 WIPRZHGCPZSPLJ-UHFFFAOYSA-N 0.000 description 1
- 125000002672 4-bromobenzoyl group Chemical group BrC1=CC=C(C(=O)*)C=C1 0.000 description 1
- JYVXNLLUYHCIIH-UHFFFAOYSA-N 4-hydroxy-4-methyl-2-oxanone Chemical compound CC1(O)CCOC(=O)C1 JYVXNLLUYHCIIH-UHFFFAOYSA-N 0.000 description 1
- YQYGPGKTNQNXMH-UHFFFAOYSA-N 4-nitroacetophenone Chemical group CC(=O)C1=CC=C([N+]([O-])=O)C=C1 YQYGPGKTNQNXMH-UHFFFAOYSA-N 0.000 description 1
- YYROPELSRYBVMQ-UHFFFAOYSA-N 4-toluenesulfonyl chloride Chemical compound CC1=CC=C(S(Cl)(=O)=O)C=C1 YYROPELSRYBVMQ-UHFFFAOYSA-N 0.000 description 1
- OZJPLYNZGCXSJM-UHFFFAOYSA-N 5-valerolactone Chemical compound O=C1CCCCO1 OZJPLYNZGCXSJM-UHFFFAOYSA-N 0.000 description 1
- MOESUCUIWOMFQA-UHFFFAOYSA-N 6-(2-carboxyphenyl)-2,3-dinitrobenzoic acid Chemical compound OC(=O)C1=CC=CC=C1C1=CC=C([N+]([O-])=O)C([N+]([O-])=O)=C1C(O)=O MOESUCUIWOMFQA-UHFFFAOYSA-N 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 241000272517 Anseriformes Species 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- KZOCXOJWWVVJFX-UHFFFAOYSA-N C=1NCC(N2C=1C1=CC=CC=C1CC2)=O Chemical compound C=1NCC(N2C=1C1=CC=CC=C1CC2)=O KZOCXOJWWVVJFX-UHFFFAOYSA-N 0.000 description 1
- GAWIXWVDTYZWAW-UHFFFAOYSA-N C[CH]O Chemical group C[CH]O GAWIXWVDTYZWAW-UHFFFAOYSA-N 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- LSPHULWDVZXLIL-UHFFFAOYSA-N Camphoric acid Natural products CC1(C)C(C(O)=O)CCC1(C)C(O)=O LSPHULWDVZXLIL-UHFFFAOYSA-N 0.000 description 1
- 241000282421 Canidae Species 0.000 description 1
- 241000282988 Capreolus Species 0.000 description 1
- 239000004215 Carbon black (E152) Substances 0.000 description 1
- 241000282693 Cercopithecidae Species 0.000 description 1
- 235000001258 Cinchona calisaya Nutrition 0.000 description 1
- AAWZDTNXLSGCEK-UHFFFAOYSA-N Cordycepinsaeure Natural products OC1CC(O)(C(O)=O)CC(O)C1O AAWZDTNXLSGCEK-UHFFFAOYSA-N 0.000 description 1
- 229920002261 Corn starch Polymers 0.000 description 1
- 241000938605 Crocodylia Species 0.000 description 1
- PMPVIKIVABFJJI-UHFFFAOYSA-N Cyclobutane Chemical compound C1CCC1 PMPVIKIVABFJJI-UHFFFAOYSA-N 0.000 description 1
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 description 1
- 239000004805 Cyclohexane-1,2-dicarboxylic acid Substances 0.000 description 1
- RGHNJXZEOKUKBD-UHFFFAOYSA-N D-gluconic acid Natural products OCC(O)C(O)C(O)C(O)C(O)=O RGHNJXZEOKUKBD-UHFFFAOYSA-N 0.000 description 1
- UYUXSRADSPPKRZ-SKNVOMKLSA-N D-glucurono-6,3-lactone Chemical compound O=C[C@H](O)[C@H]1OC(=O)[C@@H](O)[C@H]1O UYUXSRADSPPKRZ-SKNVOMKLSA-N 0.000 description 1
- 125000002682 D-glucuronoyl group Chemical group O=C[C@H](O)[C@@H](O)[C@H](O)[C@H](O)C(=O)* 0.000 description 1
- 108010074327 DECYL-2 Proteins 0.000 description 1
- 241000577452 Dicrocoelium Species 0.000 description 1
- QOSSAOTZNIDXMA-UHFFFAOYSA-N Dicylcohexylcarbodiimide Chemical compound C1CCCCC1N=C=NC1CCCCC1 QOSSAOTZNIDXMA-UHFFFAOYSA-N 0.000 description 1
- ZAFNJMIOTHYJRJ-UHFFFAOYSA-N Diisopropyl ether Chemical compound CC(C)OC(C)C ZAFNJMIOTHYJRJ-UHFFFAOYSA-N 0.000 description 1
- QXNVGIXVLWOKEQ-UHFFFAOYSA-N Disodium Chemical class [Na][Na] QXNVGIXVLWOKEQ-UHFFFAOYSA-N 0.000 description 1
- 241001126301 Echinostoma Species 0.000 description 1
- 241000283086 Equidae Species 0.000 description 1
- KRHYYFGTRYWZRS-UHFFFAOYSA-M Fluoride anion Chemical compound [F-] KRHYYFGTRYWZRS-UHFFFAOYSA-M 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- 241000238631 Hexapoda Species 0.000 description 1
- 241001672169 Hymenolepis microstoma Species 0.000 description 1
- 241001464384 Hymenolepis nana Species 0.000 description 1
- 239000005909 Kieselgur Substances 0.000 description 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 1
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 1
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 1
- 229910000003 Lead carbonate Inorganic materials 0.000 description 1
- 239000002841 Lewis acid Substances 0.000 description 1
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 241000244206 Nematoda Species 0.000 description 1
- 208000012902 Nervous system disease Diseases 0.000 description 1
- 208000025966 Neurological disease Diseases 0.000 description 1
- RDXLYGJSWZYTFJ-UHFFFAOYSA-N Niridazole Chemical compound S1C([N+](=O)[O-])=CN=C1N1C(=O)NCC1 RDXLYGJSWZYTFJ-UHFFFAOYSA-N 0.000 description 1
- IOVCWXUNBOPUCH-UHFFFAOYSA-N Nitrous acid Chemical compound ON=O IOVCWXUNBOPUCH-UHFFFAOYSA-N 0.000 description 1
- 241001480233 Paragonimus Species 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- AAWZDTNXLSGCEK-ZHQZDSKASA-N Quinic acid Natural products O[C@H]1CC(O)(C(O)=O)C[C@H](O)C1O AAWZDTNXLSGCEK-ZHQZDSKASA-N 0.000 description 1
- IWYDHOAUDWTVEP-UHFFFAOYSA-N R-2-phenyl-2-hydroxyacetic acid Natural products OC(=O)C(O)C1=CC=CC=C1 IWYDHOAUDWTVEP-UHFFFAOYSA-N 0.000 description 1
- 239000007868 Raney catalyst Substances 0.000 description 1
- NPXOKRUENSOPAO-UHFFFAOYSA-N Raney nickel Chemical compound [Al].[Ni] NPXOKRUENSOPAO-UHFFFAOYSA-N 0.000 description 1
- 229910000564 Raney nickel Inorganic materials 0.000 description 1
- 241001481789 Rupicapra Species 0.000 description 1
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 1
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 241000282887 Suidae Species 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- 241000244159 Taenia saginata Species 0.000 description 1
- 241000244157 Taenia solium Species 0.000 description 1
- ATJFFYVFTNAWJD-UHFFFAOYSA-N Tin Chemical compound [Sn] ATJFFYVFTNAWJD-UHFFFAOYSA-N 0.000 description 1
- 239000007983 Tris buffer Substances 0.000 description 1
- 241000209140 Triticum Species 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 1
- 238000005644 Wolff-Kishner reduction reaction Methods 0.000 description 1
- MZVQCMJNVPIDEA-UHFFFAOYSA-N [CH2]CN(CC)CC Chemical group [CH2]CN(CC)CC MZVQCMJNVPIDEA-UHFFFAOYSA-N 0.000 description 1
- LSQYQPRAKANFLS-UHFFFAOYSA-N [[amino-methoxy-(methylamino)methyl]-fluoroamino]methanol Chemical compound CNC(N)(OC)N(F)CO LSQYQPRAKANFLS-UHFFFAOYSA-N 0.000 description 1
- 210000000683 abdominal cavity Anatomy 0.000 description 1
- 125000000738 acetamido group Chemical group [H]C([H])([H])C(=O)N([H])[*] 0.000 description 1
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 1
- PNZVFASWDSMJER-UHFFFAOYSA-N acetic acid;lead Chemical compound [Pb].CC(O)=O PNZVFASWDSMJER-UHFFFAOYSA-N 0.000 description 1
- 230000021736 acetylation Effects 0.000 description 1
- 238000006640 acetylation reaction Methods 0.000 description 1
- 125000003668 acetyloxy group Chemical group [H]C([H])([H])C(=O)O[*] 0.000 description 1
- 239000003377 acid catalyst Substances 0.000 description 1
- 230000010933 acylation Effects 0.000 description 1
- 125000005073 adamantyl group Chemical group C12(CC3CC(CC(C1)C3)C2)* 0.000 description 1
- 235000004279 alanine Nutrition 0.000 description 1
- 125000003158 alcohol group Chemical group 0.000 description 1
- 230000001476 alcoholic effect Effects 0.000 description 1
- 150000001299 aldehydes Chemical class 0.000 description 1
- 125000001931 aliphatic group Chemical group 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 125000006323 alkenyl amino group Chemical group 0.000 description 1
- 125000005907 alkyl ester group Chemical group 0.000 description 1
- 150000001350 alkyl halides Chemical class 0.000 description 1
- HFEHLDPGIKPNKL-UHFFFAOYSA-N allyl iodide Chemical compound ICC=C HFEHLDPGIKPNKL-UHFFFAOYSA-N 0.000 description 1
- 125000002714 alpha-linolenoyl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])/C([H])=C([H])\C([H])([H])/C([H])=C([H])\C([H])([H])/C([H])=C([H])\C([H])([H])C([H])([H])[H] 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 125000004103 aminoalkyl group Chemical group 0.000 description 1
- 125000004202 aminomethyl group Chemical group [H]N([H])C([H])([H])* 0.000 description 1
- 239000003708 ampul Substances 0.000 description 1
- JFCQEDHGNNZCLN-UHFFFAOYSA-N anhydrous glutaric acid Natural products OC(=O)CCCC(O)=O JFCQEDHGNNZCLN-UHFFFAOYSA-N 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 239000003096 antiparasitic agent Substances 0.000 description 1
- 229940125687 antiparasitic agent Drugs 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 125000006615 aromatic heterocyclic group Chemical group 0.000 description 1
- 150000004945 aromatic hydrocarbons Chemical class 0.000 description 1
- 125000005142 aryl oxy sulfonyl group Chemical group 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 239000012298 atmosphere Substances 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 229910052788 barium Inorganic materials 0.000 description 1
- DSAJWYNOEDNPEQ-UHFFFAOYSA-N barium atom Chemical compound [Ba] DSAJWYNOEDNPEQ-UHFFFAOYSA-N 0.000 description 1
- 150000007514 bases Chemical class 0.000 description 1
- 150000001555 benzenes Chemical class 0.000 description 1
- 125000005605 benzo group Chemical group 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- 125000001164 benzothiazolyl group Chemical group S1C(=NC2=C1C=CC=C2)* 0.000 description 1
- YRZQHWHYGDTYOP-UHFFFAOYSA-N benzyl n-(4-carbonochloridoylphenyl)carbamate Chemical compound C1=CC(C(=O)Cl)=CC=C1NC(=O)OCC1=CC=CC=C1 YRZQHWHYGDTYOP-UHFFFAOYSA-N 0.000 description 1
- 125000000649 benzylidene group Chemical group [H]C(=[*])C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 description 1
- 125000002619 bicyclic group Chemical group 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 108010026970 bursopoietin Proteins 0.000 description 1
- 125000004063 butyryl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 235000010216 calcium carbonate Nutrition 0.000 description 1
- 239000001506 calcium phosphate Substances 0.000 description 1
- 229910000389 calcium phosphate Inorganic materials 0.000 description 1
- 235000011010 calcium phosphates Nutrition 0.000 description 1
- LSPHULWDVZXLIL-QUBYGPBYSA-N camphoric acid Chemical compound CC1(C)[C@H](C(O)=O)CC[C@]1(C)C(O)=O LSPHULWDVZXLIL-QUBYGPBYSA-N 0.000 description 1
- 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 description 1
- 125000000609 carbazolyl group Chemical group C1(=CC=CC=2C3=CC=CC=C3NC12)* 0.000 description 1
- IYRWEQXVUNLMAY-UHFFFAOYSA-N carbonyl fluoride Chemical compound FC(F)=O IYRWEQXVUNLMAY-UHFFFAOYSA-N 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 125000002057 carboxymethyl group Chemical group [H]OC(=O)C([H])([H])[*] 0.000 description 1
- 238000009903 catalytic hydrogenation reaction Methods 0.000 description 1
- 238000010531 catalytic reduction reaction Methods 0.000 description 1
- SERARPRVBWDEBA-GXDHUFHOSA-N chembl1994738 Chemical compound OC1=CC=CC=C1\C=N\NC1=CC=CC=C1 SERARPRVBWDEBA-GXDHUFHOSA-N 0.000 description 1
- 239000003638 chemical reducing agent Substances 0.000 description 1
- 125000001309 chloro group Chemical group Cl* 0.000 description 1
- 150000008422 chlorobenzenes Chemical class 0.000 description 1
- HRYZWHHZPQKTII-UHFFFAOYSA-N chloroethane Chemical compound CCCl HRYZWHHZPQKTII-UHFFFAOYSA-N 0.000 description 1
- 239000002026 chloroform extract Substances 0.000 description 1
- MXOAEAUPQDYUQM-UHFFFAOYSA-N chlorphenesin Chemical group OCC(O)COC1=CC=C(Cl)C=C1 MXOAEAUPQDYUQM-UHFFFAOYSA-N 0.000 description 1
- 125000003016 chromanyl group Chemical group O1C(CCC2=CC=CC=C12)* 0.000 description 1
- 125000004230 chromenyl group Chemical group O1C(C=CC2=CC=CC=C12)* 0.000 description 1
- KRVSOGSZCMJSLX-UHFFFAOYSA-L chromic acid Substances O[Cr](O)(=O)=O KRVSOGSZCMJSLX-UHFFFAOYSA-L 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 229940125782 compound 2 Drugs 0.000 description 1
- 235000008504 concentrate Nutrition 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 210000002808 connective tissue Anatomy 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- JGDFBJMWFLXCLJ-UHFFFAOYSA-N copper chromite Chemical compound [Cu]=O.[Cu]=O.O=[Cr]O[Cr]=O JGDFBJMWFLXCLJ-UHFFFAOYSA-N 0.000 description 1
- DOBRDRYODQBAMW-UHFFFAOYSA-N copper(i) cyanide Chemical compound [Cu+].N#[C-] DOBRDRYODQBAMW-UHFFFAOYSA-N 0.000 description 1
- GBRBMTNGQBKBQE-UHFFFAOYSA-L copper;diiodide Chemical compound I[Cu]I GBRBMTNGQBKBQE-UHFFFAOYSA-L 0.000 description 1
- 239000008120 corn starch Substances 0.000 description 1
- SUSAGCZZQKACKE-UHFFFAOYSA-N cyclobutane-1,2-dicarboxylic acid Chemical compound OC(=O)C1CCC1C(O)=O SUSAGCZZQKACKE-UHFFFAOYSA-N 0.000 description 1
- 125000004850 cyclobutylmethyl group Chemical group C1(CCC1)C* 0.000 description 1
- 125000006640 cycloheptyl carbonyl group Chemical group 0.000 description 1
- QSAWQNUELGIYBC-UHFFFAOYSA-N cyclohexane-1,2-dicarboxylic acid Chemical compound OC(=O)C1CCCCC1C(O)=O QSAWQNUELGIYBC-UHFFFAOYSA-N 0.000 description 1
- HPXRVTGHNJAIIH-UHFFFAOYSA-N cyclohexanol Chemical compound OC1CCCCC1 HPXRVTGHNJAIIH-UHFFFAOYSA-N 0.000 description 1
- UKJLNMAFNRKWGR-UHFFFAOYSA-N cyclohexatrienamine Chemical group NC1=CC=C=C[CH]1 UKJLNMAFNRKWGR-UHFFFAOYSA-N 0.000 description 1
- PAFZNILMFXTMIY-UHFFFAOYSA-O cyclohexylammonium Chemical compound [NH3+]C1CCCCC1 PAFZNILMFXTMIY-UHFFFAOYSA-O 0.000 description 1
- 125000004210 cyclohexylmethyl group Chemical group [H]C([H])(*)C1([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C1([H])[H] 0.000 description 1
- 125000006547 cyclononyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C([H])([H])C1([H])[H] 0.000 description 1
- WJTCGQSWYFHTAC-UHFFFAOYSA-N cyclooctane Chemical compound C1CCCCCCC1 WJTCGQSWYFHTAC-UHFFFAOYSA-N 0.000 description 1
- 239000004914 cyclooctane Substances 0.000 description 1
- 125000000640 cyclooctyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C([H])([H])C1([H])[H] 0.000 description 1
- ASJCSAKCMTWGAH-UHFFFAOYSA-N cyclopentane-1,2-dicarboxylic acid Chemical compound OC(=O)C1CCCC1C(O)=O ASJCSAKCMTWGAH-UHFFFAOYSA-N 0.000 description 1
- 125000004851 cyclopentylmethyl group Chemical group C1(CCCC1)C* 0.000 description 1
- 125000005507 decahydroisoquinolyl group Chemical group 0.000 description 1
- 125000004855 decalinyl group Chemical group C1(CCCC2CCCCC12)* 0.000 description 1
- 238000007791 dehumidification Methods 0.000 description 1
- 238000006356 dehydrogenation reaction Methods 0.000 description 1
- 150000008050 dialkyl sulfates Chemical class 0.000 description 1
- 210000000188 diaphragm Anatomy 0.000 description 1
- 125000000664 diazo group Chemical group [N-]=[N+]=[*] 0.000 description 1
- 229960003887 dichlorophen Drugs 0.000 description 1
- XBPCUCUWBYBCDP-UHFFFAOYSA-O dicyclohexylazanium Chemical compound C1CCCCC1[NH2+]C1CCCCC1 XBPCUCUWBYBCDP-UHFFFAOYSA-O 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 235000013681 dietary sucrose Nutrition 0.000 description 1
- DENRZWYUOJLTMF-UHFFFAOYSA-N diethyl sulfate Chemical compound CCOS(=O)(=O)OCC DENRZWYUOJLTMF-UHFFFAOYSA-N 0.000 description 1
- 229940008406 diethyl sulfate Drugs 0.000 description 1
- 125000006264 diethylaminomethyl group Chemical group [H]C([H])([H])C([H])([H])N(C([H])([H])*)C([H])([H])C([H])([H])[H] 0.000 description 1
- HPNMFZURTQLUMO-UHFFFAOYSA-O diethylammonium Chemical compound CC[NH2+]CC HPNMFZURTQLUMO-UHFFFAOYSA-O 0.000 description 1
- 150000004683 dihydrates Chemical class 0.000 description 1
- 125000004852 dihydrofuranyl group Chemical group O1C(CC=C1)* 0.000 description 1
- 125000005043 dihydropyranyl group Chemical group O1C(CCC=C1)* 0.000 description 1
- 125000004655 dihydropyridinyl group Chemical group N1(CC=CC=C1)* 0.000 description 1
- 125000004925 dihydropyridyl group Chemical group N1(CC=CC=C1)* 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 125000000118 dimethyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 125000006222 dimethylaminomethyl group Chemical group [H]C([H])([H])N(C([H])([H])[H])C([H])([H])* 0.000 description 1
- 229910001873 dinitrogen Inorganic materials 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 125000004185 ester group Chemical group 0.000 description 1
- AFAXGSQYZLGZPG-UHFFFAOYSA-N ethanedisulfonic acid Chemical compound OS(=O)(=O)CCS(O)(=O)=O AFAXGSQYZLGZPG-UHFFFAOYSA-N 0.000 description 1
- CCGKOQOJPYTBIH-UHFFFAOYSA-N ethenone Chemical compound C=C=O CCGKOQOJPYTBIH-UHFFFAOYSA-N 0.000 description 1
- CHDFNIZLAAFFPX-UHFFFAOYSA-N ethoxyethane;oxolane Chemical compound CCOCC.C1CCOC1 CHDFNIZLAAFFPX-UHFFFAOYSA-N 0.000 description 1
- 125000006534 ethyl amino methyl group Chemical group [H]N(C([H])([H])*)C([H])([H])C([H])([H])[H] 0.000 description 1
- 229960003750 ethyl chloride Drugs 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 125000004216 fluoromethyl group Chemical group [H]C([H])(F)* 0.000 description 1
- 235000003599 food sweetener Nutrition 0.000 description 1
- ZPKRCUUONTUALE-UHFFFAOYSA-N formyl 4-fluorobenzoate Chemical compound FC1=CC=C(C(=O)OC=O)C=C1 ZPKRCUUONTUALE-UHFFFAOYSA-N 0.000 description 1
- 239000001530 fumaric acid Substances 0.000 description 1
- AWJWCTOOIBYHON-UHFFFAOYSA-N furo[3,4-b]pyrazine-5,7-dione Chemical compound C1=CN=C2C(=O)OC(=O)C2=N1 AWJWCTOOIBYHON-UHFFFAOYSA-N 0.000 description 1
- 125000002541 furyl group Chemical group 0.000 description 1
- 230000004927 fusion Effects 0.000 description 1
- GAEKPEKOJKCEMS-UHFFFAOYSA-N gamma-valerolactone Chemical compound CC1CCC(=O)O1 GAEKPEKOJKCEMS-UHFFFAOYSA-N 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 239000007903 gelatin capsule Substances 0.000 description 1
- 239000012362 glacial acetic acid Substances 0.000 description 1
- 229940050410 gluconate Drugs 0.000 description 1
- 239000000174 gluconic acid Substances 0.000 description 1
- 235000012208 gluconic acid Nutrition 0.000 description 1
- QFWPJPIVLCBXFJ-UHFFFAOYSA-N glymidine Chemical compound N1=CC(OCCOC)=CN=C1NS(=O)(=O)C1=CC=CC=C1 QFWPJPIVLCBXFJ-UHFFFAOYSA-N 0.000 description 1
- 125000001188 haloalkyl group Chemical group 0.000 description 1
- 230000002140 halogenating effect Effects 0.000 description 1
- 210000002216 heart Anatomy 0.000 description 1
- 125000000268 heptanoyl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000003187 heptyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 230000003301 hydrolyzing effect Effects 0.000 description 1
- GLUUGHFHXGJENI-UHFFFAOYSA-O hydron piperazine Chemical compound [H+].C1CNCCN1 GLUUGHFHXGJENI-UHFFFAOYSA-O 0.000 description 1
- RWSOTUBLDIXVET-UHFFFAOYSA-M hydrosulfide Chemical compound [SH-] RWSOTUBLDIXVET-UHFFFAOYSA-M 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-M hydroxide Chemical compound [OH-] XLYOFNOQVPJJNP-UHFFFAOYSA-M 0.000 description 1
- 125000004356 hydroxy functional group Chemical group O* 0.000 description 1
- 125000002768 hydroxyalkyl group Chemical group 0.000 description 1
- 125000004029 hydroxymethyl group Chemical group [H]OC([H])([H])* 0.000 description 1
- 125000002632 imidazolidinyl group Chemical group 0.000 description 1
- 125000002883 imidazolyl group Chemical group 0.000 description 1
- 150000007529 inorganic bases Chemical class 0.000 description 1
- 229910001959 inorganic nitrate Inorganic materials 0.000 description 1
- 150000004694 iodide salts Chemical class 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 125000002510 isobutoxy group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])O* 0.000 description 1
- 125000005929 isobutyloxycarbonyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])OC(*)=O 0.000 description 1
- 125000004491 isohexyl group Chemical group C(CCC(C)C)* 0.000 description 1
- 229960000310 isoleucine Drugs 0.000 description 1
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 1
- 125000001972 isopentyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000005928 isopropyloxycarbonyl group Chemical group [H]C([H])([H])C([H])(OC(*)=O)C([H])([H])[H] 0.000 description 1
- 125000005956 isoquinolyl group Chemical group 0.000 description 1
- 125000004628 isothiazolidinyl group Chemical group S1N(CCC1)* 0.000 description 1
- 125000005969 isothiazolinyl group Chemical group 0.000 description 1
- QHDRKFYEGYYIIK-UHFFFAOYSA-N isovaleronitrile Chemical compound CC(C)CC#N QHDRKFYEGYYIIK-UHFFFAOYSA-N 0.000 description 1
- 125000003965 isoxazolidinyl group Chemical group 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 239000004922 lacquer Substances 0.000 description 1
- 230000001418 larval effect Effects 0.000 description 1
- 125000000400 lauroyl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 150000007517 lewis acids Chemical class 0.000 description 1
- 239000006193 liquid solution Substances 0.000 description 1
- 229910052744 lithium Inorganic materials 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 210000001365 lymphatic vessel Anatomy 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 239000000395 magnesium oxide Substances 0.000 description 1
- CPLXHLVBOLITMK-UHFFFAOYSA-N magnesium oxide Inorganic materials [Mg]=O CPLXHLVBOLITMK-UHFFFAOYSA-N 0.000 description 1
- AXZKOIWUVFPNLO-UHFFFAOYSA-N magnesium;oxygen(2-) Chemical compound [O-2].[Mg+2] AXZKOIWUVFPNLO-UHFFFAOYSA-N 0.000 description 1
- FPYJFEHAWHCUMM-UHFFFAOYSA-N maleic anhydride Chemical compound O=C1OC(=O)C=C1 FPYJFEHAWHCUMM-UHFFFAOYSA-N 0.000 description 1
- 229960002510 mandelic acid Drugs 0.000 description 1
- 229960000901 mepacrine Drugs 0.000 description 1
- 150000004681 metal hydrides Chemical class 0.000 description 1
- 229940098779 methanesulfonic acid Drugs 0.000 description 1
- WSFSSNUMVMOOMR-NJFSPNSNSA-N methanone Chemical compound O=[14CH2] WSFSSNUMVMOOMR-NJFSPNSNSA-N 0.000 description 1
- NBTOZLQBSIZIKS-UHFFFAOYSA-N methoxide Chemical compound [O-]C NBTOZLQBSIZIKS-UHFFFAOYSA-N 0.000 description 1
- UZKWTJUDCOPSNM-UHFFFAOYSA-N methoxybenzene Substances CCCCOC=C UZKWTJUDCOPSNM-UHFFFAOYSA-N 0.000 description 1
- GSYSFVSGPABNNL-UHFFFAOYSA-N methyl 2-dimethoxyphosphoryl-2-(phenylmethoxycarbonylamino)acetate Chemical group COC(=O)C(P(=O)(OC)OC)NC(=O)OCC1=CC=CC=C1 GSYSFVSGPABNNL-UHFFFAOYSA-N 0.000 description 1
- 125000006533 methyl amino methyl group Chemical group [H]N(C([H])([H])[H])C([H])([H])* 0.000 description 1
- 229940050176 methyl chloride Drugs 0.000 description 1
- 125000001570 methylene group Chemical group [H]C([H])([*:1])[*:2] 0.000 description 1
- 238000003801 milling Methods 0.000 description 1
- 239000003607 modifier Substances 0.000 description 1
- 150000004682 monohydrates Chemical class 0.000 description 1
- 229960005181 morphine Drugs 0.000 description 1
- 125000002757 morpholinyl group Chemical group 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- LNOPIUAQISRISI-UHFFFAOYSA-N n'-hydroxy-2-propan-2-ylsulfonylethanimidamide Chemical compound CC(C)S(=O)(=O)CC(N)=NO LNOPIUAQISRISI-UHFFFAOYSA-N 0.000 description 1
- 125000003136 n-heptyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000001280 n-hexyl group Chemical group C(CCCCC)* 0.000 description 1
- 125000000740 n-pentyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000001624 naphthyl group Chemical group 0.000 description 1
- 229920005615 natural polymer Polymers 0.000 description 1
- XIKYYQJBTPYKSG-UHFFFAOYSA-N nickel Chemical compound [Ni].[Ni] XIKYYQJBTPYKSG-UHFFFAOYSA-N 0.000 description 1
- RJMUSRYZPJIFPJ-UHFFFAOYSA-N niclosamide Chemical compound OC1=CC=C(Cl)C=C1C(=O)NC1=CC=C([N+]([O-])=O)C=C1Cl RJMUSRYZPJIFPJ-UHFFFAOYSA-N 0.000 description 1
- 229960005130 niridazole Drugs 0.000 description 1
- 150000002823 nitrates Chemical class 0.000 description 1
- 230000000802 nitrating effect Effects 0.000 description 1
- VXAPDXVBDZRZKP-UHFFFAOYSA-N nitric acid phosphoric acid Chemical compound O[N+]([O-])=O.OP(O)(O)=O VXAPDXVBDZRZKP-UHFFFAOYSA-N 0.000 description 1
- 150000002828 nitro derivatives Chemical class 0.000 description 1
- LQNUZADURLCDLV-UHFFFAOYSA-N nitrobenzene Chemical group [O-][N+](=O)C1=CC=CC=C1 LQNUZADURLCDLV-UHFFFAOYSA-N 0.000 description 1
- XKLJHFLUAHKGGU-UHFFFAOYSA-N nitrous amide Chemical compound ON=N XKLJHFLUAHKGGU-UHFFFAOYSA-N 0.000 description 1
- 125000001402 nonanoyl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 125000000962 organic group Chemical group 0.000 description 1
- 239000012074 organic phase Substances 0.000 description 1
- 229910000489 osmium tetroxide Inorganic materials 0.000 description 1
- 235000006408 oxalic acid Nutrition 0.000 description 1
- 125000000160 oxazolidinyl group Chemical group 0.000 description 1
- 125000005968 oxazolinyl group Chemical group 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 150000002923 oximes Chemical class 0.000 description 1
- BHIIWXJHALLFBD-UHFFFAOYSA-N oxolane;propan-2-ol Chemical compound CC(C)O.C1CCOC1 BHIIWXJHALLFBD-UHFFFAOYSA-N 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 125000001312 palmitoyl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- 125000003538 pentan-3-yl group Chemical group [H]C([H])([H])C([H])([H])C([H])(*)C([H])([H])C([H])([H])[H] 0.000 description 1
- ZDDUXABBRATYFS-UHFFFAOYSA-F pentasodium;antimony(3+);4,5-dioxidobenzene-1,3-disulfonate;heptahydrate Chemical compound O.O.O.O.O.O.O.[Na+].[Na+].[Na+].[Na+].[Na+].C1=C(S([O-])(=O)=O)C=C(S([O-])(=O)=O)C([O-])=C1O[Sb]1OC2=C(S([O-])(=O)=O)C=C(S([O-])(=O)=O)C=C2O1 ZDDUXABBRATYFS-UHFFFAOYSA-F 0.000 description 1
- 125000001147 pentyl group Chemical group C(CCCC)* 0.000 description 1
- 238000010647 peptide synthesis reaction Methods 0.000 description 1
- 210000004303 peritoneum Anatomy 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- 125000000951 phenoxy group Chemical group [H]C1=C([H])C([H])=C(O*)C([H])=C1[H] 0.000 description 1
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 1
- NHKJPPKXDNZFBJ-UHFFFAOYSA-N phenyllithium Chemical compound [Li]C1=CC=CC=C1 NHKJPPKXDNZFBJ-UHFFFAOYSA-N 0.000 description 1
- UHZYTMXLRWXGPK-UHFFFAOYSA-N phosphorus pentachloride Chemical compound ClP(Cl)(Cl)(Cl)Cl UHZYTMXLRWXGPK-UHFFFAOYSA-N 0.000 description 1
- 230000000243 photosynthetic effect Effects 0.000 description 1
- 125000000612 phthaloyl group Chemical group C(C=1C(C(=O)*)=CC=CC1)(=O)* 0.000 description 1
- 150000004885 piperazines Chemical class 0.000 description 1
- 125000004193 piperazinyl group Chemical group 0.000 description 1
- IUGYQRQAERSCNH-UHFFFAOYSA-N pivalic acid Chemical compound CC(C)(C)C(O)=O IUGYQRQAERSCNH-UHFFFAOYSA-N 0.000 description 1
- 210000004224 pleura Anatomy 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 229920006316 polyvinylpyrrolidine Polymers 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- NTTOTNSKUYCDAV-UHFFFAOYSA-N potassium hydride Chemical compound [KH] NTTOTNSKUYCDAV-UHFFFAOYSA-N 0.000 description 1
- 229910000105 potassium hydride Inorganic materials 0.000 description 1
- BDAWXSQJJCIFIK-UHFFFAOYSA-N potassium methoxide Chemical compound [K+].[O-]C BDAWXSQJJCIFIK-UHFFFAOYSA-N 0.000 description 1
- 239000004323 potassium nitrate Substances 0.000 description 1
- 235000010333 potassium nitrate Nutrition 0.000 description 1
- 159000000001 potassium salts Chemical class 0.000 description 1
- LPNYRYFBWFDTMA-UHFFFAOYSA-N potassium tert-butoxide Chemical compound [K+].CC(C)(C)[O-] LPNYRYFBWFDTMA-UHFFFAOYSA-N 0.000 description 1
- 239000010970 precious metal Substances 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- XUWVIABDWDTJRZ-UHFFFAOYSA-N propan-2-ylazanide Chemical compound CC(C)[NH-] XUWVIABDWDTJRZ-UHFFFAOYSA-N 0.000 description 1
- 235000019260 propionic acid Nutrition 0.000 description 1
- 125000001501 propionyl group Chemical group O=C([*])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000008262 pumice Substances 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 125000003373 pyrazinyl group Chemical group 0.000 description 1
- 125000003072 pyrazolidinyl group Chemical group 0.000 description 1
- 125000002755 pyrazolinyl group Chemical group 0.000 description 1
- 125000003226 pyrazolyl group Chemical group 0.000 description 1
- 125000001725 pyrenyl group Chemical group 0.000 description 1
- 125000004076 pyridyl group Chemical group 0.000 description 1
- 125000000714 pyrimidinyl group Chemical group 0.000 description 1
- 125000000719 pyrrolidinyl group Chemical group 0.000 description 1
- 125000001422 pyrrolinyl group Chemical group 0.000 description 1
- UNYNVICDCJHOPO-UHFFFAOYSA-N quabalactone III Natural products CC1OC(=O)C(O)=C1C UNYNVICDCJHOPO-UHFFFAOYSA-N 0.000 description 1
- GPKJTRJOBQGKQK-UHFFFAOYSA-N quinacrine Chemical compound C1=C(OC)C=C2C(NC(C)CCCN(CC)CC)=C(C=CC(Cl)=C3)C3=NC2=C1 GPKJTRJOBQGKQK-UHFFFAOYSA-N 0.000 description 1
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 description 1
- 229960001404 quinidine Drugs 0.000 description 1
- 229960000948 quinine Drugs 0.000 description 1
- 150000003283 rhodium Chemical class 0.000 description 1
- 229910052703 rhodium Inorganic materials 0.000 description 1
- 239000010948 rhodium Substances 0.000 description 1
- MHOVAHRLVXNVSD-UHFFFAOYSA-N rhodium atom Chemical compound [Rh] MHOVAHRLVXNVSD-UHFFFAOYSA-N 0.000 description 1
- BDDWSAASCFBVBK-UHFFFAOYSA-N rhodium;triphenylphosphane Chemical compound [Rh].C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 BDDWSAASCFBVBK-UHFFFAOYSA-N 0.000 description 1
- LMHHRCOWPQNFTF-UHFFFAOYSA-N s-propan-2-yl azepane-1-carbothioate Chemical compound CC(C)SC(=O)N1CCCCCC1 LMHHRCOWPQNFTF-UHFFFAOYSA-N 0.000 description 1
- 238000007127 saponification reaction Methods 0.000 description 1
- 150000004671 saturated fatty acids Chemical class 0.000 description 1
- 235000003441 saturated fatty acids Nutrition 0.000 description 1
- 125000005930 sec-butyloxycarbonyl group Chemical group [H]C([H])([H])C([H])([H])C([H])(OC(*)=O)C([H])([H])[H] 0.000 description 1
- 238000009394 selective breeding Methods 0.000 description 1
- 238000010956 selective crystallization Methods 0.000 description 1
- 229910052711 selenium Inorganic materials 0.000 description 1
- 239000011669 selenium Substances 0.000 description 1
- 235000011803 sesame oil Nutrition 0.000 description 1
- 239000008159 sesame oil Substances 0.000 description 1
- RMAQACBXLXPBSY-UHFFFAOYSA-N silicic acid Chemical compound O[Si](O)(O)O RMAQACBXLXPBSY-UHFFFAOYSA-N 0.000 description 1
- 235000012239 silicon dioxide Nutrition 0.000 description 1
- 229910052709 silver Inorganic materials 0.000 description 1
- 239000004332 silver Substances 0.000 description 1
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 1
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- 235000011083 sodium citrates Nutrition 0.000 description 1
- 239000012312 sodium hydride Substances 0.000 description 1
- 239000004317 sodium nitrate Substances 0.000 description 1
- 235000010344 sodium nitrate Nutrition 0.000 description 1
- VWDWKYIASSYTQR-UHFFFAOYSA-N sodium nitrate Inorganic materials [Na+].[O-][N+]([O-])=O VWDWKYIASSYTQR-UHFFFAOYSA-N 0.000 description 1
- 235000010288 sodium nitrite Nutrition 0.000 description 1
- 238000003797 solvolysis reaction Methods 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 210000000278 spinal cord Anatomy 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 125000003696 stearoyl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- RINCXYDBBGOEEQ-UHFFFAOYSA-N succinic anhydride Chemical class O=C1CCC(=O)O1 RINCXYDBBGOEEQ-UHFFFAOYSA-N 0.000 description 1
- 229940014800 succinic anhydride Drugs 0.000 description 1
- 229960004793 sucrose Drugs 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- PXQLVRUNWNTZOS-UHFFFAOYSA-N sulfanyl Chemical class [SH] PXQLVRUNWNTZOS-UHFFFAOYSA-N 0.000 description 1
- HXJUTPCZVOIRIF-UHFFFAOYSA-N sulfolane Chemical compound O=S1(=O)CCCC1 HXJUTPCZVOIRIF-UHFFFAOYSA-N 0.000 description 1
- 125000001174 sulfone group Chemical group 0.000 description 1
- 150000003460 sulfonic acids Chemical class 0.000 description 1
- 150000003462 sulfoxides Chemical class 0.000 description 1
- QHMQWEPBXSHHLH-UHFFFAOYSA-N sulfur tetrafluoride Chemical compound FS(F)(F)F QHMQWEPBXSHHLH-UHFFFAOYSA-N 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 229920001059 synthetic polymer Polymers 0.000 description 1
- 229940066771 systemic antihistamines piperazine derivative Drugs 0.000 description 1
- 125000004213 tert-butoxy group Chemical group [H]C([H])([H])C(O*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 125000006318 tert-butyl amino group Chemical group [H]N(*)C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 125000005931 tert-butyloxycarbonyl group Chemical group [H]C([H])([H])C(OC(*)=O)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 125000001973 tert-pentyl group Chemical group [H]C([H])([H])C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 125000001302 tertiary amino group Chemical group 0.000 description 1
- 210000001550 testis Anatomy 0.000 description 1
- 125000003718 tetrahydrofuranyl group Chemical group 0.000 description 1
- 125000001412 tetrahydropyranyl group Chemical group 0.000 description 1
- 125000005958 tetrahydrothienyl group Chemical group 0.000 description 1
- 125000004632 tetrahydrothiopyranyl group Chemical group S1C(CCCC1)* 0.000 description 1
- 239000004308 thiabendazole Substances 0.000 description 1
- 235000010296 thiabendazole Nutrition 0.000 description 1
- 229960004546 thiabendazole Drugs 0.000 description 1
- 125000001984 thiazolidinyl group Chemical group 0.000 description 1
- 125000002769 thiazolinyl group Chemical group 0.000 description 1
- 125000001544 thienyl group Chemical group 0.000 description 1
- 239000004408 titanium dioxide Substances 0.000 description 1
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
- ZMANZCXQSJIPKH-UHFFFAOYSA-O triethylammonium ion Chemical compound CC[NH+](CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-O 0.000 description 1
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 description 1
- RKBCYCFRFCNLTO-UHFFFAOYSA-N triisopropylamine Chemical compound CC(C)N(C(C)C)C(C)C RKBCYCFRFCNLTO-UHFFFAOYSA-N 0.000 description 1
- GETQZCLCWQTVFV-UHFFFAOYSA-N trimethylamine Chemical compound CN(C)C GETQZCLCWQTVFV-UHFFFAOYSA-N 0.000 description 1
- 125000002221 trityl group Chemical group [H]C1=C([H])C([H])=C([H])C([H])=C1C([*])(C1=C(C(=C(C(=C1[H])[H])[H])[H])[H])C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 description 1
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 1
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 1
- JOYRKODLDBILNP-UHFFFAOYSA-N urethane group Chemical group NC(=O)OCC JOYRKODLDBILNP-UHFFFAOYSA-N 0.000 description 1
- 239000004474 valine Substances 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/36—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
내용 없음.No content.
Description
본 발명은 신규한 2-아실-4-옥소-헥사하이드로-4H-피라지노[2, 1-a]이소퀴놀린 유도체 및 그의 제조방법에 관한 것이다.The present invention relates to novel 2-acyl-4-oxo-hexahydro-4H-pyrazino [2, 1-a] isoquinoline derivatives and methods for their preparation.
본 발명의 신규한 이소퀴놀린 유도체는 다음 일반식(Ⅰ)화합물 및 생리학상 허용되는 그의 염과 4급 암모니움 염류이다.The novel isoquinoline derivatives of the present invention are the following general formula (I) compounds and their physiologically acceptable salts and quaternary ammonium salts.
상기식에서 COR는 26개까지의 탄소수를 가진 아실기로서 여기서 R가 페닐기일 때 이기는 치환되어 있다.COR is an acyl group having up to 26 carbon atoms, where R is substituted when R is a phenyl group.
아래 기술에서 편의상 사용되는 약자 "HPI"는 4-옥소-1, 2, 3, 6, 7, 11b-헥사하이드로-4H-피라지노 2, 1-a이소퀴놀린이고 "HPI"는-4-옥소-1, 2, 3, 6, 7, 11b-헥사하이드로-4H-피라지노[2, 1-a]이소퀴놀린을 나타냈다. 따라서 일반식(Ⅰ)화합물은 "2-아실-HPI"로 나타낼 수 있다.The abbreviation “HPI” used for convenience in the description below is 4-oxo-1, 2, 3, 6, 7, 11b-hexahydro-4H-pyrazino 2, 1-aisoquinoline and “HPI” is 4-oxo -1, 2, 3, 6, 7, 11b-hexahydro-4H-pyrazino [2, 1-a] isoquinoline was shown. Therefore, general formula (I) compound can be represented as "2-acyl-HPI."
우리는 일반식(Ⅰ)화합물이 우수한 적용성과 뛰어난 약리작용을 갖는다는 것을 알았다. 이 화합물은 그중에서도 구충제로서 유용하며, 특히 촌충과 디스토마에 광범위한 활성을 나타낸다 더욱이 본 신규물질중 어떤 것은 신경질환이나 혈압에 영향을 주는, 성질을 가지고 있다. 그러므로 일반식(Ⅰ)화합물은 인간이나 동물용 약품, 특히 구충제로서 사용될 수 있다. 또한 이 물질들은 다른 약제 제조를 위한 중간체로서 유용하다.We found that the general formula (I) compound had excellent applicability and excellent pharmacological action. This compound is particularly useful as an antiparasitic agent, and has a wide range of activities, especially for tapeworms and dystomies. Moreover, some of the new substances have properties that affect neurological diseases and blood pressure. Therefore, general formula (I) compounds can be used as human or animal medicines, especially insect repellents. These materials are also useful as intermediates for the manufacture of other pharmaceuticals.
일반식(Ⅰ)의 라세미 화합물 뿐 아니라 그의 광학적 대장체도 유용하며 특히 광학구조면에서 좌선성 HPI에 해당되는 것이 더욱 유용하다.Not only the racemic compound of formula (I) but also the optical colon thereof are useful, and in particular, it is more useful to correspond to the left-handed HPI in terms of optical structure.
일반식(Ⅰ)의 2-아실-HPI 중에서 인식(Ⅰ)화합물에 속하고 여기서 아실기(-CO-R)가 다음과 같은 다음 일반식(Ia)-(Ik)화합물 및 생리학상 허용되는 그의 염, 4급 암모늄염과 광학대장체가 더욱 바람직하다.Among the 2-acyl-HPIs of formula (I) belong to the recognition (I) compound, wherein the acyl group (-CO-R) is the following general formula (Ia)-(Ik) compound and physiologically acceptable More preferred are salts, quaternary ammonium salts, and optically substituted.
Ia : 0-위치에서 불소로 또는 m-나-p위치에서 불소, 염소, 니트로, 하이드록시, 아미노, 포르밀아미노, 아세틸아미노, 펜타노일아미노, 헥사노일아미노, 옥타노일아미노, 올레오일아미노, 메톡시-아세틸 아미노, 메틸아미노, 디메틸아미노 또는 알릴아미노로 한번 치환된 벤조일기Ia: fluorine at the 0-position or fluorine, chlorine, nitro, hydroxy, amino, formylamino, acetylamino, pentanoylamino, hexanoylamino, octanoylamino, oleoylamino, at the m- or -p position; Benzoyl group once substituted with methoxy-acetyl amino, methylamino, dimethylamino or allylamino
Ib : 싸이클로프로필, 싸이클로부틸, 싸이클로펜틸, 싸이클로헥실 또는 싸이클로헵틸카보닐기 (각각은 불소, 염소, 니트로, 하이드록시아미노, 포르밀아미노, 아세틸아미노, 펜타노일아미노, 헥사노일아미노, 옥타노일아미노, 올레오일아미노, 메톡시아세틸아미노, 메틸아미노, 디메틸아미노 또는 알릴아미노로 한번 더 치환될 수 있다.)Ib: cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl or cycloheptylcarbonyl groups (each is fluorine, chlorine, nitro, hydroxyamino, formylamino, acetylamino, pentanoylamino, hexanoylamino, octanoylamino, May be substituted once more with oleoylamino, methoxyacetylamino, methylamino, dimethylamino or allylamino.)
Ic : 메톡시나 에톡시로 더 치환될 수 있는 8개까지의 탄소수를 가진 알카노일기Ic is an alkanoyl group having up to 8 carbon atoms which may be further substituted with methoxy or ethoxy
Id : 푸릴-2-카보닐, 푸릴-3-카보닐, 티에닐-2-카보닐, 티에닐-3-카보닐 또는 2-티에닐메르캅토메틸카보닐Id: furyl-2-carbonyl, furyl-3-carbonyl, thienyl-2-carbonyl, thienyl-3-carbonyl or 2-thienyl mercaptomethylcarbonyl
Ie : 불소, 염소, 하이드록시, 아미노, 포르밀아미노, 아세틸아미노, 펜타노일아미노, 헥사노일아미노, 옥타노일아미노, 올레오일아미노, 메톡시아세틸아미노, 메틸아미노 또는 디메틸아미노로 한번 더 치환될수 있는 2-, 3-또는 4-피리딜카보닐이나 2-, 3- 또는 4-N-옥시도-피리딜-카보닐기Ie: can be substituted once more with fluorine, chlorine, hydroxy, amino, formylamino, acetylamino, pentanoylamino, hexanoylamino, octanoylamino, oleoylamino, methoxyacetylamino, methylamino or dimethylamino 2-, 3- or 4-pyridylcarbonyl or 2-, 3- or 4-N-oxido-pyridyl-carbonyl groups
If : 탄소수 4개까지를 갖는 아미노알카노일, 6-8개의 탄소수를 갖는 아미노싸이클로알킬 카보닐, 또는 질소원자에서 벤질리덴, 2-하이드록시벤질리덴, 2-하이드록시-3-메톡시-벤질리덴, 카복시메틸리덴, 3-페닐-프로프-2-엔일리덴이나 푸르푸릴리덴으로 치환된 아미노 벤조일-이나 아미노피리딜 카보닐기If: aminoalkanoyl having up to 4 carbon atoms, aminocycloalkyl carbonyl having 6-8 carbon atoms, or benzylidene at 2-atom atoms, 2-hydroxybenzylidene, 2-hydroxy-3-methoxy-benzyl Amino benzoyl- or aminopyridyl carbonyl groups substituted with lidene, carboxymethylidene, 3-phenyl-prop-2-enylidene or furfurylidene
Ig : 말단부의 페닐기는 P-위치에서 하이드록시, 4개까지의 탄소수를 갖는 알콕시, 아미노, 4개까지의 탄소수를 갖는 알콕시, 아미노, 4개까지의 탄소수를 갖는 알킬아미노 또는 8개까지의 탄소수를 갖는 디알킬아미노로 치환되고 다른 위치는 카복시 4개까지의 탄소수를 갖는 지방족 아실아미노, 할로겐, 설포 또는 4개까지의 탄소수를 갖는 알킬로 더 치환될 수 있는 페닐 아조벤조일기;Ig: The phenyl group at the terminal is hydroxy at the P-position, alkoxy having up to 4 carbon atoms, amino, alkoxy having up to 4 carbon atoms, amino, alkylamino having up to 4 carbon atoms or up to 8 carbon atoms A phenyl azobenzoyl group which may be further substituted with an aliphatic acylamino, halogen, sulfo having up to 4 carbon atoms, or an alkyl having up to 4 carbon atoms;
Ih : 6-8개의 탄소수를 가진 아미노-싸이클로알킬-카보닐기, 아미노벤조일기 또는 아미노피리딜카보닐기, 하이드록시나 메톡시로 치환될 수 있는 벤질기로 보호된 아미노기;Ih: amino-cycloalkyl-carbonyl group having 6-8 carbon atoms, aminobenzoyl group or aminopyridylcarbonyl group, amino group protected with benzyl group which may be substituted with hydroxy or methoxy;
Ii 메틸이나 니트로로 더 치환될 수 있는 티아졸릴-, 이소티아티아졸릴-, 옥사졸릴-또는 이속사졸릴카보닐기;Thiazolyl-, isothiathiazolyl-, oxazolyl-, or isoxazolylcarbonyl groups which may be further substituted with Ii methyl or nitro;
Ik : 질소원자에서 포르밀, 아세틸, 펜타노일, 헥사노일, 옥타노일, 올레오일, 메톡시아세틸, 카복시메틸, 알릴, 벤질(하이드록시나 메톡시로 더 치환될 수 있음) 또는 3-페닐프로필로 치환된 2-, 3-또는 4-피페리딜 카보닐기;Ik: formyl, acetyl, pentanoyl, hexanoyl, octanoyl, oleoyl, methoxyacetyl, carboxymethyl, allyl, benzyl (which may be further substituted with hydroxy or methoxy) or 3-phenylpropyl at the nitrogen atom 2-, 3- or 4-piperidyl carbonyl group substituted with;
특히 일반식(Ⅰ)화합물은 R기가 싸이클로헥실, 0-, m- 및 P-플루오로페닐, P-클로로페닐, m- 및 P- 아미노페닐, m-및 P-포르밀아미노페닐, P-니트로페닐과 3-피리딜, 메틸, 에틸, 싸이클로프로필, 싸이클로부틸, 싸이클로펜틸, 싸이클로헵틸, m-클로로페닐, m- 및 P-하이드록시페닐, m- 및 P-메틸아미노페닐, m- 및 P-디메틸아미노페닐, m- 및 P-아세틸아미노페닐, m- 및 P-메톡시아세틸아미노페닐, 2-티에닐, 3-티에닐-2-티에닐메르캅토메틸, 2-푸릴, 2- 및 3-피리딜 및 1-옥시도-3-피리디니오인 화합물이 더욱 좋다.In particular, compounds of general formula (I) have R groups cyclohexyl, 0-, m- and P-fluorophenyl, P-chlorophenyl, m- and P-aminophenyl, m- and P-formylaminophenyl, P- Nitrophenyl and 3-pyridyl, methyl, ethyl, cyclopropyl, cyclobutyl, cyclopentyl, cycloheptyl, m-chlorophenyl, m- and P-hydroxyphenyl, m- and P-methylaminophenyl, m- and P-dimethylaminophenyl, m- and P-acetylaminophenyl, m- and P-methoxyacetylaminophenyl, 2-thienyl, 3-thienyl-2-thienylmercaptomethyl, 2-furyl, 2- And 3-pyridyl and 1-oxido-3-pyridinio.
일반식(Ⅰ)화합물은 4-옥소-1, 2, 3, 6, 7, 11b-헥사하이드로-4H-피라지노[2, 1-a] 이소퀴놀린(HPI)을 일반식(Ⅱ)화합물이나 그의 관능유도체와 반응시키거나, 또는 일반식(Ⅲ)화합물을 HX를 분리시키는 상태하에서 환화제로 환화시키거나, 또는 일반식(Ⅳ)화합물을 환원제로 처리하여 제조할 수 있고, 그 후 원한다면 얻어진 화합물중의 R기는 다른 R기로 전환되고, 또는 얻어진(Ⅰ)화합물의 라세미체는 그의 광학 대장체로 변형시키거나 일반식(Ⅰ)의 염기를 생리학상 허용되는 그의 산부가염이나 4급 암모늄염으로 전환시키거나 일반식(Ⅰ)의 염기는 그의 산부가염으로 부터 유리된다.Compound (I) is 4-oxo-1, 2, 3, 6, 7, 11b-hexahydro-4H-pyrazino [2, 1-a] isoquinoline (HPI). Compounds obtained by reacting with functional derivatives thereof or by cyclization of the compound of formula (III) with a cyclizing agent in the state of separating HX, or by treating the compound of formula (IV) with a reducing agent, and if desired The R group in the compound is converted to another R group, or the racemate of the obtained compound (I) is transformed into its optical colon or the base of formula (I) is converted into its physiologically acceptable acid addition salt or quaternary ammonium salt. Or base (I) is free from its acid addition salts.
상기식에서 R는 상술한 바와같고In which R is as defined above
X는 불소, 염소, 브롬, 요오드, 6-10개의 탄소수를 가진 메틸설포닐옥시나 아릴설포닐옥시, 좋기로는 P-톨루엔 설포닐옥시이고, 점선은 환의 6, 7-위치에 2중 결합이 존개할 수 있음을 의미한다.X is fluorine, chlorine, bromine, iodine, methylsulfonyloxy or arylsulfonyloxy having 6 to 10 carbon atoms, preferably P-toluene sulfonyloxy, and the dotted line double bonds at the 6 and 7-positions of the ring. This means you can survive.
일반적으로 말해서 R기는 예를들어 수소, 알킬, 싸이클로알킬, 싸이클로알킬알킬, 아랄킬, 아릴 또는 복소환기중 하나를 나타낸다.Generally speaking, the R group represents, for example, one of hydrogen, alkyl, cycloalkyl, cycloalkylalkyl, aralkyl, aryl or heterocyclic group.
알킬기는 직쇄 또는 분지쇄일 수 있으며 17개까지, 특히 6개까지의 탄소수를 가질 수 있으며 싸이클로알킬기는 3-12, 좋기로는 3-7개의 탄소수를 가질 수 있으며 2 또는 3개의 탄소원자는 엔도알킬렌연결로 서로 연결될 수도 있다. 싸이클로알킬알킬기는 특히 8개까지의 탄소수를 가질 수 있으며 아랄킬기는 10개 까지의 탄소수를 가진 것이 좋다. 아릴기는 부분적으로, 또는 나프릴기인 경우 완전히 수소화될 수 있으며 10개 까지의 탄소수를 가질 수 있다. 마지막으로 목소환기는 15개까지의 탄소수를 가질 수 있는데 직쇄 또는 분지쇄 알킬이나 4개까지의 탄소수를 가진 트리알킬기에 의해 인접카보닐기와 연결될 수 있다.The alkyl group may be straight or branched and may have up to 17 carbon atoms, in particular up to 6 carbon atoms, and the cycloalkyl group may have 3-12 carbon atoms, preferably 3-7 carbon atoms, and 2 or 3 carbon atoms may be endoalkylene. It may be connected to each other by a connection. Cycloalkylalkyl groups can in particular have up to 8 carbon atoms and aralkyl groups preferably have up to 10 carbon atoms. The aryl group can be partially hydrogenated, in part or in the case of a napryl group, and can have up to 10 carbon atoms. Finally, the cyclic group may have up to 15 carbon atoms, which may be linked to adjacent carbonyl groups by straight or branched chain alkyl or trialkyl groups having up to 4 carbon atoms.
또한 이중 또는 삼중 결합도 알킬, 싸이클로알킬, 싸이클로알킬알킬, 아랄킬 아릴 및 복소환기에 나타날 수 있으며 더욱이 이기들은 치환될 수도 있다.Double or triple bonds can also be present in alkyl, cycloalkyl, cycloalkylalkyl, aralkyl aryl and heterocyclic groups and these groups may be substituted.
R는 다음과 같은 의미중의 하나를 갖는 것이 바람직하다.R preferably has one of the following meanings.
4개까지의 탄소원자를 갖는 알콕시로 치환될 수 있는 8개까지의 탄소수를 갖는 알킬기; 불소, 염소, 니트르, 아미노, 알킬아미노나 디알킬아미노(알킬기에는 4개까지의 탄소수를 함유함), 알릴아미노, 벤질아미노(하이드록시나 메톡시로 치환될 수도 있음), 18개까지의 탄소수를 가진 포화 및 불포화된 지방족 아실아미노, 쉬프(Schiff)염기로서 보호된 아미노, 하이드록시 또는 4개까지의 탄소수를 갖는 알콕시로 치환될 수 있는 7개까지의 탄소수를 가긴 싸이클로알킬기; 불소, 염소, 니트로, 아미노, 알킬아미노나 디알킬아미노(각각 알킬기에 4개까지의 탄소원자를 함유함) 알릴아미노, 벤질아미노(하이드록시나 메톡시로 치환될 수 있음) 18개까지의 탄소수를 가진 포화 또는 불포화된 지방족 아실아미노, 쉬프염기로서 보호된 아미노, 4개까지의 탄소수를 가진 하이드록시나 알콕시, 페닐아조(하이드록시, 메톡시, 아미노, 메틸아미노, 디메틸아미노, 불소, 염소나 저급알킬로 치환될 수도 있음) 알콕시기에 4개까지의 탄소수를 함유한 카복시메틸아미노나 알콕시메틸아미노; 티에닐, 티에닐메르캅토메틸, 푸릴, 티아졸릴, 이소티아졸릴, 옥사졸릴, 이속사졸릴이나 피리딜기; 또는 4개까지의 탄소수를 가진알킬기, 벤질 또는 18개까지의 탄소수를 가진 포화 또는 불포화된 지방족아실로 치환될 수도 있는 피페리딜기이다.Alkyl groups having up to 8 carbon atoms which may be substituted with alkoxy having up to 4 carbon atoms; Fluorine, chlorine, nitrile, amino, alkylamino or dialkylamino (the alkyl group contains up to 4 carbon atoms), allylamino, benzylamino (may be substituted by hydroxy or methoxy), up to 18 Cycloalkyl groups having up to 7 carbon atoms which may be substituted with saturated and unsaturated aliphatic acylamino with carbon atoms, amino protected with Schiff base, hydroxy or alkoxy having up to 4 carbon atoms; Fluorine, chlorine, nitro, amino, alkylamino or dialkylamino (each containing up to 4 carbon atoms in the alkyl group) allylamino, benzylamino (which may be substituted by hydroxy or methoxy) Saturated or unsaturated aliphatic acylamino, amino protected as a Schiff base, hydroxy or alkoxy having up to 4 carbon atoms, phenylazo (hydroxy, methoxy, amino, methylamino, dimethylamino, fluorine, chlorine or lower) Carboxymethylamino or alkoxymethylamino containing up to 4 carbon atoms in the alkoxy group; Thienyl, thienyl mercaptomethyl, furyl, thiazolyl, isothiazolyl, oxazolyl, isoxazolyl or pyridyl groups; Or a piperidyl group which may be substituted with an alkyl group having up to 4 carbon atoms, benzyl or a saturated or unsaturated aliphatic acyl having up to 18 carbon atoms.
R기를 더욱 상세히 설명하면 다음과 같다;More detailed description of the R group is as follows;
알킬기는 6개까지의 탄소수를 가진것이 좋은데 예를들면 메틸, 에틸, 프로필, 이소프로필, n-부틸, 이소부틸, sec-부틸, tert-부틸, n-펜틸, 1-메틸-n-부틸, 2-메틸-n-부틸, 이소펜틸, 1-에틸-프로필, 1, 1-디메틸-n-프로필, tert-펜틸, n-헥실, 1, 1-디메틸-n-부틸 2, 2-디메틸-n-부틸, 이소헥실, n-헵틸, 1, 1-디메틸-n-펜틸, n-옥틸 또는 2-에틸헥실기중 하나일 수 있으나 또한 n-노일, 1-(n-부틸)-n-펜틸, n-데실, n-운데실, n-도데실, n-트리데실, n-데트라데실, n-펜타데실, n-헥사데실, n-헵타데실 또는 이소데실, 이소도데실 등과 같은 이기들의 다른 이성체일 수도 있다; 싸이클로알킬은 3-12, 좋기로는 3-7개의 탄소수를 가질 수 있는데 예를들면 싸이클로프로필, 싸이클로부틸, 싸이클로펜틸, 싸이클로헥실, 싸이클로헵틸, 싸이클로옥틸, 싸이클로노닐, 싸이클로데실, 싸이클로운데실 또는 싸이클로도데실이 있다; 싸이클로알킬기중의 2 또는 3개의 탄소원자는 엔도알킬렌고로 함께 연결될 수 있는데 예를들어 8개, 좋기로는 1 또는 2개의 탄소원자를 가진 엔도알킬렌교에 의해 결합될 수 있다. 예를들어 -CH2, -CH2-CH2, -C(CH3)2, -CH2CH2CH2-CH21-C(C2H5)2-나 CH(CH3)-CH(CH3)가 있고 이렇게 결합된 싸이클로알킬기의 예로는 비싸이클로[2, 2, 1] 헵틸-2, 비사이클로[2, 2, 2] 옥틸-2-, 비싸이클로[3, 2, 2]노닐-2, -3 및 -6, 비싸이클로[4, 2, 2] 데실-2, -3 및 -7, 비싸이클로[4, 3, 2]운데실-2, -3, , -7, -8 및 -10 또는 아다만틸 뿐만 아니라 알킬화된 이환계, 예를들면 7-메틸-비싸이클로[2, 2, 1] 헵틸, 7-에틸-비싸이클로[2, 2, 1] 헵틸, 7, 7-디메틸-비싸이클로[2, 2, 1] 헵틸, 7, 7-디에틸비싸이클로[2, 2, 1] 헵틸, [1, 7, 7]-트리메틸-비싸이클로[2, 2, 1] 헵틸, 1-메틸-비싸이클로[2, 2, 2] 옥틸 및 1, 2, 3-트리메틸-비싸이클로[2, 2, 2]옥틸이었다:Alkyl groups preferably have up to 6 carbon atoms, for example methyl, ethyl, propyl, isopropyl, n-butyl, isobutyl, sec-butyl, tert-butyl, n-pentyl, 1-methyl-n-butyl, 2-methyl-n-butyl, isopentyl, 1-ethyl-propyl, 1, 1-dimethyl-n-propyl, tert-pentyl, n-hexyl, 1, 1-dimethyl-n-butyl 2, 2-dimethyl- n-butyl, isohexyl, n-heptyl, 1, 1-dimethyl-n-pentyl, n-octyl or 2-ethylhexyl group but can also be n-noyl, 1- (n-butyl) -n Such as pentyl, n-decyl, n-undecyl, n-dodecyl, n-tridecyl, n-detradecyl, n-pentadecyl, n-hexadecyl, n-heptadecyl or isodedecyl, isododecyl, etc. It may be another isomer of yigi; Cycloalkyls may have 3-12 carbon atoms, preferably 3-7 carbon atoms, for example cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, cycloheptyl, cyclooctyl, cyclononyl, cyclodecyl, cyclodecyl or There is cyclododecyl; Two or three carbon atoms in a cycloalkyl group may be linked together by an endoalkylene, for example by an endoalkylene bridge having eight, preferably one or two carbon atoms. For example, -CH 2 , -CH 2 -CH 2 , -C (CH 3 ) 2 , -CH 2 CH 2 CH 2 CH 2 -CH 21 -C (C 2 H 5 ) 2 -or CH (CH 3 ) -CH Examples of the cycloalkyl group which are (CH 3 ) and thus bonded are bicyclo [2, 2, 1] heptyl-2, bicyclo [2, 2, 2] octyl-2-, bicyclo [3, 2, 2] Nonyl-2, -3 and -6, bicyclo [4, 2, 2] decyl-2, -3 and -7, bicycl [4, 3, 2] undecyl-2, -3,, -7, -8 and -10 or adamantyl as well as alkylated bicyclic systems such as 7-methyl-bicyclo [2, 2, 1] heptyl, 7-ethyl-bicyclo [2, 2, 1] heptyl, 7, 7-dimethyl-bicyclo [2, 2, 1] heptyl, 7, 7-diethylbicyclo [2, 2, 1] heptyl, [1, 7, 7] -trimethyl-bicyclo [2, 2, 1 ] Heptyl, 1-methyl-bicyclo [2, 2, 2] octyl and 1, 2, 3-trimethyl-bicyclo [2, 2, 2] octyl:
싸이클로알킬기는 8개까지의 탄소수를 갖는 것이 좋은데 예를들면 싸이클로부틸메틸, 싸이클로펜틸메틸, 싸이클로펜틸에틸, 싸이클로헥실메틸이나 싸이클로헥실에틸이 있다.The cycloalkyl group preferably has up to 8 carbon atoms, for example cyclobutylmethyl, cyclopentylmethyl, cyclopentylethyl, cyclohexylmethyl or cyclohexylethyl.
알킬 및 싸이클로알킬기는 불포화 결합을 가질 수 있는데 예를들면 에텐일, 에텐일, 1-프로핀일, 2-프로펜일, 8-헵타데센일 , 1-싸이클로펜틴엘, 2-싸이클로펜틴일, 3-싸이클로펜텐일, 1-싸이클로헥센일, 2-싸이클로헥센일, 3-싸이클로헥센일, 1-싸이 클로헵텐일, 2-싸이클로햅텐일, 3-싸이클로헵텐일, 4-싸이클로헵텐일, 1-부테일, 2-부텐일, 3-부텐일, 1-싸이클로옥텐일, 2-싸이클로옥텐일, 3-싸이클로옥텐일, 4-싸이클로옥텐일, 5-싸이클로콜로옥텐일, 1-프로핀일 및 2-프로핀일이 있다.Alkyl and cycloalkyl groups may have unsaturated bonds, for example ethenyl, ethenyl, 1-propynyl, 2-propenyl, 8-heptadecenyl, 1-cyclopentinel, 2-cyclopentinyl, 3- Cyclopentenyl, 1-cyclohexenyl, 2-cyclohexenyl, 3-cyclohexenyl, 1-cycloheptenyl, 2-cycloheptenyl, 3-cycloheptenyl, 4-cycloheptenyl, 1-part Tail, 2-butenyl, 3-butenyl, 1-cyclooctenyl, 2-cyclooctenyl, 3-cyclooctenyl, 4-cyclooctenyl, 5-cyclocolococtenyl, 1-propynyl and 2- Propynyl.
아랄킬은 10개까지의 탄소수를 가진것이 좋은데 예를들면 벤질, 1-또는 2-페닐에틸, 3-페닐프로필, 1-메틸-1-페닐에틸이나 1-메틸-2-페닐에틸일 수 있다.Aralkyl is preferably up to 10 carbon atoms, for example benzyl, 1- or 2-phenylethyl, 3-phenylpropyl, 1-methyl-1-phenylethyl or 1-methyl-2-phenylethyl .
아릴은 10개까지의 탄소수를 가진 것이 좋은데 예를들면 치환된 페닐, 나프틸-1, 나프틸-2 또는 페난트릴-1 (또는 -2, -3, -4, -9)일 수 있다. 나프틸기도 일부 또는 전체가 수소화될 수 있는데 예를들면 1, 2-디하이드로나프틸, 1, 2, 3, 4-테트라하이드로나프틸이나 데칼리닐(시스나 트란스)일 수 있다.Aryl preferably has up to 10 carbon atoms, for example substituted phenyl, naphthyl-1, naphthyl-2 or phenanthryl-1 (or -2, -3, -4, -9). Some or all of the naphthyl groups may be hydrogenated, for example 1, 2-dihydronaphthyl, 1, 2, 3, 4-tetrahydronaphthyl or decalinyl (cisna trans).
복소환기는 예를들어 하나 또는 두개의 벤조기나 제2의 5또는 6-원자복소환과 축합될 수 있는 5- 및 6-원자의 방향족 복소환계통일 수 있는데 예를들면 피릴 1-(또는 -2 나-3), 티에닐-2(또는 -3), 푸릴-2(또는 3) 안돌릴-1(또는 -2, -3, -4, -6 또는 -7), 벤조푸릴-2(또는 -3, -4, -5, -6 또는 -7), 벤조티에닐-2(또는 -3, -4, -5, -6 또는 -7) 피리딜 -2(또는 -3 또는 -4), α-또는 γ-피라닐-2 (또는 -3이나 4) α- 또는 γ-티오피라닐-2 (또는 -3이나 -4), 퀴놀릴-2 (또는 -3, -4, -5, -6, -7 또는 -8), 이소퀴놀릴-1 (또는 -3, -4, -5, -6, -7 또는 -8), 카바졸일 -1(또는 -2, -3, -4 또는 -9) 피라졸일 -1 (또는 -3, -4 또는 -5), 이미다졸일 -1 (또는 -2, -4 또는 -9) 벤즈피라졸릴-1(또는 -2, -4, -5, -6 또는 7), 벤즈이미다졸일-1 (또는 -2, -4 또는 -5) 옥사졸일 -2 (또는 -4 나 -5), 벤즈옥사졸일-2 (또는 -4, -5, -6 또는 -7) 티아졸일 -2 (또는 -4 나 -5) 벤즈티아졸일 -2 (또는 -4, -5, -6 또는 -7) 이스옥사졸일 -3 (또는 -4 나 -5) 이소티아졸일 -3 (또는 -4 나 -5), 1, 2, 3-트리아졸일-1 (또는 -2 나 -4) 1, 2, 4-트리아졸일-1 ( 또는 -3 이나 -5) 테트라졸일-1 (또는 -2 나 -5) 1, 2, 3-또는 1, 2, 4-옥사디아졸일, 1, 2, 4-, 1, 3, 4- 또는 2, 1, 5-티아디아졸일, 2, 1, 3-벤조-티아디아졸일-5, 아크리디닐-1 (또는 -2, -3, -4, -5, -6, -7, -8 또는 -9) 피라다지닐-3 (또는 -4) 피리미디닐-2 (또는 -4 또는 -5), 피라지닐, 페나지닐-1 (또는 -2), 페녹사지닐-1 (또는 -2, -3, -4 또는 -9) 페노티아지닐-1 (또는 -2, -3, -4 또는 -9), 티안트레닐-1 (또는-2) 1, 2, 5-, 1, 2, 4- 또는 1, 2, 3-트리아지닐, 1, 2, 3, 4- 또는 1, 2, 4, 5-데트라지닐, 푸리닐-2 (또는-6, -7, -8 또는 -9) 피라졸로[3, 4-d] 피리미디닐-2 (또는 -6, -7 또는 -9), 프테리디닐, 시노리닐-3 (또는 -4, -5, -6, -7 또는 -8) 프탈라지닐-1(또는 -5 또는 -6), 퀴니졸리닐-2 (또는 -4, -5, -6, 7 또는 -8) 퀴녹사졸리닐-2 (또는 -5 또는 -6), 1, 5-나프틸리디닐-2 (또는 -3 또는 -4) 또는 나리딕시닐이 있다. 복소환기는 또한부분적으로나 전체적으로 수소화될 수 있는데 좋은것은 예를들어, 1, 4-디옥사닐, 모르폴리닐, 피롤리디닐, 테트라하이드로푸릴, 테트라하이드로티에닐, 피라졸리디닐, 이미다졸리디닐, 1, 2, 3, 4-태트라하이드로피리딜, 1, 2, 5, 6-테트라하이드로피리딜, 피페리딜, 테트라하이드로피라닐, 1, 2, 3, 4-테트라하이드로퀴놀릴, 1, 2, 3, 4-테트라하이드로이소퀴놀릴, 헥사하이드로피리다닐, 헥사하이드로피리미디닐, 피페라지닐, 1, 3-디옥사닐, 피롤리닐, 디하이드로푸릴, 피라졸리닐, 이미다졸리닐, 옥사졸리닐, 윽사졸리디닐, 티아졸리디닐, 티아졸리닐, 이속사졸리디닐, 이소티아졸리닐, 이소티아졸리디닐, 2, 3-디하이드로벤즈티아졸릴, 디하이드로피리딜, 디하이드로피라닐, 테트라하이드로티오피라닐, 1, 2-디하이드로퀴놀릴, 3, 4-디하이드로퀴놀릴, 1, 2-디하이드로이소퀴놀릴, 3, 4-디하이드로이소퀴놀릴, 데카하이드로퀴놀릴, 데카하이드로이소퀴놀릴, 크로메닐, 크로마닐, 디하이드로피리다지닐, 테트라하이드로피리다지닐, 디하이드로피리이디닐, 테트라하이드로피리미디닐, 디하이드로피라지논, 테트라하이드로피라지닐 또는 1, 4-티아지닐이 있다.The heterocyclic group can be, for example, a 5- or 6-membered aromatic heterocyclic system which can be condensed with one or two benzo groups or a second 5 or 6-membered heterocycle, for example pyryl 1- (or- 2na-3), thienyl-2 (or -3), furyl-2 (or 3) anddolyl-1 (or -2, -3, -4, -6 or -7), benzofuryl-2 ( Or -3, -4, -5, -6 or -7), benzothienyl-2 (or -3, -4, -5, -6 or -7) pyridyl-2 (or -3 or -4) ), α- or γ-pyranyl-2 (or -3 or 4) α- or γ-thiopyranyl-2 (or -3 or -4), quinolyl-2 (or -3, -4,- 5, -6, -7 or -8), isoquinolyl-1 (or -3, -4, -5, -6, -7 or -8), carbazolyl -1 (or -2, -3, -4 or -9) pyrazolyl -1 (or -3, -4 or -5), imidazolyl -1 (or -2, -4 or -9) benzpyrazolyl-1 (or -2, -4 , -5, -6 or 7), benzimidazolyl-1 (or -2, -4 or -5) oxazolyl -2 (or -4 or -5), benzoxazolyl-2 (or -4, -5, -6 or -7) thiazolyl -2 ( Is -4 or -5) benzthiazolyl -2 (or -4, -5, -6 or -7) isoxazolyl -3 (or -4 or -5) isothiazolyl -3 (or -4 i- 5), 1, 2, 3-triazolyl-1 (or -2 or -4) 1, 2, 4-triazolyl-1 (or -3 or -5) tetrazolyl-1 (or -2 or -5) ) 1, 2, 3- or 1, 2, 4-oxadiazolyl, 1, 2, 4-, 1, 3, 4- or 2, 1, 5-thiadiazolyl, 2, 1, 3-benzo- Thiadiazolyl-5, acridinyl-1 (or -2, -3, -4, -5, -6, -7, -8 or -9) pyrazazinyl-3 (or -4) pyrimidinyl -2 (or -4 or -5), pyrazinyl, phenazinyl-1 (or -2), phenoxazinyl-1 (or -2, -3, -4 or -9) phenothiazinyl-1 (or -2, -3, -4 or -9), thianthrenyl-1 (or-2) 1, 2, 5-, 1, 2, 4- or 1, 2, 3-triazinyl, 1, 2, 3, 4- or 1, 2, 4, 5-detrazinyl, furinyl-2 (or-6, -7, -8 or -9) pyrazolo [3, 4-d] pyrimidinyl-2 ( Or -6, -7 or -9), putridinyl, cynolinyl-3 (or -4, -5, -6, -7 or -8) phthal Lazinyl-1 (or -5 or -6), quinizolinyl-2 (or -4, -5, -6, 7 or -8) quinoxazolinyl-2 (or -5 or -6), 1 , 5-naphthyridinyl-2 (or -3 or -4) or naridixinyl. Heterocyclic groups may also be partially or wholly hydrogenated, for example 1, 4-dioxanyl, morpholinyl, pyrrolidinyl, tetrahydrofuryl, tetrahydrothienyl, pyrazolidinyl, imidazolidinyl , 1, 2, 3, 4-tatrahydropyridyl, 1, 2, 5, 6-tetrahydropyridyl, piperidyl, tetrahydropyranyl, 1, 2, 3, 4-tetrahydroquinolyl, 1, 2, 3, 4-tetrahydroisoquinolyl, hexahydropyridanyl, hexahydropyrimidinyl, piperazinyl, 1, 3-dioxanyl, pyrrolinyl, dihydrofuryl, pyrazolinyl, already Dazolinyl, oxazolinyl, oxazolidinyl, thiazolidinyl, thiazolinyl, isoxazolidinyl, isothiazolinyl, isothiazolidinyl, 2, 3-dihydrobenzthiazolyl, dihydropyridyl , Dihydropyranyl, tetrahydrothiopyranyl, 1, 2-dihydroquinolyl, 3, 4-dihydroqui Reel, 1, 2-dihydroisoquinolyl, 3, 4-dihydroisoquinolyl, decahydroquinolyl, decahydroisoquinolyl, chromenyl, chromanyl, dihydropyridazinyl, tetrahydropyridazinyl , Dihydropyridinyl, tetrahydropyrimidinyl, dihydropyrazinone, tetrahydropyrazinyl or 1,4-thiazinyl.
이러한 알킬, 싸이클로알킬, 싸이클로알킬알킬, 아르알킬, 아릴 또는 복소환기는 또한 한번 이상 치환될 수 있는데 여러 치환기는 또한 하나의 탄소원자에 있을 수 있고 또는 가능하다면 치환기들은 시스나 트란스관계로 있을 수 있다. 그러한 치환기는 예를들어 하나 이상의 다음 기들이 있다; 즉Such alkyl, cycloalkyl, cycloalkylalkyl, aralkyl, aryl or heterocyclic groups may also be substituted more than once and several substituents may also be on one carbon atom or if possible the substituents may be cis or trans. . Such substituents are for example one or more of the following groups; In other words
메틸, 에틸, n-프로필, 이소프로필, n-부틸, 이소부틸, sec-부틸 및 tert-부틸같은 4개까지의 탄소수를 가진 알킬; 플루오로메틸, 트리플루오로메틸, 및 클로로메틸같은 4개까지의 탄소수를 가진 할로알킬 : 하이드록시 메틸 및 하이드록시에틸 같은 4개까지의 탄소수를 가진 하이드록시 알킬; 아미노메틸, 메틸아미노메틸, 디메틸아미노메틸, 메틸아미노에틸, 디메틸아미노에틸, 에틸아미노메틸, 디에틸아미노메틸, 에틸아미노에틸, 디에틸아미노에틸, 메틸아미노-n-프로필, 디메틸아미노-n-프르필 및 디에틸아미노-n-부틸등과 같은 모노-및 디-에틸뿐 아니라 모노-및 디-메틸아미노 같은 4개까지의 탄소수를 가진 아미노알킬; 페닐같은 6-10개의 탄소수를 가진 아릴; 벤질 및 트리페닐메틸같은 7-19개의 탄소수를 가진 아르알킬; 불소, 염소, 브롬, 요오드같은 할로겐;Alkyl having up to 4 carbon atoms such as methyl, ethyl, n-propyl, isopropyl, n-butyl, isobutyl, sec-butyl and tert-butyl; Haloalkyl with up to 4 carbon atoms such as fluoromethyl, trifluoromethyl, and chloromethyl: hydroxy alkyl with up to 4 carbon atoms such as hydroxy methyl and hydroxyethyl; Aminomethyl, methylaminomethyl, dimethylaminomethyl, methylaminoethyl, dimethylaminoethyl, ethylaminomethyl, diethylaminomethyl, ethylaminoethyl, diethylaminoethyl, methylamino-n-propyl, dimethylamino-n-pr Aminoalkyl having up to 4 carbon atoms such as mono- and di-ethyl as well as mono- and di-methylamino such as fill and diethylamino-n-butyl and the like; Aryl having 6-10 carbon atoms such as phenyl; Aralkyl having 7 to 19 carbon atoms such as benzyl and triphenylmethyl; Halogen such as fluorine, chlorine, bromine and iodine;
하이드록시; 메톡시, 에톡시, h-프로폭시, 이소프로폭시, n-부톡시 이소부톡시, sec-부톡시 및 tert-부톡시같은 4개까지의 탄소수를 가진 알콕시; 포르밀옥시, 아세톡시 및 프로피오닐옥시와 같은 4개까지의 탄소수를 가진 아실옥시; 트리플루오로아세톡시 및 메톡시 아세톡시같은 치환된 아세톡시; 페녹시같은 6-10개의 탄소수를 가진 아릴옥시; 0-, m- 및 P-플루오로페녹시, 0-, m- 및 P-클로로페녹시, 0-, m- 및 P-아미노페녹시, 0-, m-, 및 P-메틸아미노페녹시, 0-, m- 및 P-디메틸아미노페녹시, 0-, m- 및 P-포르밀아미노페녹시 및 0-, m- 및 P-아세틸아미노페녹시와 같은 치환된 아릴옥시; 메틸아미노, 에틸아미노, n-프로필아미노, 이소프로필아미노, n-부틸아미노, 이소부틸아미노, sec-부틸아미노 및 tert-부틸아미노같은 4개까지의 탄소수를 가진 아미노, 알킬아미노; 디메틸아미노, 디에틸아미노, 메틸에틸아미노, 메틸-n-프로필아미노, 메틸-이소프로필-아미노, 메틸-n-부틸아미노, 에틸-n-프로필아미노, 에틸이소프로필아미노, 에틸-n-부틸 아미노, 디-n-프르필아미노, 디이소프로필아미노 및 디-n-부틸아미노와 같은 알킬기가 4개까지의 탄소수를 가진 디알킬아미노; 트리메틸암모니움 및 트리에틸암모니움같이 알킬기가 4개까지의 탄소수를 가진 트리알킬암모니움; 비닐아미노, 1-프로펜일 아미노, 알릴아미노, 1-부텐일아미노2-부텐일아미노 및 3-부텐일아미노 같은 4개까지의 탄소수를 가진 알케닐아미노; 벤질아미노, 2-하이드록시벤질아미노, 및 2-하이드록시-3-메톡시벤질아미노 같은 임의로 하이드록실, 메톡시메틸아미노, 디메틸아미노, 메틸티오, 메틸 또는 에틸로치환된 아르알킬; 포르밀아미노, 아세틸아미노, 프로피오닐아미노, 부티릴아미노, 펜타노일아미노, 헥사노일아미노, 헵타노일아미노, 옥타노일아미노, 데카노일아미노, 도데카노일아미노, 팔미토일아미노, 스테아로일아미노, 올레오일아미노, 리놀로일아미노, 리놀레노일아미노 같이 아실기가 포화 또는 불포화지방산으로 부터 유도되고 좋기로는 지방산으로 부터 유도되어 18개까지의 탄소수를 가진 것인 18개까지의 탄소수를 가진 아실아미노; 트리플루오로아세틸아미노, 메톡시아세틸아미노, 에톡시아세틸아미노, 프로폭시아세틸아미노, 이소프로폭시아세틸아미노, 부톡시아세틸아미노 및 tert-부톡시아세틸아미노처럼 아실기가 트리플루오로초산이나 저급알콕시초산(여기서 알콕시는 4개까지의 탄소수를 가짐)으로 부터 유도된 아실아미노; 3-카복시프로피오닐아미노(석시노일아미노) 3-카복시-시스-프로프-2-엔오일아미노(말레인오일아미노), 2-카복시-싸이클로펜틸카보닐아미노, 2-카복시-싸이클로헥실카보닐아미노, 프탈로일아미노, 2- 및 3-카복시-피리딜-3- 및-2-카보닐아미노 및 3-(카복시에틸-메르캅토)-프로피오닐아미노처럼 아실기가 환상무수물을 형성시킬 수 있는 4-8개의 탄소를 가진 디카복실산으로부터 유도된 아실아미노; 설프아미노; 에톡시카보닐아미노, tert-브톡시카보닐아미노, 벤질옥시카보닐아미노, 3, 5-디메톡시벤질옥시카보닐아미노, 시아노-tert-부톡시카보닐아미노, 2-비페닐일-(4)-이소프로폭시카보닐아미노, 2, 2, 2-트리클로로에톡시카보닐아미노, 플루오레닐-(9)-메톡시카보닐아미노, P-니트로벤질옥시카보닐아미노, P-클로로벤질옥시카보닐아미노, P-페닐아조벤질옥시카보닐아미노, P-(P-메톡시페닐아조)-벤질옥시카보닐아미노 및 싸이클로펜틸옥시카보닐아미노처럼 15개까지의 탄소수를 가진 유기기로 치환된 옥시카보닐아미노; 벤질리덴아미노, P-메틸벤질리덴아미노, 0-하이드록시벤질리덴아미노, P-메톡시벤질리덴아미노, 3, 4-디메톡시벤질리덴아미노, 2-하이드록시-3-메톡시벤질리덴아미노, 이소프로필리덴아미노, sec-부틸리덴아미노, 카복시메틸렌아미노, 3-페닐-2-프로펜-1-일리덴아미노, 푸르푸릴리덴아미노 및 5-니트로 푸르푸릴리덴아미노처럼 9개까지의 탄소수를 가진 알킬리덴-및 아랄킬리덴아미노; α-설포-벤질아미노, α-설포-2-하이드록시벤질아미노, α-설포-2-하이드록시-3-메톡시벤질아미노, 설포메틸아미노, 1-설포에틸아미노, 1-설포-1-카복시메틸아미노 및 (1, 3-디설포-3-페닐)프르필아미노처럼 디설포기에 비설파이트를 부가하여 얻어진 설포 및 디설포기; 하이드록시, 메톡시나 에톡시처럼 4개까지의 탄소수를 가진 알콕시, 아미노, 메틸아미노나 에틸아미노처럼 4개까지의 탄소수를 가진 알킬아미노, 디메틸아미노나 디에틸아미노처럼 8개까지의 탄소수를 가진 디알킬아미노, 카복시로 치환될 수 있는 나프틸아조-1이나 -2, 메톡시카보닐 및 에톡시카보닐 같은 저급알콕시카보닐, 포르밀아미노 및 아세틸아미노같은 4개까지의 탄소수를 가진 아실아미노, 불소나 염소 및 브롬같은 할로겐, 설포, 메톡시설포닐이나 에톡시설포닐같은 알콕시설포닐, 또는 메틸, 에틸, 프로필, 이소부틸 및 tert-부틸같은 까지의 탄소수를 가진 알킬로 치환된, 좋기로는 P-치환된, 페닐아조로서 예를들면 3-카복시-4-하이드록시페닐아조, 4-디메틸아미노페닐아조, 4-디에틸아미노페닐아조, 2-메틸-4-하이드록시-페닐아조, 4-메톡시-및 4-에톡시-페닐아조가 있다; 글루코노일아미노, 글루쿠로노일아미노, 시카로일아미노, 갈락토노일아미노, 갈락투로노일아미노, 무코일아미노, 만노노일아미노, 만노-삭카로일아미노, 아라비노노일아미노, 리보노일아미노, 말토비오노일아미노, 락토비오노일아미노 및 삭카로비오노일아미노처럼 5-12개의 탄소원자를 가진 모노-또는 디-삭카라이드, 좋기로는 상응하는 카복실산의 말단부탄소원자나 제1탄소원자에서 산화된 모노삭카라이드기에 의해 보호된 아미노기, 메르캅토, 메틸메르캅토, 에틸메르캅토, n-프로필메르캅토, 이소프로필메르캅토, n-부틸메르캅토, 이 소부틸메르캅토, sec-브틸메르캅토와 tert-부틸메르캅토처럼 4개까지의 탄소원자를 가진 알킬메틸캅토, 페닐메르캅토처럼 6-10개의 탄소원자를 가진 아릴메르캅토, 포르밀메르캅토, 아세틸메르캅토 및 프로피오닐메르캅토처럼 4개까지의 탄소수를 가진 아실메르캅토, 티에닐-2-메르캅토, 티에닐-3-메르캅토, 니트로, 시아노, 카복시, 메톡시카보닐, 에톡시카보닐, n-프로폭시카보닐, 이소프로폭시카보닐, n-부톡시카보닐, 이소부톡시카보닐, sec-부톡시카보닐 및 tert-부톡시카보닐처럼 알콜성분에 4개까지의 탄소수를 가진 알콕시카보닐, 하이드라지노, 1-메틸하이드라지노, 2-메틸하이드라지노, 1-에틸하이드라지노, 2-에틸하이드라지노, 1, 2-디메틸하이드라지노, 2, 2-디메틸-하이드라지노, 1, 2, 2-트리메틸하이드라지노 및 2-페닐하이드라지노같은 알킬-및 아틸-하이드라지노, 아지도, 설포, 메톡시설포닐, 에톡시설포닐 및 P-톨루엔옥시설포닐같은 7개까지의 탄소수를 가진 알콕시설포닐 및 아릴옥시설포닐, 티오노기로서 황, 또는 케토나 N-옥시도(N-옥사이드)기로서의 산소가 있다.Hydroxy; Alkoxy having up to 4 carbon atoms such as methoxy, ethoxy, h-propoxy, isopropoxy, n-butoxy isobutoxy, sec-butoxy and tert-butoxy; Acyloxy having up to 4 carbon atoms such as formyloxy, acetoxy and propionyloxy; Substituted acetoxy such as trifluoroacetoxy and methoxy acetoxy; Aryloxy having 6-10 carbon atoms, such as phenoxy; 0-, m- and P-fluorophenoxy, 0-, m- and P-chlorophenoxy, 0-, m- and P-aminophenoxy, 0-, m-, and P-methylaminophenoxy Substituted aryloxy such as 0-, m- and P-dimethylaminophenoxy, 0-, m- and P-formylaminophenoxy and 0-, m- and P-acetylaminophenoxy; Amino, alkylamino having up to 4 carbon atoms such as methylamino, ethylamino, n-propylamino, isopropylamino, n-butylamino, isobutylamino, sec-butylamino and tert-butylamino; Dimethylamino, diethylamino, methylethylamino, methyl-n-propylamino, methyl-isopropyl-amino, methyl-n-butylamino, ethyl-n-propylamino, ethylisopropylamino, ethyl-n-butyl amino Dialkylamino having an alkyl group of up to 4 carbon atoms, such as di-n-propylamino, diisopropylamino and di-n-butylamino; Trialkylammonium having alkyl groups of up to 4 carbon atoms, such as trimethylammonium and triethylammonium; Alkenylamino having up to 4 carbon atoms such as vinylamino, 1-propenyl amino, allylamino, 1-butenylamino2-butenylamino and 3-butenylamino; Aralkyl optionally substituted with hydroxyl, methoxymethylamino, dimethylamino, methylthio, methyl or ethyl, such as benzylamino, 2-hydroxybenzylamino, and 2-hydroxy-3-methoxybenzylamino; Formylamino, acetylamino, propionylamino, butyrylamino, pentanoylamino, hexanoylamino, heptanoylamino, octanoylamino, decanoylamino, dodecanoylamino, palmitoylamino, stearoylamino, oleic Acylamino having up to 18 carbon atoms in which acyl groups such as oilamino, linoloylamino, linolenoylamino are derived from saturated or unsaturated fatty acids and preferably derived from fatty acids and having up to 18 carbon atoms; Acyl groups such as trifluoroacetylamino, methoxyacetylamino, ethoxyacetylamino, propoxyacetylamino, isopropoxyacetylamino, butoxyacetylamino and tert-butoxyacetylamino may be substituted with trifluoroacetic acid or lower alkoxyacetic acid ( Wherein alkoxy is acylamino derived from up to 4 carbon atoms); 3-carboxypropionylamino (succinoylamino) 3-carboxy-cis-prop-2-enoylamino (maleoylamino), 2-carboxy-cyclopentylcarbonylamino, 2-carboxy-cyclohexylcarbon Acyl groups can form cyclic anhydrides such as nylamino, phthaloylamino, 2- and 3-carboxy-pyridyl-3- and-2-carbonylamino and 3- (carboxyethyl-mercapto) -propionylamino Acylamino derived from dicarboxylic acids having 4-8 carbons present; Sulfamino; Ethoxycarbonylamino, tert-butoxycarbonylamino, benzyloxycarbonylamino, 3, 5-dimethoxybenzyloxycarbonylamino, cyano-tert-butoxycarbonylamino, 2-biphenylyl- ( 4) -isopropoxycarbonylamino, 2, 2, 2-trichloroethoxycarbonylamino, fluorenyl- (9) -methoxycarbonylamino, P-nitrobenzyloxycarbonylamino, P-chloro Substitution with organic groups of up to 15 carbon atoms, such as benzyloxycarbonylamino, P-phenylazobenzyloxycarbonylamino, P- (P-methoxyphenylazo) -benzyloxycarbonylamino and cyclopentyloxycarbonylamino Oxycarbonylamino; Benzylideneamino, P-methylbenzylideneamino, 0-hydroxybenzylideneamino, P-methoxybenzylideneamino, 3, 4-dimethoxybenzylideneamino, 2-hydroxy-3-methoxybenzylideneamino, Up to 9 such as isopropylideneamino, sec-butylideneamino, carboxymethyleneamino, 3-phenyl-2-propene-1-ylideneamino, furfurylideneamino and 5-nitrofurfurylideneamino Alkylidene- and aralkylideneamino having carbon number; α-sulfo-benzylamino, α-sulfo-2-hydroxybenzylamino, α-sulfo-2-hydroxy-3-methoxybenzylamino, sulfomethylamino, 1-sulfoethylamino, 1-sulfo-1- Sulfo and disulfo groups obtained by adding bisulfite to a disulfo group, such as carboxymethylamino and (1,3-disulfo-3-phenyl) propylamino; Alkyl having up to 4 carbon atoms like hydroxy, methoxy or ethoxy, alkylamino having up to 4 carbon atoms like methylamino or ethylamino, and up to 8 carbon atoms like dimethylamino or diethylamino Dialkylamino, acylamino having up to 4 carbon atoms such as naphthylazo-1 or -2 which may be substituted by carboxy, lower alkoxycarbonyl such as methoxycarbonyl and ethoxycarbonyl, formylamino and acetylamino Preferably substituted with halogen, sulfo, alkoxysulfonyl, such as methoxysulfonyl or ethoxysulfonyl, or alkyl having carbon numbers up to methyl, ethyl, propyl, isobutyl and tert-butyl, such as fluorine or chlorine and bromine P-substituted, phenylazo, for example 3-carboxy-4-hydroxyphenylazo, 4-dimethylaminophenylazo, 4-diethylaminophenylazo, 2-methyl-4-hydroxy-phenylazo, 4 -Methoxy-and 4-ethoxy-phenylazo; Glunoylamino, Glucuronoylamino, Cycloylamino, Galactonoylamino, Galacturnoylamino, Mucoylamino, Mannonoylamino, Manno-saccharoylamino, Arabinonoylamino, Ribonoylamino , Mono- or di-saccharides having 5 to 12 carbon atoms, such as maltobionoylamino, lactobionoylamino and zaccarbionoylamino, preferably oxidized at the terminal carbon atom or the first carbon atom of the corresponding carboxylic acid Amino group, mercapto, methyl mercapto, ethyl mercapto, n-propyl mercapto, isopropyl mercapto, n-butyl mercapto, isobutyl mercapto, sec-butyl methyl capto Alkylmethylcapto with up to 4 carbon atoms like tert-butyl mercapto, aryl mercapto with 6-10 carbon atoms like phenyl mercapto, formyl mercapto, acetyl mercapto and propionylme Acylmercapto with up to 4 carbon atoms like lecapto, thienyl-2-mercapto, thienyl-3-mercapto, nitro, cyano, carboxy, methoxycarbonyl, ethoxycarbonyl, n-pro Alkoxycarbonyl having up to 4 carbon atoms in the alcohol component, such as epoxycarbonyl, isopropoxycarbonyl, n-butoxycarbonyl, isobutoxycarbonyl, sec-butoxycarbonyl and tert-butoxycarbonyl, Hydrazino, 1-methylhydrazino, 2-methylhydrazino, 1-ethylhydrazino, 2-ethylhydrazino, 1, 2-dimethylhydrazino, 2, 2-dimethyl-hydrazino Alkyl- and acyl-hydrazinos such as 1, 2, 2-trimethylhydrazino and 2-phenylhydrazino, azido, sulfo, methoxysulfonyl, ethoxysulfonyl, and P-tolueneoxasulfonyl Alkoxysulfonyl and aryloxysulfonyl having a carbon number up to, Sulfur as a thiono group, or Acid as a ketone or N-oxide (N-oxide) group A.
만약 R기에 제2급아미노기가 있다면 이것은 여러가지 아실기, 예를들면, 포르밀, 아세틸, 프로피오닐, 부티릴, 이소부티릴, 펜타노일, 헥사노일, 헵타노일, 옥타노일, 노나노일, 데카노일, 도데카노일, 팔미토일, 스테아로일, 올레오일, 리놀로일이나 리놀레노일 같이 18개까기의 탄소수를 가진 포화 또는 불포화된 지방족아실, 메톡시아세틸, 에톡시아세틸, 프로폭시아세틸, 부톡시아세틸, 이소부톡시아세틸, tert-부톡시아세틸 같이 알콕시기에 4개까지의 탄소수를 가진 알콕시아세틸기, 글루코노일, 글루쿠로노일, 삭카로일, 갈락토노일, 갈락투로노일, 무코일, 만노노일, 만노-시카로일, 아라비노노일, 리보노일, 말토비오노일, 락토비오노일 또는 삭카로비오노일 같이 상응하는 카복시기의 말단탄소에서나 제1탄소에서 산화된 모노-또는 디-삭카라이드기, 3-카복시프르피오닐(석시노일), 3-카복시-시스-프로프-2-엔오일(말레이노일), 2-카복시-싸이클로헥실, 카보닐, 프탈로일, 2 또는 3-카복시피리딜-3-또는-2-카보닐 또는 3-(카복시에틸메르캅토)-프르피오닐 같이 환상 무수물을 형성할 수 있는 4-8개의 탄소수를 가진 디카복실산의 아실기, 또는 설폰기에 의해서 치환될 수 있다. 만약 R기에 카복시나 설포기가 포함되어 있다면 이것들은 그들의 알칼리금속, 알카리토금속이나 암모늄염, 좋기로는 소디움이나 포타슘염의 형태로 존재할 수도 있다.If there is a secondary amino group in the R group, it may be a different acyl group, for example, formyl, acetyl, propionyl, butyryl, isobutyryl, pentanoyl, hexanoyl, heptanoyl, octanoyl, nonanoyl, deca Saturated or unsaturated aliphatic acyl with up to 18 carbon atoms, such as noil, dodecanoyl, palmitoyl, stearoyl, oleoyl, linoloyl or linolenoyl, methoxyacetyl, ethoxyacetyl, propoxyacetyl, Alkoxy acetyl groups having up to 4 carbon atoms, gluconoyl, glucuronoyl, saccharoyl, galactonoyl, galacturonoyl, mucoyl such as butoxyacetyl, isobutoxyacetyl, tert-butoxyacetyl Mono- or oxidized at the first carbon or at the end carbon of the corresponding carboxyl group, such as mannonoyl, manno-cyclocaryl, arabinoyl, ribonyl, maltobionoyl, lactobionoyl or zaccarbionoyl Di-saccharide group , 3-carboxypropionyl (succinoyl), 3-carboxy-cis-prop-2-enoyl (maleinoyl), 2-carboxy-cyclohexyl, carbonyl, phthaloyl, 2 or 3-carboxy Substitution by acyl or sulfone groups of dicarboxylic acids having 4 to 8 carbon atoms which can form cyclic anhydrides such as pyridyl-3- or-2-carbonyl or 3- (carboxyethylmercapto) -propionyl Can be. If the R groups contain carboxy or sulfo groups, they may be present in the form of their alkali metal, alkaline earth or ammonium salts, preferably sodium or potassium salts.
출발물질로 사용되는 구조식(Ⅱ)화합물은 유리산이나 기능적유도체의 형태로 사용될 수 있다. 그러한 기능적유도체의 예로는 알킬에스테르, 락톤, 할라이드, 아자이드 및 무수물이 있다. 에스테르기의 알킬기는 4개까지의 탄소원자를 가질 수 있는데 예를들면 메딜, 에틸, 프로필, 이소프로필, n-부틸, 이소부틸 및 tert-부틸이 있다. 락톤으로서는 예를들어 4-부티로락톤, 4-및 5-발레로락톤 및 3-하이드록시-3-메틸-5-발레로락톤이 사용될 수 있다. 할라이드로서는 염화물이나 브롬화물이 좋으나 불소화물이나 요오드화물도 사용될 수 있다.Formula (II) compounds used as starting materials may be used in the form of free acids or functional derivatives. Examples of such functional derivatives are alkylesters, lactones, halides, azides and anhydrides. The alkyl group of the ester group may have up to 4 carbon atoms, for example medyl, ethyl, propyl, isopropyl, n-butyl, isobutyl and tert-butyl. As the lactone, for example 4-butyrolactone, 4- and 5-valerolactone and 3-hydroxy-3-methyl-5-valerolactone can be used. The halide is preferably chloride or bromide, but fluoride or iodide may also be used.
무수물로서는 이들이 형성될 수만 있다면 대칭 무수물뿐 아니라 혼합된, 환상 및 로이히(Leuchs)무수물도 사용될 수 있다. 혼합무수물(하이드록시기가 아실옥시기로 치환된 화합물 2)중의 아실옥시기는 트리플루오로아세톡시, 아세톡시, 포르밀옥시, 프로피오닐옥시, 부티릴옥시 또는 이소부틸옥시가 좋다. 환상 무수물은 예를들어 글루타린산, 말레산, 석신산, 싸이클로부탄-1, 2-디카복실산, 싸이클로펜탄-1, 2-디카복실산, 싸이클로헥산-1, 2-디카복실산 및 프탈산같은 디카복실산으로부터 유도될 수 있다.As anhydrides, mixed, cyclic and Leuchs anhydrides can be used as well as symmetric anhydrides as long as they can be formed. The acyloxy group in the mixed anhydride (compound 2 in which the hydroxy group is substituted with the acyloxy group) is preferably trifluoroacetoxy, acetoxy, formyloxy, propionyloxy, butyryloxy or isobutyloxy. Cyclic anhydrides are, for example, dicarboxylic acids such as glutaric acid, maleic acid, succinic acid, cyclobutane-1, 2-dicarboxylic acid, cyclopentane-1, 2-dicarboxylic acid, cyclohexane-1, 2-dicarboxylic acid and phthalic acid. Can be derived from.
로이히 무수물은 글리신, 루신, 이소루신 같은 지방족아미노산뿐만 아니라 싸이클로부탄, 싸이클로펜탄, 싸이클로헥산, 싸이클로헵탄, 싸이클로옥탄 또는 티오피탄의 1-아미노-1-카복실산같은 아미노산과 포스겐으로부터 형성된다.Leihi anhydrides are formed from aliphatic amino acids such as glycine, leucine, isoleucine, as well as amino acids and phosgene such as 1-amino-1-carboxylic acids of cyclobutane, cyclopentane, cyclohexane, cycloheptane, cyclooctane or thiopitane.
X기가 아릴설포닐옥시기일때는 이것은 페닐설포닐옥시, P-톨릴설포닐옥시, 나프틸-1-설포닐옥시 또는 나프틸-2-설포닐옥시기가 좋다.When the X group is an arylsulfonyloxy group, this is preferably a phenylsulfonyloxy, P-tolylsulfonyloxy, naphthyl-1-sulfonyloxy or naphthyl-2-sulfonyloxy group.
일반식(Ⅰ)의 신규화합물의 제조와 일반식(Ⅰ)의 다른 화합물로의 전환은 각 반응에 적당한 공지의 반응조건하에서 문헌(참조예, Houben Weyl, Methoden der organischen Chemie Pnb, Georg-Thieme-Verlag, Stuttgart)에 기술된 바와같은 공지 방법으로 수행될 수 있다.The preparation of novel compounds of general formula (I) and the conversion to other compounds of general formula (I) are described in the literature (see, eg, Houben Weyl, Methoden der organischen Chemie Pnb, Georg-Thieme-) under known reaction conditions suitable for each reaction. Verlag, Stuttgart).
일반식(Ⅰ)의 신규물질을 제조하기 위해 필요한 모든 출발물질들은 원한다면 반응혼합물로부터 분리하지 않고 즉시 더욱 반응시켜 일반식(Ⅰ)의 목적화합물을 얻는 것 같이 그 자체내에서 생산될 수 있다.All starting materials necessary for the preparation of novel substances of general formula (I) can be produced in themselves, such as if desired, without further separation from the reaction mixture and immediately further reaction to obtain the desired compound of general formula (I).
일반식(Ⅰ)화합물은 HPI를 일반식(Ⅱ)인 카복실산이나 그의 기능적유도체와 반응시켜 제조할 수 있다. 바람직한 기능적유도체로는 카복실산무수물, p-플루오로벤조산-포름산무수물같은 혼합된 카복실산무수물, 불화물, 염화물, 브롬화물 및 요오드화물 같은 카복실산 할라이드 및 아자이드가 있다. 과량의 카복실산 유도체는 용매로서 사용될 수 있거나 이 반응은 벤젠이나 톨루엔같은 방향족 탄화수소, 디이소프로필에테르, 테트라하이드로푸란이나 디옥산같은 에테르, 아세토니트릴같은 니트릴, 디클로로메탄, 클로로포름, 사염화탄소나 클로로벤젠같은 할로겐화탄화수소같은 불활성용매 존재하에 수행된다.The compound of formula (I) can be prepared by reacting HPI with a carboxylic acid of formula (II) or a functional derivative thereof. Preferred functional derivatives include carboxylic acid anhydrides, mixed carboxylic acid anhydrides such as p-fluorobenzoic acid-formic anhydride, carboxylic acid halides and azides such as fluorides, chlorides, bromide and iodides. Excess carboxylic acid derivatives may be used as solvents or the reaction may be carried out with aromatic hydrocarbons such as benzene or toluene, diisopropyl ether, ethers such as tetrahydrofuran or dioxane, nitriles such as acetonitrile, dichloromethane, chloroform, halogenated carbons or chlorobenzenes. It is carried out in the presence of an inert solvent such as a hydrocarbon.
아실화할때는 수산화나트륨, 수산화칼륨, 탄산나트륨, 탄산칼륨, 피리딘, 트리에틸아민이나 트리이소프로필아민같은 유기 또는 무기염기를 가하는 것이 좋다. 산(Ⅱ)자체와의 반응은 0-200℃에서 수행하는 것이 좋고 그의 기능적유도체를 사용하는 경우는 0℃와 사용되는 용매의 비점사이가 좋고 바람직하기로는 0℃-80℃가 좋다. 반응시 간은 10분-48시간이고, 좋기로는 30분-5시간이다.When acylating, it is preferable to add organic or inorganic bases such as sodium hydroxide, potassium hydroxide, sodium carbonate, potassium carbonate, pyridine, triethylamine or triisopropylamine. The reaction with the acid (II) itself is preferably carried out at 0-200 ° C., and its functional derivative is preferably between 0 ° C. and the boiling point of the solvent used, preferably 0 ° C.-80 ° C. The reaction time is 10 minutes-48 hours, preferably 30 minutes-5 hours.
실리콘테트라콜로라이드, 포스포러스 트리클로라이드, 브로마이드, 포스포러스 옥시클로라이드, 티오닐 클로라이드나 포스포러스펜타클로라이드같은 할로겐화제와 상응하는 카복실산(Ⅱ)으로부터 좋기로는 상기용매중 하나내에서 또는 상기한 유기염기중 하나를 부가하여 자체내에서 카복실산할라이드, 특히 염화물을 생산할 수도 있다. 이 경우 40-200℃가 좋고 특히 70-140℃가 좋다.From the corresponding carboxylic acids (II) with halogenating agents such as silicon tetrachloride, phosphorus trichloride, bromide, phosphorus oxychloride, thionyl chloride or phosphorus pentachloride, preferably in one of the above solvents or the organic bases mentioned above One can also be added to produce carboxylic acid halides, in particular chlorides, in-house. In this case, 40-200 ° C. is particularly preferable.
HPI와 유리카복실산(Ⅱ)의 반응은 예를들어 상기불활성용매중의 하나내에서 디싸이클로헥실카보디이미드 존재하에, 또는 피리딘내에서, 저온(예, 0-20℃)에서 수행하는 것이 좋다.The reaction of HPI with free carboxylic acid (II) is preferably carried out at low temperature (eg 0-20 ° C.), for example in the presence of dicyclohexylcarbodiimide in one of the inert solvents or in pyridine.
또한 소디움이나 포타슘하이드라이드 같은 염기성촉매 존재 또는 부재하에 그리고 통상 크실렌, 디메틸포름아미드, 디메틸설폭사이드, 설폰란, 디옥산, 테트라하이드로푸란이나 디에틸에테르 존재하에 약 0°-200℃에서 HPI와 상기한 락톤중의 하나를 반응시킬 수 있다.HPI and the above at about 0 ° -200 ° C. in the presence or absence of a basic catalyst such as sodium or potassium hydride and usually in the presence of xylene, dimethylformamide, dimethylsulfoxide, sulfolane, dioxane, tetrahydrofuran or diethyl ether One of the lactones can be reacted.
출발물질로서 라세미 HPI외에도 두가지 광학 이성체중의 하나, 특히 (-)대칭체는 아실화에 의해 약리학상 특히 가치있는 광학적으로 활성있는(Ⅰ)화합물로 전환될 수 있다.In addition to the racemic HPI as starting material, one of the two optical isomers, in particular the (-) symmetry, can be converted into an optically active (I) pharmacologically valuable compound by acetylation.
출발물질(카복실산(Ⅱ)뿐 아니라, HPI도)은 알려져 있거나 대표적인 방법에 따라 공지물질과 마찬가지로 제조될 수 있다.Starting materials (as well as carboxylic acid (II) as well as HPI) can be prepared as well as known materials by known or representative methods.
일반식(Ⅰ)화합물은 또한 HX를 분리시키는 조건하에서 환화제의 존재하에 일반식(Ⅲ)화합물을 환화시켜 제조될 수 있다. 환화제로서 부틸리튬, 포타슘-tert-부틸레이트, 페닐리튬, 소디움하이드라이드, 소디움이나 포타슘메틸레이트, 에틸레이트, 프로필레이트, 이소프로필레이트, n-부틸레이트과 tert-부틸레이트 같은 알코홀레이트, 리튬의 이소프로필아마이드나 상응하는 소디움이나 포타슘아마이드 같은 아마이드등의 강염기가 사용될 수 있다. 이 반응은 통상 벤젠, 헥산, tert-부탄올, 테트라하이드로푸탄, 헥사메틸포스포린산, 트리아마이드, 디옥산, 에테르, 디메틸포름아미드, 디메틸설폭사이드나 아세토니트릴같은 불활성용매내에서 원한다면 질소기류하에 진행된다. 반응온도는 -20℃- 사용되는 용매의 비점 사이가 좋고 반응은 15분 내지 30시간, 좋기로는 10-14시간 진행시킨다. 환화는 출발물질로서 광학적으로 활성인 화합물(Ⅲ)을 사용하여 수행하므로서 광학적으로 활성인 이성체인(Ⅰ)화합물을 얻을 수 있다.Compounds of formula (I) may also be prepared by cyclization of compounds of formula (III) in the presence of cyclizing agents under conditions separating HX. As cyclizing agents, alcohols such as butyllithium, potassium-tert-butylate, phenyllithium, sodium hydride, sodium or potassium methylate, ethylate, propylate, isopropylate, n-butylate and tert-butylate, lithium Strong bases such as isopropylamide or the corresponding amides such as sodium or potassium amide may be used. This reaction is usually carried out under nitrogen stream if desired in an inert solvent such as benzene, hexane, tert-butanol, tetrahydrobutan, hexamethylphosphoric acid, triamide, dioxane, ether, dimethylformamide, dimethylsulfoxide or acetonitrile. do. The reaction temperature is good between the boiling point of the solvent used at -20 ° C- and the reaction proceeds for 15 minutes to 30 hours, preferably 10 to 14 hours. Cyclization is carried out using optically active compound (III) as a starting material, thereby obtaining an optically active isomer (I) compound.
일반식(Ⅲ)인 출발물질은 문헌에 공지된 방법에 따라 예를들어 2-위치에서 R-CO-기(일반식 Ⅰ에서와 같은 의미를 갖음)로 치환된 상응하는 1-시아노-1, 2-디하이드로- 또는 1-시아노-1, 2, 3, 4-테트라하이드로-이소퀴놀린으로부터 얻어질 수 있다. 이것은 높은 온도와 압력하에서 타니니켈 존재하에 R-CO-기를 분리시켜 환원되어 상응하는 N-(1, 2, 3, 4-테트라하이드로이소퀴놀릴-1-메틸)아실아미드를 얻고 이것은 계속 예를들어 클로로아세틸 클로라이드같은 일반식 X-CH2-CO-X화합물과 함께 일반식(Ⅲ)화합물로 전환될 수 있다.Starting materials of the general formula (III) are, for example, corresponding 1-cyano-1 substituted in the 2-position with an R-CO- group (which has the same meaning as in general formula I) according to methods known in the literature. , 2-dihydro- or 1-cyano-1, 2, 3, 4-tetrahydro-isoquinoline. It is reduced by separating the R-CO- group in the presence of tannickel under high temperature and pressure to give the corresponding N- (1, 2, 3, 4-tetrahydroisoquinolyl-1-methyl) acylamide, which continues to be an example. For example, the compound may be converted into a general formula (III) compound together with the general formula X-CH 2 -CO-X compound such as chloroacetyl chloride.
또한 일반식(Ⅳ)화합물을 환원시켜 좋기로는 촉매적 수소첨가시켜 일반식(Ⅰ)화합물을 얻을 수도 있다. 이러한 목적의 촉매로는 문헌에 알려진 통상의 촉매, 좋기로는 귀금속 촉매, 그러나 니켈 및 코발트촉매뿐 아니라 구리-크롬옥사이드촉매도 사용될 수 있다.In addition, the compound of formula (I) may be obtained by reducing the compound of formula (IV), preferably by catalytic hydrogenation. As catalysts for this purpose, conventional catalysts known in the literature, preferably noble metal catalysts, but not only nickel and cobalt catalysts but also copper-chromium oxide catalysts can be used.
귀금속촉매는 예를들어 담체상에서(예 활성탄상의 팔라듐) 또는 옥사이드촉매로서(예, 산화백금) 또는 미세하게 분쇄된 금속촉매로서(예, 백금스폰지)사용될 수 있다. 니켈과 코발트촉매는 라니금속으로서 사용하는 것이 좋고 니켈은 또한 담체로서 규조토나 경석을 사용할 수도 있다. 수소화반응은 약 1-200기압에서, 0-200℃로 좋기로는 메탄올, 에탄올, 이소프로판올이나 tert-부탄올 같은 알콜류, 에틸아세테이트, 디옥산이나 테트라하이드로푸란같은 에테르, 물, 또는 알카리용액같은 용매존재하에 수행하는 것이좋다.Precious metal catalysts can be used, for example, on a carrier (eg palladium on activated carbon) or as an oxide catalyst (eg platinum oxide) or as a finely ground metal catalyst (eg platinum sponge). Nickel and cobalt catalysts are preferably used as Raney metals, and nickel may also use diatomaceous earth or pumice as a carrier. The hydrogenation reaction is carried out at about 1-200 atm, preferably 0-200 ° C., preferably alcohols such as methanol, ethanol, isopropanol or tert-butanol, ethers such as ethyl acetate, dioxane or tetrahydrofuran, water or solvents such as alkaline solutions. It is recommended to carry out under.
원한다면 수소화반응은 또한 균일상에서 수행될 수도 있다. 이러한 목적의 촉매로서는 예를들면 하이드리도-카보닐-트리스(트리페닐-포스핀)로디움 같은 가용성 로디움 착화합물 같은 중금속착화합물이 사용될 수 있다. (Ⅳ)화합물의 환원은 또한 예를들어 비대칭 수소화반응시켜 전부 또는 대부분이 화합물(Ⅰ)의 이성체가 되도록 진행시킬 수 있다. 이러한 목적의 촉매로는 예를들어 광학적으로 활성인 하이드록시의 수용액이나 주석산, 구연산, 아라닌, 이소루닌, 라이신, 페닐아라닌, 발린 또는 루신등의 아미노산과 같은 비대칭변형제로 전처리한 라니니켈을 사용할 수 있다.If desired, the hydrogenation can also be carried out in a homogeneous phase. As a catalyst for this purpose, for example, heavy metal complexes such as soluble rhodium complexes such as hydrido-carbonyl-tris (triphenyl-phosphine) rhodium can be used. Reduction of compound (IV) can also be carried out, for example, by asymmetric hydrogenation so that all or most of the compound is isomer of compound (I). Catalysts for this purpose include, for example, an aqueous solution of optically active hydroxy, or a rannickel pretreated with an asymmetric modifier such as amino acids such as tartaric acid, citric acid, alanine, isorucine, lysine, phenylalanine, valine or leucine. Can be used.
비대칭 수소화반응을 위해서는 문헌에 소개된 바와같이 천연이나 합성중합체에 작용시킨 중금속촉매를 사용할 수 있다. 예를들어 팔라듐이나 백금을 명주나 특별히 제조된 실리카겔 또는 폴리아미노산 담체상에서 사용한다. 균일상내에서 비대칭 수소화반응은 예를들어 광학활성이고 가용성인 로디움 착염으로 수행될 수 있다. 비대칭 수소화반응은 상술한 조건하에서 좋기로는 1-3기압에서 20-50℃로 수행한다.For asymmetric hydrogenation, heavy metal catalysts acting on natural or synthetic polymers can be used as described in the literature. Palladium or platinum, for example, is used on silk or specially prepared silica gel or polyamino acid carriers. Asymmetric hydrogenation in a homogeneous phase can be carried out, for example, as an optically active and soluble rhodium complex salt. The asymmetric hydrogenation reaction is preferably carried out at 20-50 ° C. at 1-3 atmospheres under the above-mentioned conditions.
출발물질(Ⅳ)는 예를들어 11b(1)-위치에서 포화된 일반식(Ⅰ)의 상응하는 화합물을 황, 셀레니움, 클로라닐이나 문헌에 알려진 다른 탈수소화제로 탈수소시켜 제조할 수 있다. 이러한 반응은 11b(1)-위치에서 포화된 화합물이 광학적으로 활성있는 이성체이고 다른 가능한 이성체보다 효과가 적을 때 특히 흥미있다. 이 경우 효과가 더 적은 이성체는 탈수소화시켜 화합물(Ⅳ)으로 전환시킬 수 있고 계속 수소화시켜 더욱 효과있는 포화된 구조식(Ⅰ)의 라세미형태를 얻거나 비대칭수소화시켜 거의 완전히 더욱 효과적인 구조식(Ⅰ)의 이성체로 전환시킬 수 있다.Starting material (IV) can be prepared, for example, by dehydrogenation of the corresponding compound of formula (I) saturated at the 11b (1) -position with sulfur, selenium, chloranyl or other dehydrogenating agents known from the literature. This reaction is of particular interest when the compounds saturated at the 11b (1) -position are optically active isomers and are less effective than other possible isomers. In this case, less effective isomers can be dehydrogenated to convert to compound (IV) and continue to hydrogenate to obtain racemic form of the more saturated saturated formula (I), or asymmetric hydrogenation to almost completely more effective formula (I). Can be converted to isomers.
얻어진 일반식(Ⅰ)화합물의 R기는 원한다면 문헌에 기술된 방법에 따라 다른 R기로 전환시킬 수 있다. 예를들어 이미 존재하던 치환기는 다른 치환기로 전환시킬 수 있다.The R group of the obtained compound of formula (I) may be converted to another R group according to the method described in the literature, if desired. For example, existing substituents can be converted to other substituents.
이렇게 니트로기와 같은 환원될 수 있는 치환체는 촉매적 수소화나 화학적으로 환원될 수 있다. 촉매적 환원은 상술한 조건하에서 수행될 수 있다. 이 환원반응을 수행하기 위해서 예를들어 금속(예, 철, 아연)과 산(예, 염산이나 초산) 또는 염화주석을 사용할 수 있다.Such reducible substituents, such as nitro groups, can be catalytically hydrogenated or chemically reduced. Catalytic reduction can be carried out under the conditions described above. To carry out this reduction reaction, for example, metals (eg iron, zinc) and acids (eg hydrochloric acid or acetic acid) or tin chloride can be used.
화합물(Ⅰ)의 아실기에 있는 추가적인 케토기는 수소화반응이나 화학적으로 하이드록실기로 전환될 수 있다. 이 수소화반응은 상술한 방법에 따라 쉽게 수행된다. 더욱이 케토기는 예를어 아연/산(예, 초산)이나 아연/알카리금속 하이드록사이드 수용액으로 처리하여 발생기수소로 환원시킬 수 있다. 에탄올, 이소프로판올이나 이소아밀 알콜같은 저급알콜내에서 소디움이나 다른 알카리금속을 사용할 수가 있다. 또한 케토기는 금속하이드라이드, 좋기로는 예를들어, 소디움보로하이드라이드, 라티움 보로하이드라이드, 포타슘트리(sec-부틸)-브로하이드라이드 또는 포타슘트리메톡시보로하이드라이드 같은 환증의 아미드기를 공격하지 않는 착염 금속하이드라이드로서 좋기로는 예를들어 디에틸에테르, 테트라하이드로푸란, 디옥산, 1, 2-디메톡시에탄이나 디글라일 같은 에테르 처럼 불활성용매 존재하에 환원시킬 수 있다. 반응은 -80-100℃특히 -20℃-사용용매의 비등점사이에서 수행할 수 있다.Additional keto groups in the acyl group of compound (I) can be hydrogenated or chemically converted to hydroxyl groups. This hydrogenation reaction is easily carried out according to the method described above. Furthermore, keto groups can be reduced to hydrogen gas by treatment with, for example, an aqueous solution of zinc / acid (eg acetic acid) or zinc / alkali metal hydroxide. Sodium or other alkali metals may be used in lower alcohols such as ethanol, isopropanol or isoamyl alcohol. Keto groups may also be metal hydrides, preferably amides such as sodium borohydride, sodium borohydride, potassium tri (sec-butyl) -brohydride or potassium trimethoxyborohydride. Complex salt metal hydrides which do not attack groups can be reduced in the presence of an inert solvent, for example ethers such as diethyl ether, tetrahydrofuran, dioxane, 1, 2-dimethoxyethane or diglyl. The reaction can be carried out between -80-100 ° C., in particular between -20 ° C. and the boiling point of the solvent.
더욱이 케토기는 예를들어 하이드라진과 반응시키고 형성된 하이드라존을 분해시키는 울프-키슈너법(Wolff--Kishner method)에 의하여 메틸렌기로 전환시킬 수 있다. 또한 상술한 조건하에서 이중 결합은 단일결합으로 환원될 수 있거나 삼중결합이 이중결합이나 단일 결합으로 환원될 수 있다. R 기중의 N-옥사이드기는 수소/팔라듐을 사용하여 공지방법에 따라 상응하는 3급 아민으로 환원될 수 있다. 아실기에 3급 질소원자를 가진 화합물(Ⅰ)은 예를들어 과산화수소(좋기로는 30% 수용액이나 과산화수소와 포름산의 혼합물). 과초산, 과벤조산, 3-클로로 과벤조산이나 tert-부틸하이드로퍼옥사이드 같은 무기나 유기과산화물과 반응시켜 상용하는 N-옥사이드로 전환시킬 수 있다.Furthermore, keto groups can be converted to methylene groups, for example, by the Wolff-Kishner method, which reacts with hydrazine and decomposes the formed hydrazone. In addition, under the above conditions, the double bond may be reduced to a single bond or the triple bond may be reduced to a double bond or a single bond. N-oxide groups in the R group can be reduced to the corresponding tertiary amines according to known methods using hydrogen / palladium. Compounds (I) having tertiary nitrogen atoms in acyl groups are for example hydrogen peroxide (preferably a 30% aqueous solution or a mixture of hydrogen peroxide and formic acid). It can be converted to commercially available N-oxides by reacting with inorganic or organic peroxides such as peracetic acid, perbenzoic acid, 3-chloro perbenzoic acid or tert-butylhydroperoxide.
유기과산화물의 용매로서 예를들어 메틸렌클로라이드, 클로로포름, 또는 메탄올이나 이소프로판올 같은 알콜을 사용할 수 있고 이 반응은 0-50℃, 좋기로는 실온에서 진행할 수 있으며 반응시간은 1-48시간이다.As a solvent of the organic peroxide, for example, methylene chloride, chloroform, or alcohols such as methanol or isopropanol can be used, and the reaction can proceed at 0-50 ° C, preferably at room temperature, and the reaction time is 1-48 hours.
R기에 메르캅토기를 가진 화합물(Ⅰ)은 예를들어 질산으로 산화시켜 상응하는 설포화합물로 만들 수 있으며 마찬가지로 상응하는 알킬티오기는 예를들어, 질산, 과산화수소나 3-클로로퍼벤조산 수용액으로서 설폰이나 설폭사이드로 전환시킬 수 있다. R기중의 알콜기는 이산화망간이나 크롬산으로 산화시켜 카보닐기로 전환시킬 수 있다.Compounds (I) having a mercapto group in the R group can be oxidized with nitric acid to form the corresponding sulfo compound. Similarly, the corresponding alkylthio group can be, for example, sulfonic acid as an aqueous solution of nitric acid, hydrogen peroxide or 3-chloroperbenzoic acid. Can be converted to sulfoxide. The alcohol group in the R group can be converted to a carbonyl group by oxidation with manganese dioxide or chromic acid.
치환체로서 하나 또는 그 이상의 유리 하이드록시, 메르캅토, 아미노 또는 모노알킬아미노기를 가진 화합물(Ⅰ)은 상응하는 알콜시, 알킬티오, 모노알킬아미노, 디알킬아미노나 트리알킬암모늄화합물로 알킬화되거나 상응하는 아실화물로 아실화될 수 있다.Compound (I) having one or more free hydroxy, mercapto, amino or monoalkylamino groups as substituents may be alkylated or correspondingly substituted with the corresponding alcohol, alkylthio, monoalkylamino, dialkylamino or trialkylammonium compounds. Acylates can be acylated.
0-및 S-알킬화반응을 위해서는 출발물질은 예를들어 수산화나트륨, 수산화칼륨이나 탄산칼륨 수용액의 염기를 가하여 상응하는 염으로 우선전환시키는 것이 좋다. 사용될 수 있는 알킬화제의 예로는 메틸클로라이드브로마이드나, 요오다이드, 에틸클로라이드, 브로마이드나 요오다이드 같은 알킬할라이드, 디메틸설페이트, 디에틸설페이트나 메틸 P-톨루엔설포네이트 같은 상응하는 디알킬황산이나 알킬설폰산, 또는 디아조메탄 같은 디아조화합물이 있다. 아미노화합물은 수소와 촉매존재하에 또는 포름산존재하에 포름알데히드나 아세트알데히드로 환원적으로 알킬화시킬 수 있다. 용매로서는 예를들어 물이나 수산화나트륨수용액, 메탄올, 에탄올이나 n-부탄올 같은 알콜 : 벤젠이나 크실렌같은 탄소수소, 테트라하이드로푸란 이나 디옥산같은 에테르, 디메틸포름 아마이드같은 아마이드가 사용될 수 있다. 알킬화반응은 -10-150℃, 특히 실온과 사용되는 용매의 비등점사이에서 수행하는 것이 좋다.For the 0- and S-alkylation reactions the starting materials are preferably converted to the corresponding salts by the addition of a base of, for example, sodium hydroxide, potassium hydroxide or potassium carbonate aqueous solution. Examples of alkylating agents that may be used are methyl chloride bromide, alkyl halides such as iodide, ethyl chloride, bromide or iodide, dimethyl sulfate, diethyl sulfate or corresponding dialkyl sulfates or alkyl sulfides such as methyl P-toluenesulfonate Diazo compounds such as phonic acid or diazomethane. The amino compound can be reductively alkylated with formaldehyde or acetaldehyde in the presence of hydrogen and a catalyst or in the presence of formic acid. As a solvent, for example, water or an aqueous solution of sodium hydroxide, alcohols such as methanol, ethanol or n-butanol: hydrocarbons such as benzene or xylene, ethers such as tetrahydrofuran or dioxane and amides such as dimethylformamide may be used. The alkylation reaction is preferably carried out between -10-150 ° C., in particular between room temperature and the boiling point of the solvent used.
상응하는 아실화반응은 예를들어 HPI의 아실화반응에서 기술한 바와 같은 조건하에서 카복실산이나 카복실산 유도체로 수행하는 것이 좋다. 또한 아실화반응은 좋기로는 예를들어 에테르, 디클로로메탄, 클로로포름, 벤젠이나 톨루엔 같은 불활성용매내에서 커텐으로 수행할 수 있다. 황산이나 P-톨루엔 설폰산 같은 산 촉매를 가하여서도 가능하다. 즉, 예를들면 2-(4-하이드록시벤조일)-HPI와 케텐으로부터 2-(4-아세톡시 벤조일)-HPI가 얻어진다. R기에 1급 또는 2급 아미노기를 가진 얻어진 일반식(Ⅰ)화합물을 상술한 조건하에서 당유도체로 반응시켜 R기중의 아미노기가 당산으로 보호된 화합물을 제조할 수 있다. 당 유도체로서 예를들어 글루콘산 락톤이나 글루쿠론산 락톤 같은 당의락톤을 사용할 수 있다. 또한 R 기중의 아미노기는 당산이나 그의 기능적 유도체로 반응될 수 있으며, 예를들어 벤질기로 보호된 다른 하이드록실기는 예를들어 수소화반응에 의해 다시 분리된다. 이렇게하여 예를들면 2-(4-아미노벤조일)-HPI를 2, 3, 4, 5, 6-펜타-0-벤질-글루코노일 클로라이드와 반응시키고 생성된 2-[4-(2, 3, 4, 5, 6-펜타-0-벤질-글루코노일아미노)-벤조일]-HPI중의 벤질기를 가수분해시켜 2-(4-글루코노일아미노벤조일)-HPI를 얻을 수 있다.Corresponding acylation reactions are preferably carried out with carboxylic acids or carboxylic acid derivatives under conditions as described, for example, in the acylation of HPI. The acylation reaction may also be carried out with a curtain, preferably in an inert solvent such as ether, dichloromethane, chloroform, benzene or toluene. It is also possible to add an acid catalyst such as sulfuric acid or P-toluene sulfonic acid. That is, for example, 2- (4-acetoxy benzoyl) -HPI is obtained from 2- (4-hydroxybenzoyl) -HPI and ketene. The obtained general formula (I) compound having a primary or secondary amino group in the R group can be reacted with a sugar derivative under the above-described conditions to prepare a compound in which the amino group in the R group is protected with sugar acid. As a sugar derivative, sugar lactone, such as gluconate lactone and glucuronic acid lactone, can be used, for example. The amino groups in the R groups can also be reacted with sugar acids or functional derivatives thereof, for example other hydroxyl groups protected by benzyl groups, for example separated again by hydrogenation. Thus for example 2- (4-aminobenzoyl) -HPI is reacted with 2, 3, 4, 5, 6-penta-0-benzyl-gluconoyl chloride and the resulting 2- [4- (2, 3, The benzyl group in 4, 5, 6-penta-0-benzyl-gluconoylamino) -benzoyl] -HPI can be hydrolyzed to obtain 2- (4-gluconoylaminobenzoyl) -HPI.
R기중의 아미노기가 하나이상의 설포기로 보호된 화합물(Ⅰ)은 예를 들어 HPI를 산할라이드와 반응시킬때 기술한 반응조건하에서 R기에 하나이상의 유리아미노기를 가진 화합물(Ⅰ)을 클로로설폰산으로 반응시켜 얻을 수 있다. 또한 가용매분해제조 처리하여 얻어진 일반식(Ⅰ) 화합물중의 아실옥시(예, 포르밀옥시, 아세톡시, 트리플루오로아세톡시, 프탈로일옥시 또는 다른 쉽게 검화될 수 있는 기). 아실 메르벳토기나 알콕시카보닐기(예. 메톡시카보닐이나 에톡시시카보닐)를 하이드록실, 메르캅토나 카복실기로 전환시킬 수 있다. 이런 목적으로 염산이나 초산같은 산, 또는 좋기로는 소디움이나 포다슘카보네이트나 칼슘, 바륨, 소디움이나 포스슘하이드록사이드 같은 염기를 예를들어 메탄올수용액 내에서 사용할 수 있다.Compound (I) in which the amino group in the R group is protected by at least one sulfo group, for example, reacts the compound (I) having one or more free amino groups in the R group with chlorosulfonic acid under the reaction conditions described when reacting HPI with an acid halide. It can be obtained by reacting. Acyloxy (eg, formyloxy, acetoxy, trifluoroacetoxy, phthaloyloxy or other readily saponifiable groups) in the compound of formula (I) obtained by solvolysis preparation treatment. An acyl merbetto group or an alkoxycarbonyl group (for example, methoxycarbonyl or ethoxycarbonyl) can be converted into a hydroxyl, mercapto or carboxyl group. For this purpose, acids such as hydrochloric acid or acetic acid, or preferably bases such as sodium or potassium carbonate or calcium, barium, sodium or phosphium hydroxide can be used, for example, in aqueous methanol solution.
산아마이드기를 공격하지 않도록 하기 위해서 혼화한 반응조건을 사용하는 것이 좋다. 일반적으로 -40-90℃에서 2-50 시간동안 반응을 진행시킨다.In order to avoid attacking acid amide groups, it is better to use mixed reaction conditions. In general, the reaction proceeds for 2-50 hours at -40-90 ℃.
일반식(Ⅰ)화합물중의 시아노기는 산성매질(예, 염산이나 황산수용액, 메탄올, 에탄올, 디옥산이나 초산수용액) 또는 알카리성매질(예, 에탄 올수용액이나 싸이클로헥산올내의 수산화칼륨)내에서 카바모일기로 가수분해될 수 있다. 또한 일반적으로 실온내지 80℃로 1-5시간동안 알카리용액내에서 과산화수소를 사용할 수도 있다.The cyano group in the compound of formula (I) is in an acidic medium (e.g. aqueous hydrochloric acid or sulfuric acid solution, methanol, ethanol, dioxane or acetic acid aqueous solution) or an alkaline medium (e.g. ethanol aqueous solution or potassium hydroxide in cyclohexanol). Carbamoyl groups can be hydrolyzed. Hydrogen peroxide can also be used in alkaline solutions, typically at room temperature to 80 ° C. for 1-5 hours.
아실기중의 아미노기가 쉬프(schiff) 염기형태로 보호된 화합물은 수소분해 방법으로 상응하는 2급아민으로 전환될 수 있다. 쉬프염기는 예를들어 포름알데히드, 벤즈알데히드나 글리 옥실산 같은 알데히드나아세톤 같은 케톤으로부더 쉽게 유도된다.Compounds in which the amino group in the acyl group is protected in the form of a schiff base can be converted to the corresponding secondary amine by the hydrolysis method. Schiffbases are more easily derived from, for example, ketones such as aldehydes such as formaldehyde, benzaldehyde or glyoxylic acid or acetone.
수소화반응을 위해서는 예를들어 대기압하에서 실온으로 백금이나 라니니켈 존재하에 수소를 사용할 수 있다.For hydrogenation, hydrogen may be used, for example, in the presence of platinum or nickel, at room temperature under atmospheric pressure.
벤질아미노화합물은 예를들어 팔라듐 같은 귀금속촉매 존재하에 수소로 분해하여 상응하는 일급아민을 얻을 수 있다.Benzylamino compounds can be decomposed with hydrogen, for example in the presence of a noble metal catalyst such as palladium to obtain the corresponding primary amine.
또한 얻어진 쉬프염기를 비설파이트와의 반응에 의하여 상응하는 비설파이드 내전체로 전환시킬 수 있다. 비설파이트 내전체는 알데히드-비설파이트 부가 생성물을 R기에 유리아미노기를 가진 화합물로 직접반응시켜서도 얻을 수 있다.It is also possible to convert the Schiff base obtained into a corresponding bisulfide whole by reaction with bisulfite. Bisulfite inner parts can also be obtained by directly reacting an aldehyde-bisulfite addition product with a compound having a free amino group in the R group.
화합물(Ⅰ)의 R기중에 있는 우레탄기, 예를들면 N-에톡시카보닐이나 N-벤질옥시카보닐기는 초산내에서 염화수소로 반응시켜 분리시킬 수 있다. 화합물(Ⅰ)의 R기중에 있는 피오우레반기로부터 예를들어 메탄올이나 에탄올 같은 알콜에서 알카리금속 아세테이트나 이초산납으로, 또는 이수산납이나 탄산납 존재하에 알카리금속하이드록 사이드 용액으로 상응하는 아미노기를 유리시킬 수 있다. 이론적으로 볼때 구조식(Ⅰ)화합물의 아실기중의 아미노보호기로서는 펩타이드 합성에 성공적으로 사용되는 모든것들이 있을 수 있다.The urethane group in the R group of compound (I), for example, N-ethoxycarbonyl or N-benzyloxycarbonyl group, can be separated by reaction with hydrogen chloride in acetic acid. The corresponding amino group is liberated from the piouureban group in the R group of compound (I), for example, with an alkali metal acetate or lead diacetate in an alcohol such as methanol or ethanol, or with an alkali metal hydroxide solution in the presence of lead dihydrate or lead carbonate. You can. Theoretically, as the amino protecting group in the acyl group of the compound of formula (I), there may be everything that is successfully used for peptide synthesis.
따라서 이 보호기를 제기시키는 문헌에 알려진 방법들도 사용할 수 있다. 또한 화합물(Ⅰ)의 알킬아미노 치환기는 예를들어 아질산으로 반응시키고 얻어진 니트로소아미노 화합물을 발생기수소(예, 아연/초산으로부터) 나염화주석으로 환원시켜 1-알킬하이드라지노 치환체로 전환시킬 수 있다. 더욱이 화합물(Ⅰ)의(R)기에 있는 케토기는 아미노기로 전환될 수 있는데 예를들면 케톤을 하이드록실아민이나 하이드라진과 반응시키고 생성된 옥심이나 하이드라존을 라니니켈 존재하에 1-50기압에서 수소화 시킨다. 다른 방법으로 케톤은 암모니아나 1급 또는 2급 아민 존재하에 수소화되어 일급, 이급 또는 삼급 아민(Ⅰ)이 얻어진다. 이 반응은 1-200기압에서 -40-150℃ 로 예를들어 메 탄올, 에탄올, 이소프로판올 테트라하이드로 푸란이나 액체암모니아 내에서 수행하는 것이 좋다.Thus, methods known in the literature raising this protecting group can also be used. The alkylamino substituents of compound (I) can also be converted to 1-alkylhydrazino substituents by, for example, reacting with nitrous acid and reducing the resulting nitrosoamino compound to hydrogen chloride (eg from zinc / acetic acid) tin chloride. have. Furthermore, the keto group in the (R) group of compound (I) can be converted to an amino group, for example by reacting ketones with hydroxylamine or hydrazine and reacting the resulting oxime or hydrazone at 1-50 atm in the presence of nickel. Hydrogenation. Alternatively, the ketone is hydrogenated in the presence of ammonia or primary or secondary amines to yield primary, secondary or tertiary amines (I). The reaction is preferably carried out in -40-150 ° C. at 1-200 atm, for example in methanol, ethanol, isopropanol tetrahydrofuran or liquid ammonia.
또한 화합물(Ⅰ)중의 케토기는 통상의 방법에 따라, 예를들어 불화수소산 존재하에사불화황이나 삼불화페닐황으로, 또는 피리딘 존재하에 카보닐디플루오라이도로 반응시켜 CF2기로 전환될 수 있다. 이 반응은 오토클레이브내에서 약간 고압으로 메틸렌클로라이드, 클로로포름, 테트라하이드로푸란 같은 불활성용매내에서 0-150℃로 수행하는 것이 좋다.The keto groups in compound (I) can also be converted to CF 2 groups according to conventional methods, for example by reacting with sulfur tetrafluoride or phenyl trifluoride in the presence of hydrofluoric acid or with carbonyldifluoride in the presence of pyridine. . This reaction is preferably carried out at 0-150 ° C. in an inert solvent such as methylene chloride, chloroform and tetrahydrofuran at slightly high pressure in the autoclave.
화합물(Ⅰ)에 있는 알콕시나 알킬티오기를 분리시켜 하이드록실기나 메르캅토기를 얻을수도 있다. 이반응조건은 산아마이드기가 안전한 상태에서 선택되어야 한다. 디클로로메탄, 클로로포름이나 사염화탄소같은 불활성용매내에서 약-40-50℃로 보론트리브로 마이드 같은 루이스산을 사용하는 것이 좋다.The alkoxy or alkylthio group in compound (I) may be separated to obtain a hydroxyl group or a mercapto group. This reaction condition should be chosen with a safe acid amide group. It is recommended to use Lewis acids such as borontribromide at about -40-50 ° C in an inert solvent such as dichloromethane, chloroform or carbon tetrachloride.
하나 또는 그 이상의 아미노기를 가진 화합물(Ⅰ)은 통상의 디아조화 방법에 따라 상응하는 디아조니움화합물로 전환된 후 이 디아조니움기는 예를들어 불소, 염소, 브롬, 요오드, 시아노, 하이드록실, 메르캅토, 0-알킬이나 S-알킬에 의해 치환될 수 있다.Compound (I) having one or more amino groups is converted to the corresponding diazonium compound according to a conventional diazotization method, and then this diazonium group is, for example, fluorine, chlorine, bromine, iodine, cyano, hydroxyl , May be substituted by mercapto, 0-alkyl or S-alkyl.
아미노화합물의 디아조화는 예를들어 황산, 염산, 브롬산이나 테트라플루오로보릭산 수용액내에서 -20-10℃-로 소디움이나 포타슘니트레이트 같은 무기니트레이트를 가하여 수행할 수 있다.Diazolation of amino compounds can be carried out, for example, by addition of inorganic nitrates such as sodium or potassium nitrate at -20-10 ° C in aqueous sulfuric acid, hydrochloric acid, bromic acid or tetrafluoroboric acid.
또한 디에틸에테르 테트라하이드로퓨란이나 디옥산 같은 불활성 유기용매내에서 -20-50℃로 n-부틸니트라이트, n-아밀니트라이트 또는 이소아밀니트라이트 같은 유기니트라이트를 사용할 수 있다.In addition, organic nitrile such as n-butyl nitrile, n-amyl nitrile or isoamyl nitrile may be used at -20-50 ° C. in an inert organic solvent such as diethyl ether tetrahydrofuran or dioxane.
불소원자를 도입하기위해서 디아조화 반응은 무수불화수소산용액을 가열하여 실시하거나 디아조니움염을 4불 화붕산과 반응시켜 일부 용해되는 디아조니움테트라플루오로보리이트를 얻는다.In order to introduce fluorine atoms, the diazotization reaction is carried out by heating anhydrous hydrofluoric acid solution, or the diazonium salt is reacted with tetrafluoroboric acid to obtain diazonium tetrafluoroborate which is partially dissolved.
이 화합물은 불활성용매내에서 가열시켜 분리되고 발열하면서 원하는 불소화합물로 전환될수 있다. 그러나, 디아조니움 테트라 플루오로보레이트, 특히 복소황 화합물인 것은 분리시키지 않고 현탁수용액내에서 수은 등으로 조사하여 원하는 불소화합물을 얻는다. 이 디아조니움기는 염화구리나 브롬화구리 존재하에 좋기로는 뜨거운 수용액내에서 염소나 브롬으로 치환될수 있다.This compound can be separated by heating in an inert solvent and converted to the desired fluorine compound while generating heat. However, diazonium tetrafluoroborate, especially a heterosulfur compound, is irradiated with mercury or the like in a suspension solution without separation to obtain a desired fluorine compound. This diazonium group may be substituted with chlorine or bromine in a hot aqueous solution, preferably in the presence of copper chloride or copper bromide.
디아조니움 요오다이드기를 요오드로 치환시키는 것은 요오드화구리, 브롬화구리 또는 염화구리를 가하면서 조금만 가온해도 일어난다.Substitution of the diazonium iodide group with iodine occurs even with a slight warming with addition of copper iodide, copper bromide or copper chloride.
디아조니움기를 시아노기로 치환시키는 것은 예를들어 소디움이나 포타스시아나이드 같은 알카리금속시아나이드와 시안화구리 존재하에 약 0-50℃에서 일어난다. 디아조니움기는 알콜수용액을 가열하여 알콕시기로 치환될 수도 있다.Substitution of the diazonium group with a cyano group occurs at about 0-50 ° C. in the presence of alkali metal cyanide and copper cyanide, such as, for example, sodium or potascyanide. Diazonium groups may be substituted with alkoxy groups by heating an alcoholic solution.
메르캅토기로의 치환은 디아조니움 화합물을 소디움에 틸크산토겐에이트, 같은 알카리금속 크산토겐에이트로 반응시키고 알카리검화시켜 쉽게 수행된다. 디아조니움 화합물은 또한 적당한 커플링화제와 커플링되어 상응하는 디아조염료를 얻을 수 있다. 커플링화제로서는 아미노, 알킬아미노, 디알킬아미노, 하이드록시나 알콕시기 같은 활성 있는 치환기를 가진 벤젠화합물을 사용하는 것이 특히 좋고 또한 카복시, 할로겐(좋기로는 불소나 염소), 설포나 알킬기 같은 치환기가 더 있는 것이 좋다.Substitution with the mercapto group is readily accomplished by reacting the diazonium compound with sodium with an alkali metal xanthogenate, such as thylkanthogenate, and with an alkaline gum. Diazonium compounds may also be coupled with suitable coupling agents to obtain the corresponding diazo dyes. As the coupling agent, it is particularly preferable to use benzene compounds having active substituents such as amino, alkylamino, dialkylamino, hydroxy or alkoxy groups and also substituents such as carboxy, halogen (preferably fluorine or chlorine), sulfo or alkyl groups. It is better to have more.
염기성 화합물(Ⅰ)은 원한다면 생리적으로 허용되는 그의 산부가염으로 전환될 수 있다. 이런 목적으로 예를들어 염산, 브롬산, 요오드산, 황산, 질산 인산 오르토인산 또는 설파민산 같은 무기산 : 포름산, 초산, 프로피온산, 부틸산, 피발릭산, 디에틸 초산, 옥살산, 말론산, 석신산, 피멜산, 푸마르산, 말레산, 구연산, 글루콘산, 젖산, 주석산, 말산, 벤조산, 살리실산, 페닐프로피온산, 아스코르빈산, 이소니코틴산, 메탄설폰산, 에탄디설폰산, 2-하이드록시에탄설폰산(이세티온산), P-톨루엔-설폰산, 나프탈렌-모노 또는 디설폰산(예, 나프탈렌-1-또는-2-설폰산이나 나프탈렌-1, 5-또는-2, 6-디설폰산) 같은 유기산 등의 지방족, 환상지방족, 아르알리파틱, 방향족이나 복소환식-모노 또는 폴리염기성 카복실산이나 설폰산 같은 무기 또는 유기산을 사용할 수 있다.Basic compound (I) can be converted to its physiologically acceptable acid addition salt, if desired. For this purpose, for example, inorganic acids such as hydrochloric acid, bromic acid, iodic acid, sulfuric acid, nitric acid orthophosphoric acid or sulfamic acid: formic acid, acetic acid, propionic acid, butyric acid, pivalic acid, diethyl acetate, oxalic acid, malonic acid, succinic acid, Pimelic acid, fumaric acid, maleic acid, citric acid, gluconic acid, lactic acid, tartaric acid, malic acid, benzoic acid, salicylic acid, phenylpropionic acid, ascorbic acid, isnicotinic acid, methanesulfonic acid, ethanedisulfonic acid, 2-hydroxyethanesulfonic acid (Ise Ionic acid), organic acids such as P-toluene-sulfonic acid, naphthalene-mono or disulfonic acid (e.g., naphthalene-1- or-2-sulfonic acid or naphthalene-1, 5-or-2, 6-disulfonic acid) Inorganic or organic acids such as aliphatic, cycloaliphatic, araliphatic, aromatic or heterocyclic-mono or polybasic carboxylic acids or sulfonic acids can be used.
유리카복실기나 유리 설포기를 가진 화합물(Ⅰ)은 염기와 반응시켜 생리적으로 허용되는 그의 금속염이나 암모늄염으로 전환시킬 수 있다. 그러나 염의 예로는, 소디움, 칼륨, 마그네슘, 칼륨 및 암모늄염 및 디메틸과 디에틸 암모늄, 싸이클로헥실암모늄, 디싸이클로헥실암모늄, N-알킬-이나 N-아릴-치환된 피페라지니움염(예, 메틸-피페 라지니움과 에틸-피페라지니움염), N, N-디벤질-에틸렌-디암모니움염 같은 치환된 암모늄염이 있다.Compound (I) having a free carboxyl group or a free sulfo group can be reacted with a base and converted into its physiologically acceptable metal salt or ammonium salt. However, examples of salts include sodium, potassium, magnesium, potassium and ammonium salts and dimethyl and diethyl ammonium, cyclohexyl ammonium, dicyclohexyl ammonium, N-alkyl- or N-aryl-substituted piperazinium salts (e.g. methyl- Substituted ammonium salts such as piperazinium and ethyl-piperazinium salts), N, N-dibenzyl-ethylene-diazomium salts.
반면에 염기성물질(Ⅰ)은 소디움이나 포타슘하이드록사이드 또는 탄산나트륨이나 칼륨과 같은 염기로 처리하여 그외 산부가염으로부터 유리될 수 있고 산, 특히 묽은 염산이나 황산 같은 무기산으로 처리하여 그의 금속 및 암모늄염으로부터 산성화합물(Ⅰ)을 유리시킬 수 있다. 일급, 이급 또는 삼급아미노기를 가진 화합물(Ⅰ)은 요오드화메틸, 디메틸설페이트 또는 에틸 할라이드 같은 4급 알킬화제로 처리하여 생리적으로 허용되는 그의 4급 암모늄염으로 전환될 수 있다.The basic substance (I), on the other hand, can be freed from other acid addition salts by treatment with sodium or potassium hydroxide or with a base such as sodium carbonate or potassium, and acidic from its metals and ammonium salts by treatment with acids, especially inorganic acids such as dilute hydrochloric or sulfuric acid. Compound (I) may be liberated. Compound (I) having a primary, secondary or tertiary amino group can be converted to its physiologically acceptable quaternary ammonium salt by treatment with quaternary alkylating agents such as methyl iodide, dimethylsulfate or ethyl halide.
일반식(Ⅰ)의 광합활성화합물은 이미 광학적으르 활성인 출발물질을 사용하여 쉽게 얻어질 수 있다.Photosynthetic compounds of general formula (I) can be readily obtained using starting materials which are already optically active.
HPI나 구조식(Ⅰ) 화합물의 대칭체가 보통 사용된다. 그러나 얻어진 일반식(Ⅰ)의 라세미체를 그의 광학이성체로 분리시킬 수 있는데 화학적인 분리 방법이 보통 사용된다. 예를들어 일반식(Ⅰ)의 라세미체를 광학활성인 보조제와 반응시켜 얻어진 부분기하입치이성체 혼합물을 적당한 방법으로 분리시킬 수 있다. 즉, 산성기(예, 카복실기)를 가진 일반식(Ⅰ)의 라세미체는 광학활성 염기와 반응될 수 있고, 또는 염기성기(예, 아미노기)를 가진 라세미체(Ⅰ)는 광학활성산과 반응될 수 있다. 광학활성염기에는 퀴닌, 신코니딘, 부르신, 신코닌, 하이드록시하이드린다민, 모르핀, 1-페닐에틸아민, 1-나프틸에틸아민, 퀴니딘이나 스트리크닌 같은 광학활성아민, 또는 라이신이나 아르기닌 같은 염기성 아미노산, 또는 아미노산 에스테르가 있다. 또한 광학활성산으로는 주석산, 디벤조일주석산, 디아세틸주석산, 캄포르산, β-캄포-설폰산, 만델산, 말산, 2-페닐부틸산, 디니트로디펜산, 젖산 또는 퀴닌산의 (+)와 (-)형을 사용할 수 있다. 얻어진 부분입체기하이성체 혼합물은 선택적 결정화나 인위적 선택으로 거의 분리시킬 수 있다. 결국 분리된 부분입체기하이성체는 가수분해 방법으로 일반식(Ⅰ)의 원하는 광학활성 화합물로 분리될 수 있다. 일반식(Ⅰ) 화합물은 촌충류와 디스토마류에 대해 구충작용이 있으며, 숙주에 따라 정리하면 다음과 같은 촌충류에 구충제로 사용될 수 있다.The symmetry of HPI or the compound of formula (I) is usually used. However, the racemate of formula (I) obtained can be separated by its optical isomer, and chemical separation methods are usually used. For example, the partial geometric isomer mixture obtained by reacting the racemate of formula (I) with an optically active adjuvant can be separated by a suitable method. That is, racemates of general formula (I) with acidic groups (eg carboxyl groups) can be reacted with optically active bases, or racemates (I) with basic groups (eg amino groups) are optically active Can be reacted with an acid. Optically active bases include, but are not limited to, quinine, cinconidine, bursin, cinconine, hydroxyhydrindamin, morphine, 1-phenylethylamine, 1-naphthylethylamine, optically active amines such as quinidine or strikin, or lysine or arginine Basic amino acids, or amino acid esters. As optically active acids, (+) of tartaric acid, dibenzoyltinic acid, diacetyltinic acid, camphoric acid, β-campo-sulfonic acid, mandelic acid, malic acid, 2-phenylbutyl acid, dinitrodiphenic acid, lactic acid or quinic acid (+ ) And (-) types can be used. The resulting diastereomeric mixtures can be almost separated by selective crystallization or artificial selection. The separated diastereomeric isomers can in turn be separated into the desired optically active compounds of formula (I) by hydrolysis methods. The general formula (Ⅰ) compound has an antiparasitic effect on tapeworms and dystomies, and can be used as an insect repellent in the following tapeworms according to the host.
1. 반추동물 : 모니에지아, 스틸레시아, 아비텔리나, 티사노소마, 티사니에지아, 타에니아속의 포충, 코에 누루스 세레브라리스와 에키노콕시포충.Ruminants: Moniezia, Stilsia, Abitellina, Tisanosoma, Tisaniezia, Taenian Insects, Koenurus Cerebraris and Echinoccosi.
2. 유제류(有蹄類) : 아노플로세팔라.2. ungulates: Anoflocepala.
3. 설치류 : 하이모노렙시스(특히, H, 나나와 H, 디미누타).3. Rodents: Hymonorepsis (especially H, Nana and H, Diminuta).
4. 조류 : 다바이네아, 라일리에티나와 하이모노레피스.4. Birds: Davainea, Riley Tina and Hymonorepis.
5. 개(犬)와 고양이류 : 타에니아(특히, T, 하이다티게나, T, 피시포미스, T, 타에니아에포미스, T. 오비아, T. 세리알리스, 세르비 및 T. 물티셉스). 디필리디움(특히, D, 카니눔), 및 에키노코커스(특히, E. 그라눌로수소와 E, 물티로쿨라리스).5. Dogs and cats: Taenia (especially T, Heidatigena, T, Fish Pomis, T, Taenia Epomis, T. Ovia, T. Serialis, Servi and T. suticeptes). Depilidedium (particularly D, caninum), and echinococcus (particularly E. granulohydrogen and E, multyrokularis).
6. 인간 : 타에니아(특히, T. 솔리움, T. 사기나타와 T. 세리알리스). 하이메졸레피스(특히, H. 나나와 H. 디미누타), 드레파니도타에니아, 디필리디움, 디플로필리둠, 코에누루스(특히, C. 세레브랄리스). 디필로보티움(특히, D. 라툼) 및 에키노코커스 포층(특히 E. 그라눌로수소와 E. 몰티로쿠라티스).6. Humans: Taenia (especially T. Solium, T. Saginata and T. Serialis). Himezolepis (especially H. Nana and H. Diminuta), Drephanidotaenia, Diphylldium, Diplophilidum, Coenurus (especially C. Cerebrilis). Dipillobotium (especially D. Ratum) and echinococcus fossils (especially E. granulohydrogen and E. moltyrocactis).
의약과 수의약품에서 구제하여야 할 중요한 흡충류는 시스토소미다에속에 속하는 것들이며 특히 시스토소마종(시스토소마 만소니, 시스토소마 해마토비움 및 시스토소마 자포니쿰)에 속하는 것이다. 더욱이 파시올라, 디크로코엘리움, 클로노키스, 오피스토르키스, 파라고니무스, 파람피스토뭄, 에키노스트마종 등도 영향을 미칠 수 있다.Important reptiles to be remedied in medicine and veterinary medicine belong to the genus Cistosomida, especially cistosoma species (cystosoma mansony, cystosoma hamatobium and cystosoma japonicum). . In addition, passiola, dicrocoelium, clonokis, office torques, paragonimus, pararamptomum, and echinostoma species may also have an effect.
화합물(Ⅰ)은 다음과 같은 숙주나 중간매개숙주에 촌충이나 흡충 또는 그의 유충을 퇴치하는데 사용할수 있다 : 즉 인간, 원숭이 종류, 또는 개나 여우 같은 개속동물, 고양이 같은 고양이종류, 말, 당나귀, 나귀 같은 유제류, 노루나 야생 사슴 같은 사슴속, 샤모이스, 설치류, 소양 산양 같은 반추동물, 닭, 오리, 같은 조류, 돼지 및 물고기 같은 가장 중요한 가축이나 야생동물에 사용할 수 있다.Compound (I) can be used to combat tapeworms, worms or larvae in hosts or intermediate media such as: humans, monkeys, or dogs or foxes, cats such as cats, horses, donkeys and donkeys. It can be used for most important livestock or wildlife, such as ungulates, deer such as roe deer or wild deer, ruminants such as chamois, rodents, goats, goats, ducks, birds, pigs and fish.
영양을 미칠 수 있는 기생충이나 유충의 서식처는 예를들어, 위, 장, 취장 및 담관 같은 위장관이다.The habitats of parasites or larvae that can nourish are, for example, the gastrointestinal tract such as the stomach, intestines, intestines and bile ducts.
그러나 여러가지 다른 기관, 예를들면 간, 신장, 폐, 심장, 림프관, 뇌, 척수, 고환, 복강, 결체조직, 근육, 복막, 늑막, 횡경막, 혈관 등이 포함된다.However, various other organs include the liver, kidneys, lungs, heart, lymphatic vessels, brain, spinal cord, testes, abdominal cavity, connective tissue, muscles, peritoneum, pleura, diaphragm, blood vessels, and the like.
화합물(Ⅰ)은 예를들어 혈관계통의 시스토소마속, 담관의 하이메노레피스 미크로스트마와 간의 T·하이다티게나 기생충에 우수한 퇴치력을 발휘한다.Compound (I), for example, exerts excellent fighting ability against T. hidatigen and parasites of cystosoma in the vascular system, hymenorepis microma of the bile duct and liver.
화합물(Ⅰ)은 자체 그대로 사용하거나 약제학상 허용되는 불활성담체와 혼합하여 사용할 수 있는데 이러한 담체에는 캅셀, 고체희석제나 충진제, 무균증류수나 여러가지 비독성 유기용매가 있다.Compound (I) can be used as is or mixed with a pharmaceutically acceptable inert carrier. Such carriers include capsules, solid diluents or fillers, sterile distilled water or various non-toxic organic solvents.
사용될 수 있는 투여형태로는 정제, 당의정(축적된 형태로 활성물질을 함유할 수 있음), 발포정, 캅셀, 과립제, 현탁수용액, 주사용액, 유화제, 현탁제, 엘틱서제, 시럽제 및 연고제 등이 있다.Dosage forms that may be used include tablets, dragees (which may contain the active substance in accumulated form), effervescent tablets, capsules, granules, suspensions, injectables, emulsifiers, suspensions, elticoses, syrups and ointments. have.
이러한 제제는 활성물질을 용매나 담체에 유화제나 현탁제와 함께 가하는 것 같은 공지방법에 따라 제조될 수 있다.Such formulations may be prepared according to known methods, such as adding the active substance with an emulsifier or suspending agent to a solvent or a carrier.
보조제로서는 물, 비독성 유기용매(예, 파라핀, 글리세롤이나 폴리에틸렌 글리콜 같은 알콜류), 식물유(예, 참기름), 천년 또는 합성무기분말(예, 활석, 미세한 실릭산) 같은 고체담체, 설탕, 유화제(예, 이온성 또는 비이온성), 현탁화제(예, 메틸 셀룰로스, 폴리비닐 피롤리딘)이나 윤활제(예, 마그네슘 스테아레이트)를 사용할 수 있다.Auxiliaries include water, non-toxic organic solvents (e.g. paraffin, alcohols such as glycerol or polyethylene glycol), vegetable oils (e.g. sesame oil), solid carriers such as millennium or synthetic inorganic powders (e.g. talc, fine silicic acid), sugars, emulsifiers ( For example, ionic or nonionic), suspending agents (eg methyl cellulose, polyvinyl pyrrolidine) or lubricants (eg magnesium stearate) can be used.
정제는 또한 감미제, 소디움 시트레이트, 탄산칼슘, 인산칼슘 같은 보조제를 전분, 젤라틴 같은 부가물질과 함께 함유할 수 있다. 수성현틱액이나 엘릭서는 교미제나 착색제를 함유할 수 있다. 화합물(Ⅰ)은 또한 캅셀제에서와 같이 보조제가 거의 없이 또는 완전히 없이 투여할 수 있다.Tablets may also contain adjuvants such as sweeteners, sodium citrate, calcium carbonate, calcium phosphate, together with adducts such as starch, gelatin. Aqueous solutions or elixirs may contain a mate or colorant. Compound (I) may also be administered with little or no adjuvant as in capsules.
활성물질(Ⅰ)을 경구투여하는 것이 좋으나 비경구투여, 특히 피하주사할 수도 있다.Oral administration of the active substance (I) is preferred, but may also be parenterally administered, especially subcutaneously.
성장한 촌충류를 퇴치하기 위해서는 활성성분을 1일 1회 이상 체중당 0.01-250, 좋기로는 0.5-100mg 경구 또는 피하투여하는 것이 좋다. 성장한 디스토마유충이나 시스토소메스를 퇴치하기 위해서는 더 많은 활성 성분이 필요할지도 모른다.In order to combat the growing tapeworms, the active ingredient is recommended to be administered orally or subcutaneously, 0.01-250, preferably 0.5-100mg per body weight per day. More active ingredients may be needed to combat growing dystomosis larvae or cystosomes.
비교적 다량의 활성성분을 투여하는 경우에는 소량씩 몇번으로 나누어 투여할수있는데 예를들면 1, 000mg 대신에 200mg씩 5회 투여할 수 있다. 동물에 투여하는 경우에는 음식과 함께 투여할 수도 있고 미리 혼합한 것을 음식에 가하는 것이 좋다. 체중이나 투여경로의 특성뿐 아니라 종류 및 약제에 대한 그의 반응, 제제의 성질, 투여시간이나 투여간격에 따라 투여용량을 다양하게 할 수 있다. 즉, 어떤 경우에는 상기한 최소량보다 적은 양으로도 충분한 반면 어떤 경우에는 상기한 최대량을 초과할 때도 있다.When a relatively large amount of the active ingredient is administered, it may be divided into several small portions, for example, 200 mg instead of 1,000 mg may be administered five times. In the case of administration to animals, it may be administered with food, or a premixed food may be added to the food. The dosage may vary depending on the nature of the weight or route of administration as well as the type and its response to the drug, the nature of the formulation, the time of administration or the interval of administration. That is, in some cases an amount less than the minimum amount is sufficient, while in some cases the maximum amount is exceeded.
투여방식에 따라 화합물(Ⅰ)과 담체 또는 사용되는 보조제의 비율은 상당히 다양하게 할 수 있는데 예를들어 화합물(Ⅰ)을 정제나 당의정으로 투여할 때는 약 0.01-2, 500mg의 활성물질을 약 1-10, 0000mg의 보조제와 혼합할 수 있고 반면에 화합물(Ⅰ)을 사료에 혼합시킬 때는 담체나 보조제 1kg당 화합물(Ⅰ)을 0.1-400g 사용할 수 있다. 주사제를 제조할 때는 1ℓ액체용액은 사용되는 용제의 성질에 따라 약 0.5-100g의 화합물(Ⅰ)을 함유할 수 있다. 마찬가지로 1ℓ시럽에는 0.5-250g의 화합물(Ⅰ)을 용해하거나 현탁시킬 수 있다. 화합물(Ⅰ)은 다른 활성물질과 혼합된 제제로도 할수 있다. 즉, 광범위한 활성을 얻기위해서, 예를들어 티아벤다졸 [2-(4-티아졸릴) 벤즈이미다졸]이나 피페라진(또는 N-메틸-피페라진같은 피페라진 유도체) 같은 선충류에 활성있는 활성물질을 가하는 것이 유리할 수 있다.Depending on the mode of administration, the ratio of compound (I) to carrier or adjuvant used can vary considerably. For example, when administering compound (I) in tablets or dragees, about 0.01-2, 500 mg of active substance is used. -10, 0000 mg of adjuvant can be mixed, while 0.1-400 g of compound (I) per kg of carrier or adjuvant can be used when admixing compound (I) to feed. In preparing injections, 1 L liquid solution may contain about 0.5-100 g of compound (I) depending on the nature of the solvent used. Likewise, 1 liter syrup can dissolve or suspend 0.5-250 g of compound (I). Compound (I) may also be in admixture with other active substances. That is, to obtain a wide range of activities, for example, active substances active against nematodes, such as thiabendazole [2- (4-thiazolyl) benzimidazole] or piperazine (or piperazine derivatives such as N-methyl-piperazine) It may be advantageous to add.
또한 두가지 이상의 일반식(Ⅰ)의 화합물 혼합물을 투여할 수도 있다. 화합물(Ⅰ)의 구충작용은 다음실시예에 더욱 상세히 기술되어 있다.It is also possible to administer a mixture of two or more compounds of general formula (I). The antiparasitic action of compound (I) is described in more detail in the following examples.
A. 약리학적 실시예A. Pharmacological Examples
다음 화합물(Ⅰ)들을 시험하였다.The following compounds (I) were tested.
비교약제로서 다음 화합물들을 사용하였다.The following compounds were used as comparative agents.
퀴나크린 [2-메톡시-6-클로로-9-[(1-메틸-4-디에틸아미노부틸) 아미노]-아크리딘Quinacrine [2-methoxy-6-chloro-9-[(1-methyl-4-diethylaminobutyl) amino] -acridine
니트로스아미드 [N-(2-클로로-4-니트로페닐)-5-클로로살리실아마이드Nitrosamide [N- (2-chloro-4-nitrophenyl) -5-chlorosalicylamide
디클로로펜(2, 2'-디하이드록시-5, 5'-디클로로디페닐메탄).Dichlorophene (2, 2'-dihydroxy-5, 5'-dichlorodiphenylmethane).
루칸톤[1-(2-디에틸아미노에틸아미노)-4-메틸티오크산톤염산염Lucantone [1- (2-diethylaminoethylamino) -4-methylthioxanthone hydrochloride
니리다졸[1-(5-니트로-2-티아졸릴)-이미다졸리딘-2-은]Niridazole [1- (5-nitro-2-thiazolyl) -imidazolidine-2-silver]
스티 보펜 [소디움안티모니-비스-(피로카테콜-2, 4-디설포네이트)]Styvofen [Sodium antimony-bis- (pyrocatechol-2, 4-disulfonate)]
[실시예 a]Example a
하이메노레피스 나나, 성충, 유충/생쥐,Hymenorepis nana, adult, larvae / mouse,
하이메노레피스 미크로스토마, 성충/생쥐,Hymenorepis microstomes, adult / mouse,
하이메노레피시 디미누타/쥐Hymenorfish Diminuta / Rat
시험적으로 H. 나나, H. 미크로스토마 또는 H. 디미누타로 감염시킨 시험동물을 유충으로 감염시킨 후나 기생충이 활동하기 시작한 후 1-3일간 처리하고 활성물질을 수성현탁액상태로 경구 또는 피하투여하였다. 시험동물을 절계하여 제제의 활성정도를 시험동물중에 남아있는 기생충의 수효를 세어측정하고 처리하지 않은 동물과 비교하여 작용효과의 백분율을 계산하여 다음표 1를 얻었다.Test animals infected with H. nana, H. microstoma or H. diminuta after larval infection or after parasites began to work were treated for 1-3 days and the active substance was orally or subcutaneously in aqueous suspension. Administered. The test animals were counted and the activity of the preparation was counted by counting the number of parasites remaining in the test animals and compared to the untreated animals to calculate the percentage of effect.
[표 1]TABLE 1
[실시예 b]Example b
테니아 테니아에 포르미스 유충(포충)/생쥐Formia larvae (larva) / mice
테아마 테니아어포르미스 유충으로 실험적으로 감염시킨 생쥐들을 감염 후 약 2-5개월 처리하고 활성 물질을 수성현탁액 상태로 경구 투여하였다. 제제의 활성 정도는 생쥐를 절게하여 살아있는 유충과 죽은 유충의 수를 세어 처리하지 않은 비교동물과 비교하여 활성의 백분율을 계산하여 다음 표 2를 얻었다.Mice experimentally infected with theteaterian larvae larvae were treated for about 2-5 months after infection and the active substance was orally administered in an aqueous suspension. The activity level of the preparation was obtained by counting the number of live larvae and dead larvae in mice, and calculating the percentage of activity compared to the non-treated comparison animals.
[표 2]TABLE 2
[실시예 c]Example c
테니아속/개Dogs
테니아 하이다티게나 또는 테니아 피시포르미스로 시험적으로나 자연히 감염된 개를 기생충이 활동하기 시작한 후에 처리하고 활성성분을 젤라틴 칼셀제로 경구 투여하였다. 활성 정도는 절개하여 처리 후에 없어진 기생충과 시험동물에 남아있는 숫자를 세어 없어진 기생충의 백분율을 계산하여 다음 표3을 얻었다.Dogs that were experimentally or naturally infected with Tenia Haidatigen or Tenia Fishformis were treated after parasite activity and the active ingredient was orally administered with gelatin calcel. The degree of activity was determined by counting the number of parasites lost after treatment and the number of parasites remaining in the test animals. Table 3 was then obtained.
[표 3]TABLE 3
[실시예 d]Example d
에키노코커스 멀티로쿨라리스/개Echinococcus multiroculus / dog
에키노코커스 멀터로쿨라리스로 실험적으로 감염된 개를 감염 후 25-29일째에 처리하고 활성성분을 젤라틴 캅셀에 순수물질 상태로 경구 투여하였다. 활성 정도는 실시예 a)와 마찬가지 방법으로 계산하여 다음 표 4를 얻었다.Dogs experimentally infected with Echinococcus multeroculus were treated 25-29 days after infection and the active ingredient was orally administered to the gelatin capsules in the pure state. Activity level was calculated in the same manner as in Example a) to obtain the following Table 4.
[표 4]TABLE 4
[실시예 e]Example e
시스토소마 만소니/생쥐Sistosoma Mansony / Mice
시스토소마 만소니로 실험적으로 감염시킨 생쥐를 기생충이 활동하기 시작한 후 처리하여 활성성분을 수성 현탄액 상태로 경구 투여하였다. 실험동물을 절개하여 생존 중인 기생충과 죽은 기생충의 수효를 세어 효과를 측정하여 다음 표 5를 얻었다.Mice experimentally infected with cystosoma mansoni were treated with parasites after active activity, and the active ingredient was orally administered in an aqueous suspension. Experimental animals were excised to count the number of living parasites and dead parasites to determine the effect of Table 5 below.
[표 5]TABLE 5
다음 실시예는 본 발명을 설명하기 위한 것으로 [α]는 클로로포름 내에서의을 의미한다.The following example illustrates the present invention in which [α] represents chloroform. Means.
[실시예 1]Example 1
클로로포름 50ml에 니트로벤조일 클로라이드 3.71g을 넣은 것은 클로로포름 50ml (±)-HPI 4.04g과 트리에틸아민 2.8ml을 넣은것에 20℃에서 적가하고 1시간후에 반응혼합물을 묽은 염산과 물로 진탕시켰다. 이것을 건조하고 증발시켜 (±)-2-(4-니트로벤조일)-HPI를 얻고 메탄올로 재결정시켰을 때 융점은 212-213℃였다. 적당한 카복실산 염화물로부터 유사한 방법으로 다음 화합물들이 제조되었다.50 ml of chloroform and 3.71 g of nitrobenzoyl chloride were added dropwise at 50 ° C. with 50 ml (±) -HPI 4.04 g of chloroform and 2.8 ml of triethylamine, and the reaction mixture was shaken with dilute hydrochloric acid and water after 1 hour. It was dried and evaporated to give (±) -2- (4-nitrobenzoyl) -HPI, and the melting point was 212-213 ° C when recrystallized from methanol. The following compounds were prepared in a similar manner from suitable carboxylic acid chlorides.
2-아세틸-HPI; 융점 139℃2-acetyl-HPI; Melting point 139 ℃
2-프로피오닐-HPI; 2-n-부티릴-HPI;2-propionyl-HPI; 2-n-butyryl-HPI;
2-이소부티릴-HPI; 융점 120℃;2-isobutyryl-HPI; Melting point 120 ° C;
2-n-발레릴-HPI;2-n-valeryl-HPI;
2-이소발레릴-HPI; 2-(2-메틸부티릴)-HPI;2-isovaleryl-HPI; 2- (2-methylbutyryl) -HPI;
2-트리메틸아세틸-HPI; 융점 150℃;2-trimethylacetyl-HPI; Melting point 150 ° C .;
2-n-헥사노일-HPI;2-n-hexanoyl-HPI;
2-(2-메틸-n-발레릴)-HPI;2- (2-methyl-n-valeryl) -HPI;
2-(3-메틸-n-발레릴)-HPI;2- (3-methyl-n-valeryl) -HPI;
2-(4-메틸발레릴)-HPI;2- (4-methylvaleryl) -HPI;
2-(1-에틸-n-부티릴)-HPI;2- (1-ethyl-n-butyryl) -HPI;
2-(2, 2-디메틸-n-부티릴)-HPI;2- (2, 2-dimethyl-n-butyryl) -HPI;
2-(3, 3-디메틸-n-부티릴)-HPI; 융점 113℃;2- (3, 3-dimethyl-n-butyryl) -HPI; Melting point 113 ° C .;
2-헵타노일-HPI; 융점 90-91℃;2-heptanoyl-HPI; Melting point 90-91 ° C .;
2-(2, 2-디메틸 발레릴)-HPl; 융점 129℃;2- (2, 2-dimethyl valeryl) -HPl; Melting point 129 ° C .;
2-옥타노일-HPI; 2-(2-n-프로필-헥사노일)-HPI;2-octanoyl-HPI; 2- (2-n-propyl-hexanoyl) -HPI;
2-데카노일-HPI;2-decanoyl-HPI;
2-(2-n -부틸헥사노일)-HPI; 융점 96℃2- (2-n-butylhexanoyl) -HPI; Melting point 96 ℃
2-운데카노일-HPI;2-undecanoyl-HPI;
2-헥사데카노일-HPI; 융점 101-102℃;2-hexadecanoyl-HPI; Melting point 101-102 ° C .;
2-옥타데카노일-HPI;2-octadecanoyl-HPI;
2-트리플루오로아세틸-HPI;2-trifluoroacetyl-HPI;
2-클로로아세틸-HPI;2-chloroacetyl-HPI;
2-디클로로아세틸--HPI; 융점 151-152℃2-dichloroacetyl-HPI; Melting Point 151-152 ℃
2-트리클로로아세틸-HPI; 융점 184-185℃2-trichloroacetyl-HPI; Melting point 184-185 ℃
2-(3-클로로프로피오닐)-HPI;2- (3-chloropropionyl) -HPI;
2-트리스-(클로로메틸)-아세틸-HPI; 융점 133-135℃2-tris- (chloromethyl) -acetyl-HPI; Melting point 133-135 ℃
2-(2-아세톡시아세틸)-HPI;2- (2-acetoxyacetyl) -HPI;
2-(2-에톡시아세틸)-HPI; 융점 135℃2- (2-ethoxyacetyl) -HPI; Melting point 135 ℃
2-(2-에톡시아세틸)-HPI;2- (2-ethoxyacetyl) -HPI;
2-디메틸아미노아세틸-HPI;2-dimethylaminoacetyl-HPI;
2-디메틸아미노아세틸-HPI;2-dimethylaminoacetyl-HPI;
2-메틸-에틸아미노아세틸-HPI;2-methyl-ethylaminoacetyl-HPI;
2-(2-디메틸아미노-프로피오닐)-HPI;2- (2-dimethylamino-propionyl) -HPI;
2-(2-디에틸아미노-프로피오닐)-HPI;2- (2-diethylamino-propionyl) -HPI;
2-(3-디메틸아미노-프로피오닐)-HPI;2- (3-dimethylamino-propionyl) -HPI;
2-(3-디에틸아미노-프로피오닐)-HPI;2- (3-diethylamino-propionyl) -HPI;
2-(2-디메틸아미노-n-부티릴)-HPI;2- (2-dimethylamino-n-butyryl) -HPI;
2-(2-디에틸아미노-n-부티릴)-HPI;2- (2-diethylamino-n-butyryl) -HPI;
2-(4-디메틸아미노-n-부티릴)-HPI;2- (4-dimethylamino-n-butyryl) -HPI;
2-(4-디에틸아미노-n-부티릴)-HPI;2- (4-diethylamino-n-butyryl) -HPI;
2-(2-디메틸아미노-n-발레릴)-HPI;2- (2-dimethylamino-n-valeryl) -HPI;
2-(2-디에틸아미노-n-발레릴)-HPI;2- (2-diethylamino-n-valeryl) -HPI;
2-(5-디메틸아미노-n-발레릴)-HPI;2- (5-dimethylamino-n-valeryl) -HPI;
2-(5-디에틸아미노-n-발레릴)-HPI;2- (5-diethylamino-n-valeryl) -HPI;
2-(2-디메틸아미노-n-헥사노일)-HPI;2- (2-dimethylamino-n-hexanoyl) -HPI;
2-(6-디메틸아미노-n-헥사노일)-HPI;2- (6-dimethylamino-n-hexanoyl) -HPI;
2-(6-디에틸아미노-n-헥사노일)-HPI;2- (6-diethylamino-n-hexanoyl) -HPI;
2-(2-페닐아세틸)-HPI; 융점 123-124℃2- (2-phenylacetyl) -HPI; Melting point 123-124 ℃
2-(2-히드록시-2-페닐아세틸)-HPI;2- (2-hydroxy-2-phenylacetyl) -HPI;
2-(2-아세톡시-2-페닐아세틸)-HPI; 융점 101-102℃2- (2-acetoxy-2-phenylacetyl) -HPI; Melting point 101-102 ℃
2-페녹시아세틸-HPI;2-phenoxyacetyl-HPI;
2-(4-플루오로페녹시아세틸)-HPI;2- (4-fluorophenoxyacetyl) -HPI;
2-(3-클로로페녹시아세틸)-HPI;2- (3-chlorophenoxyacetyl) -HPI;
2-(4-클로로페녹시아세틸)-HPI; 융점 159-160℃2- (4-chlorophenoxyacetyl) -HPI; Melting point 159-160 ℃
2-(3-(4-플루오로페녹시)프로피오닐)-HPI;2- (3- (4-fluorophenoxy) propionyl) -HPI;
2-(3-(3-크로로페녹시)-프로피오닐)-HPI;2- (3- (3-Chlorophenoxy) -propionyl) -HPI;
2-(3-(4-클로로페녹시)-프로피오닐)-HPI;2- (3- (4-chlorophenoxy) -propionyl) -HPI;
2-(티에닐-2-메르캅토아세틸)-HPI; 융점 89-90℃2- (thienyl-2-mercaptoacetyl) -HPI; Melting point 89-90 ℃
2-(티에닐-3-메르캅토아세틸)-HPI;2- (thienyl-3-mercaptoacetyl) -HPI;
2-크로로노일-HPI;2-chloronoyl-HPI;
2-메타크릴로일-HPI;2-methacryloyl-HPI;
2-비닐아세틸-HPI;2-vinylacetyl-HPI;
2-신나모일-HPI; 융점 152℃2-cinnamoyl-HPI; Melting point 152 ℃
2-페닐프로피오로일-HPI; 융점 155℃2-phenylpropioyl-HPI; Melting point 155 ℃
2-페녹시카르보닐-HPI; 융점 136-137℃2-phenoxycarbonyl-HPI; Melting point 136-137 ℃
2-에톡사릴-HPI; 융점 126℃2-ethoxysaryl-HPI; Melting point 126 ℃
2-시클로프로필-카르보닐-HPI; 융점 148℃2-cyclopropyl-carbonyl-HPI; Melting point 148 ℃
2-(2-아세톡시시클로프로필-카르보닐)-HPI;2- (2-acetoxycyclopropyl-carbonyl) -HPI;
2-(2-플루오로시클로프로필-카르보닐)-HPI;2- (2-fluorocyclopropyl-carbonyl) -HPI;
2-시클로부틸-카르보닐-HPI; 융점 154-155℃2-cyclobutyl-carbonyl-HPI; Melting Point 154-155 ℃
2-(2-케토시클로부틸-카르보닐)-HPI;2- (2-ketocyclobutyl-carbonyl) -HPI;
2-(3-케토시클로부틸-카르보닐)-HPI;2- (3-ketocyclobutyl-carbonyl) -HPI;
2-(2-플루오로시클로부틸-카르보닐)-HPI;2- (2-fluorocyclobutyl-carbonyl) -HPI;
2-(3-플루오로시클로부틸-카르보닐)-HPI;2- (3-fluorocyclobutyl-carbonyl) -HPI;
2-(2-클로로시클로부틸-카르보닐)-HPI;2- (2-Chlorocyclobutyl-carbonyl) -HPI;
2-(3-클로로시클로부틸-카르보닐)-HPI;2- (3-Chlorocyclobutyl-carbonyl) -HPI;
2-(2-메틸시클로부틸-카르보닐)-HPI;2- (2-methylcyclobutyl-carbonyl) -HPI;
2-(3-메틸시클로부틸-카르보닐)-HPI;2- (3-methylcyclobutyl-carbonyl) -HPI;
2-(2, 2-디플루오토시클로부틸-카르보닐)-HPI;2- (2, 2-difluorotocyclobutyl-carbonyl) -HPI;
2-(3, 3-디플루오로시클로부틸-카르보닐)-HPI;2- (3, 3-difluorocyclobutyl-carbonyl) -HPI;
2-(1-아세톡시시클로부틸-카르보닐)-HPI;2- (1-acetoxycyclobutyl-carbonyl) -HPI;
2-(2-아세톡시시클로부틸-카르보닐)-HPI;2- (2-acetoxycyclobutyl-carbonyl) -HPI;
2-(3-아세톡시시클로부틸-카르보닐)-HPI;2- (3-acetoxycyclobutyl-carbonyl) -HPI;
2-(1-디메틸아미노시클로부틸-카르보닐)-HPI;2- (1-dimethylaminocyclobutyl-carbonyl) -HPI;
2-(2-디메틸아미노시클로부틸-카르보닐)-HPI;2- (2-dimethylaminocyclobutyl-carbonyl) -HPI;
2-(3-디메틸아미노시클로부틸-카르보닐)-HPI;2- (3-dimethylaminocyclobutyl-carbonyl) -HPI;
2-(2-메톡시카르보닐시클로부틸-카르보닐)-HPI;2- (2-methoxycarbonylcyclobutyl-carbonyl) -HPI;
2-(2-에톡시카르보닐시클로부틸-카르보닐)-HPI;2- (2-ethoxycarbonylcyclobutyl-carbonyl) -HPI;
2-(3-메톡시카르보닐시클로부틸-카르보닐)-HPI;2- (3-methoxycarbonylcyclobutyl-carbonyl) -HPI;
2-(3-에톡시카르보닐시클로부틸-카르보닐)-HPI;2- (3-ethoxycarbonylcyclobutyl-carbonyl) -HPI;
2-시클로펜릴-카르보닐-HPI; 융점 127℃2-cyclophenyl-carbonyl-HPI; Melting point 127 ℃
2-(2-케토시클로펜틸-카르보닐)-HPI;2- (2-ketocyclopentyl-carbonyl) -HPI;
2-(3-케토시클로펜틸-카르보닐)-HPI;2- (3-ketocyclopentyl-carbonyl) -HPI;
2-(1-아세톡시시클로로펜틸-카르보닐)-HPI;2- (1-acetoxycyclopentyl-carbonyl) -HPI;
2-(2-아세톡시시클로펜틸-카르보닐)-HPI;2- (2-acetoxycyclopentyl-carbonyl) -HPI;
2-(3-아세톡시시클로펜틸-카르보닐)-HPI;2- (3-acetoxycyclopentyl-carbonyl) -HPI;
2-(2-플루오로시클로펜틸-카르보닐)-HPI;2- (2-fluorocyclopentyl-carbonyl) -HPI;
2-(3-플루오로시클로펜틸-카르보닐)-HPI;2- (3-fluorocyclopentyl-carbonyl) -HPI;
2-(2, 2-디플루오로시클로펜틸-카르보닐)-HPI;2- (2, 2-difluorocyclopentyl-carbonyl) -HPI;
2-(3, 3-디플루오로시클로펜틸-카르보닐)-HPI;2- (3, 3-difluorocyclopentyl-carbonyl) -HPI;
2-(2-클로로시클로펜틸-카르보닐)-HPI;2- (2-chlorocyclopentyl-carbonyl) -HPI;
2-(3-클로로시클로펜틸-카르보닐)-HPI;2- (3-chlorocyclopentyl-carbonyl) -HPI;
2-(2-메틸시클로펜틸-카르보닐)-HPI;2- (2-methylcyclopentyl-carbonyl) -HPI;
2-(3-메틸시클로펜틸-카르보닐)-HPI;2- (3-methylcyclopentyl-carbonyl) -HPI;
2-(1-디메틸아미노시클로펜틸-카르보닐)-HPI;2- (1-dimethylaminocyclopentyl-carbonyl) -HPI;
2-(2-디메틸아미노시클로펜틸-카르보닐)-HPI;2- (2-dimethylaminocyclopentyl-carbonyl) -HPI;
2-(3-디메틸아미노시클로펜틸-카르보닐)-HPI;2- (3-dimethylaminocyclopentyl-carbonyl) -HPI;
2-(2-메톡시카르보닐시클로펜틸-카르보닐)-HPI;2- (2-methoxycarbonylcyclopentyl-carbonyl) -HPI;
2-(2-에톡시카르보닐시클로펜틸-카르보닐)-HPI;2- (2-ethoxycarbonylcyclopentyl-carbonyl) -HPI;
2-(3-메톡시카르보닐시클로펜틸-카르보닐)-HPI;2- (3-methoxycarbonylcyclopentyl-carbonyl) -HPI;
2-(3-에톡시카르보닐시클로펜틸-카르보닐)-HPI;2- (3-ethoxycarbonylcyclopentyl-carbonyl) -HPI;
2-시클로헥실카르보닐-HPI; 융점 136-138℃2-cyclohexylcarbonyl-HPI; Melting point 136-138 ℃
2-(1-시클로헥세닐-카르보닐)-HPI;2- (1-cyclohexenyl-carbonyl) -HPI;
2-(2-시클로헥세닐-카르보닐)-HPI;2- (2-cyclohexenyl-carbonyl) -HPI;
2-(3-시클로헥세닐-카르보닐)-HPI; 융점 126℃2- (3-cyclohexenyl-carbonyl) -HPI; Melting point 126 ℃
2-(2-케토시클로헥실-카르보닐)-HPI;2- (2-ketocyclohexyl-carbonyl) -HPI;
2-(3-케토시클로헥실-카르보닐)-HPI;2- (3-ketocyclohexyl-carbonyl) -HPI;
2-(4-케토시클로헥실-카르보닐)-HPI; 융점 154℃2- (4-ketocyclohexyl-carbonyl) -HPI; Melting point 154 ℃
2-(1-아세톡시시클로헥실-카르보닐)-HPI;2- (1-acetoxycyclohexyl-carbonyl) -HPI;
2-(2-아세톡시시클로헥실-카르보닐)-HPI;2- (2-acetoxycyclohexyl-carbonyl) -HPI;
2-(3-아세톡시시클로헥실-카르보닐)-HPI;2- (3-acetoxycyclohexyl-carbonyl) -HPI;
2-(4-아세톡시시클로헥실-카르보닐)-HPI;2- (4-acetoxycyclohexyl-carbonyl) -HPI;
2-(1-포름아미도시클로헥실-카르보닐)-HPI;2- (1-formamidocyclohexyl-carbonyl) -HPI;
2-(2-포름아미도시클로헥실-카르보닐)-HPI;2- (2-formamidocyclohexyl-carbonyl) -HPI;
2-(3-포름아미도시클로헥실-카르보닐)-HPI;2- (3-formamidocyclohexyl-carbonyl) -HPI;
2-(4-포름아미도시클로헥실-카르보닐)-HPI;2- (4-formamidocyclohexyl-carbonyl) -HPI;
2-(1-디메틸아미노시클로헥실-카르보닐)-HPI;2- (1-dimethylaminocyclohexyl-carbonyl) -HPI;
2-(2-디메틸아미노시클로헥실-카르보닐)-HPI;2- (2-dimethylaminocyclohexyl-carbonyl) -HPI;
2-(3-디메틸아미노시클로헥실-카르보닐)-HPI;2- (3-dimethylaminocyclohexyl-carbonyl) -HPI;
2-(4-디메틸아미노시클로헥실-카르보닐)-HPI;2- (4-dimethylaminocyclohexyl-carbonyl) -HPI;
2-(2, 4-비스-(디메틸아미노)-시클로헥실-카르보닐)-HPI;2- (2, 4-bis- (dimethylamino) -cyclohexyl-carbonyl) -HPI;
2-(3, 4-비스-(디메틸아미노)-시클로헥실-카르보닐)-HPI;2- (3, 4-bis- (dimethylamino) -cyclohexyl-carbonyl) -HPI;
2-(3, 5-비스-(디메틸아미노)-시클로헥실-카르보닐)-HPI;2- (3, 5-bis- (dimethylamino) -cyclohexyl-carbonyl) -HPI;
2-(1-디에틸아미노시클로헥실-카르보닐)-HPI;2- (1-diethylaminocyclohexyl-carbonyl) -HPI;
2-(2-디에틸아미노시클로헥실-카르보닐)-HPI;2- (2-Diethylaminocyclohexyl-carbonyl) -HPI;
2-(3-디에틸아미노시클로헥실-카르보닐)-HPI;2- (3-Diethylaminocyclohexyl-carbonyl) -HPI;
2-(4-디에틸아미노시클로헥실-카르보닐)-HPI;2- (4-Diethylaminocyclohexyl-carbonyl) -HPI;
2-(3-메틸에틸아미노시클로헥실-카르보닐)-HPI;2- (3-methylethylaminocyclohexyl-carbonyl) -HPI;
2-(4-메틸에틸아미노시클로헥실-카르보닐)-HPI;2- (4-Methylethylaminocyclohexyl-carbonyl) -HPI;
2-(2-플루오로시클로헥실-카르보닐)-HPI;2- (2-fluorocyclohexyl-carbonyl) -HPI;
2-(3-플루오로시클로헥실-카르보닐)-HPI;2- (3-fluorocyclohexyl-carbonyl) -HPI;
2-(4-플루오로시클로헥실-카르보닐)-HPI;2- (4-fluorocyclohexyl-carbonyl) -HPI;
2-(2, 2-디플루오로시클로헥실-카르보닐)-HPI;2- (2, 2-difluorocyclohexyl-carbonyl) -HPI;
2-(3, 3-디플루오로시클로헥실-카르보닐)-HPI;2- (3, 3-difluorocyclohexyl-carbonyl) -HPI;
2-(4, 4-디플루오로시클로헥실-카르보닐)-HPI;2- (4, 4-difluorocyclohexyl-carbonyl) -HPI;
2-(2-클로로시클로헥실-카르보닐)-HPI;2- (2-Chlorocyclohexyl-carbonyl) -HPI;
2-(3-클로로시클로헥실-카르보닐)-HPI;2- (3-Chlorocyclohexyl-carbonyl) -HPI;
2-(4-클로로시클로헥실-카르보닐)-HPI;2- (4-Chlorocyclohexyl-carbonyl) -HPI;
2-(2-브로모시클로헥실-카르보닐)-HPI;2- (2-bromocyclohexyl-carbonyl) -HPI;
2-(3-브로모시클로헥실-카르보닐)-HPI;2- (3-bromocyclohexyl-carbonyl) -HPI;
2-(4-브로모시클로헥실-카르보닐)-HPI;2- (4-bromocyclohexyl-carbonyl) -HPI;
2-(2-메틸시클로헥실-카르보닐)-HPI;2- (2-methylcyclohexyl-carbonyl) -HPI;
2-(3-메틸시클로헥실-카르보닐)-HPI;2- (3-methylcyclohexyl-carbonyl) -HPI;
2-(4-메틸시클로헥실-카르보닐)-HPI;2- (4-methylcyclohexyl-carbonyl) -HPI;
2-(2-메톡시카르보닐시클로헥실-카르보닐)-HPI;2- (2-methoxycarbonylcyclohexyl-carbonyl) -HPI;
2-(3-메톡시카르보닐시클로헥실-카르보닐)-HPI;2- (3-methoxycarbonylcyclohexyl-carbonyl) -HPI;
2-(4-메톡시카르보닐시클로헥실-카르보닐)-HPI;2- (4-methoxycarbonylcyclohexyl-carbonyl) -HPI;
2-(2-에톡시카르보닐시클로헥실-카르보닐)-HPI;2- (2-ethoxycarbonylcyclohexyl-carbonyl) -HPI;
2-(3-에톡시카르보닐시클로헥실-카르보닐)-HPI;2- (3-ethoxycarbonylcyclohexyl-carbonyl) -HPI;
2-(4-에톡시카르보닐시클로헥실-카르보닐)-HPI;2- (4-ethoxycarbonylcyclohexyl-carbonyl) -HPI;
2-시클로헵틸카르보닐-HPI; 융점 91℃2-cycloheptylcarbonyl-HPI; Melting point 91 ℃
2-(4-디메틸아미노시클로헵틸-카르보닐)-HPI;2- (4-dimethylaminocycloheptyl-carbonyl) -HPI;
2-(4-디에틸아미노시클로헵틸-카르보닐)-HPI;2- (4-Diethylaminocycloheptyl-carbonyl) -HPI;
2-(4-플루오로시클로헵틸-카르보닐)-HPI;2- (4-fluorocycloheptyl-carbonyl) -HPI;
2-(4-클로로시클로헵틸-카르보닐)-HPI;2- (4-Chlorocycloheptyl-carbonyl) -HPI;
2-시클로옥틸카르보닐-HPI; 융점 109℃2-cyclooctylcarbonyl-HPI; Melting point 109 ℃
2-시클로노일카르보닐-HPI;2-cyclonoylcarbonyl-HPI;
2-시클로데실카르보닐-HPI;2-cyclodecylcarbonyl-HPI;
2-시클로운데실카르보닐-HPI; 융점 150-151℃2-cycloundecylcarbonyl-HPI; Melting point 150-151 ℃
2-시클로도데실카테보닐-HPI;2-cyclododecylcatebonyl-HPI;
2-비시클로(2, 2, 1) 헵틸-2-카르보닐-HPI;2-bicyclo (2, 2, 1) heptyl-2-carbonyl-HPI;
2-바시클로(2, 2, 2)-옥틸-2-카르보닐-HPI;2-bacyclo (2, 2, 2) -octyl-2-carbonyl-HPI;
2-(아담만틸-카르보닐)-HPI; 융점 159-160℃2- (adammantyl-carbonyl) -HPI; Melting point 159-160 ℃
2-(2-메틸벤조일)-HPI;2- (2-methylbenzoyl) -HPI;
2-(3-메틸벤조일)-HPI; 융점 124℃2- (3-methylbenzoyl) -HPI; Melting point 124 ℃
2-(4-메틸벤조일)-HPI; 융점 183-184℃2- (4-methylbenzoyl) -HPI; Melting point 183-184 ℃
2-(4-에틸벤조일)-HPI;2- (4-ethylbenzoyl) -HPI;
2-(4-n-프로클벤조일)-HPI;2- (4-n-procklebenzoyl) -HPI;
2-(4-이소프로필벤조일)-HPI;2- (4-isopropylbenzoyl) -HPI;
2-(4-3급-부틸벤조일)-HPI; 융점 198℃2- (4-tert-butylbenzoyl) -HPI; Melting Point 198 ℃
2-(4-페닐벤조일)-HPI;2- (4-phenylbenzoyl) -HPI;
2-(3, 4-디메틸벤조일)-HPI;2- (3, 4-dimethylbenzoyl) -HPI;
2-(3, 5-디메틸벤조일)-HPI;2- (3, 5-dimethylbenzoyl) -HPI;
2-(3, 4-디에틸벤조일)-HPI;2- (3, 4-diethylbenzoyl) -HPI;
2-(3, 5-디에틸벤조일)-HPI;2- (3, 5-diethylbenzoyl) -HPI;
2-(2-플루오로벤조일)-HPI; 융점 129℃2- (2-fluorobenzoyl) -HPI; Melting point 129 ℃
2-(3-플루오로벤조일)-HPI; 융점 164-166℃2- (3-fluorobenzoyl) -HPI; Melting Point 164-166 ℃
2-(4-플루오로벤조일)-HPI; 융점 181-182℃2- (4-fluorobenzoyl) -HPI; Melting Point 181-182 ℃
2-(2-클로로벤조일)-HPI;2- (2-chlorobenzoyl) -HPI;
2-(3-클로로벤조일)-HPI; 융점 181-182℃2- (3-chlorobenzoyl) -HPI; Melting Point 181-182 ℃
2-(4-클로로벤조일)-HPI; 융점 214-215℃2- (4-chlorobenzoyl) -HPI; Melting Point 214-215 ° C
2-(2-브로모벤조일)-HPI;2- (2-bromobenzoyl) -HPI;
2-(3-브로모벤조일)-HPI;2- (3-bromobenzoyl) -HPI;
2-(4-브로모벤조일)-HPI; 2-(2-요오드벤조일)-HPI;2- (4-bromobenzoyl) -HPI; 2- (2-iodinebenzoyl) -HPI;
2-(3-요오드벤조일)-HPI; 2-(4-요오드벤조일)-HPI;2- (3-iodinebenzoyl) -HPI; 2- (4-iodinebenzoyl) -HPI;
2-(2, 3-디플루오로벤조일)-HPI;2- (2, 3-difluorobenzoyl) -HPI;
2-(2, 4-디플루오로벤조일)-HPI;2- (2, 4-difluorobenzoyl) -HPI;
2-(2, 5-디플루오로벤조일)-HPI;2- (2, 5-difluorobenzoyl) -HPI;
2-(2, 6-디플루오로벤조일)-HPI;2- (2, 6-difluorobenzoyl) -HPI;
2-(3, 4-디플루오로벤조일)-HPI;2- (3, 4-difluorobenzoyl) -HPI;
2-(3, 5-디플루오로벤조일)-HPI;2- (3, 5-difluorobenzoyl) -HPI;
2-(3, 4-디클로로벤조일)-HPI;2- (3, 4-dichlorobenzoyl) -HPI;
2-(3, 5-디클로로벤조일)-HPI; 융점 165-166℃2- (3, 5-dichlorobenzoyl) -HPI; Melting Point 165-166 ℃
2-(3, 4-디브로모벤조일)-HPI;2- (3, 4-dibromobenzoyl) -HPI;
2-(3, 5-디브로모벤조일)-HPI;2- (3, 5-dibromobenzoyl) -HPI;
2-(3, 4, 5-트리플루오로벤조일)-HPI;2- (3, 4, 5-trifluorobenzoyl) -HPI;
2-(2, 3, 4, 5, 6-펜타플루오로벤조일)-HPI; 융점 156℃2- (2, 3, 4, 5, 6-pentafluorobenzoyl) -HPI; Melting point 156 ℃
2-(2-히드록시벤조일)-HPI;2- (2-hydroxybenzoyl) -HPI;
2-(3-히드록시벤조일)-HPI; 융점 153℃2- (3-hydroxybenzoyl) -HPI; Melting point 153 ℃
2-(4-히드록시벤조일)-HPI; 융점 243-245℃2- (4-hydroxybenzoyl) -HPI; Melting point 243-245 ℃
2-(3, 4-디히드록시벤조일)-HPI;2- (3, 4-dihydroxybenzoyl) -HPI;
2-(3, 5-디히드록시벤조일)-HPI; 융점 250-254℃(분해)2- (3, 5-dihydroxybenzoyl) -HPI; Melting Point 250-254 ° C (Decomposition)
2-(3, 4, 5-트리히드록시벤조일)-HPI;2- (3, 4, 5-trihydroxybenzoyl) -HPI;
2-(3-메톡시벤조일)-HPI;2- (3-methoxybenzoyl) -HPI;
2-(4-메톡시벤조일)-HPI; 융점 204-205℃2- (4-methoxybenzoyl) -HPI; Melting point 204-205 ℃
2-(3-아세톡시벤조일)-HPI;2- (3-acetoxybenzoyl) -HPI;
2-(4-아세톡시벤조일)-HPI;2- (4-acetoxybenzoyl) -HPI;
2-(3-트리플루오로아세톡시벤조일)-HPI;2- (3-trifluoroacetoxybenzoyl) -HPI;
2-(4-트리플루오로아세톡시벤조일)-HPI;2- (4-trifluoroacetoxybenzoyl) -HPI;
2-(3, 4-디메톡시벤조일)-HPI;2- (3, 4-dimethoxybenzoyl) -HPI;
2-(3, 5-디메톡시벤조일)-HPI;2- (3, 5-dimethoxybenzoyl) -HPI;
2-(3, 4, 5-트리메톡시벤조일)-HPI;2- (3, 4, 5-trimethoxybenzoyl) -HPI;
2-(4-페녹시벤조일)-HPI;2- (4-phenoxybenzoyl) -HPI;
2-(2-디메틸아미노벤조일)-HPI;2- (2-dimethylaminobenzoyl) -HPI;
2-(3-디메틸아미노벤조일)-HPI;2- (3-dimethylaminobenzoyl) -HPI;
2-(4-디메틸아미노벤조일)-HPI; 융점 225-226℃2- (4-dimethylaminobenzoyl) -HPI; Melting point 225-226 ℃
2-(2-디에틸아미노벤조일)-HPI;2- (2-diethylaminobenzoyl) -HPI;
2-(3-디에틸아미노벤조일)-HPI;2- (3-diethylaminobenzoyl) -HPI;
2-(4-디에틸아미노벤조일)-HPI;2- (4-diethylaminobenzoyl) -HPI;
2-(4-메틸에틸아미노벤조일)-HPI;2- (4-methylethylaminobenzoyl) -HPI;
2-(3, 4-비스-(디메틸아미노)-벤조일)-HPI;2- (3, 4-bis- (dimethylamino) -benzoyl) -HPI;
2-(3, 5-비스-(디메틸아미노)-벤조일)-HPI;2- (3, 5-bis- (dimethylamino) -benzoyl) -HPI;
2-(2-포름아미도벤조일)-HPI;2- (2-formamidobenzoyl) -HPI;
2-(3-포름아미도벤조일)-HPI; 융점 176℃2- (3-formamidobenzoyl) -HPI; Melting point 176 ℃
2-(4-포름아미도벤조일)-HPI; 융점 207-208℃2- (4-formamidobenzoyl) -HPI; Melting point 207-208 ℃
2-(2-아세트아미도벤조일)-HPI;2- (2-acetamidobenzoyl) -HPI;
2-(3-아세트아미도벤조일)-HPI;2- (3-acetamidobenzoyl) -HPI;
2-(4-아세트아미도벤조일)-HPI; 융점 247-248℃2- (4-acetamidobenzoyl) -HPI; Melting point 247-248 ℃
2-(2-프로피온아마이드벤조일)-HPI;2- (2-propionamidebenzoyl) -HPI;
2-(2-프로피온아마이드벤조일)-HPI;2- (2-propionamidebenzoyl) -HPI;
2-(3-프로피온아마이드벤조일)-HPI;2- (3-propionamidebenzoyl) -HPI;
2-(4-프로피온아마이드벤조일)-HPI;2- (4-propionamidebenzoyl) -HPI;
2-(3-n-부틸아미드벤조일)-HPI;2- (3-n-butylamidebenzoyl) -HPI;
2-(4-n-부틸아미드벤조일)-HPI;2- (4-n-butylamidebenzoyl) -HPI;
2-(3, 4-비스-(포름아미도)-벤조일)-HPI;2- (3, 4-bis- (formamido) -benzoyl) -HPI;
2-(3, 5-비스-(포름아미도)-벤조일)-HPI2- (3, 5-bis- (formamido) -benzoyl) -HPI
2-(3-이소부틸아미드벤조일)-HPI2- (3-isobutylamidebenzoyl) -HPI
2-(4-이소부틸아미드벤조일)-HPI2- (4-isobutylamidebenzoyl) -HPI
2-(2-펜타노일아미드벤조일)-HPI2- (2-pentanoylamidebenzoyl) -HPI
2-(3-펜타노일아미드벤조일)-HPI2- (3-pentanoylamidebenzoyl) -HPI
2-(4-펜타노일아미드벤조일)-HPI2- (4-pentanoylamidebenzoyl) -HPI
2-(2-헥사노일아미드벤조일)-HPI2- (2-hexanoylamidebenzoyl) -HPI
2-(3-헥사노일아미드벤조일)-HPI2- (3-hexanoylamidebenzoyl) -HPI
2-(4-헥사노일아미드벤조일)-HPI2- (4-hexanoylamidebenzoyl) -HPI
2-(2-옥타노일아미드벤조일)-HPI2- (2-octanoylamidebenzoyl) -HPI
2-(3-옥타노일아미드벤조일)-HPI2- (3-octanoylamidebenzoyl) -HPI
2-(4-옥타노일아미드벤조일)-HPI2- (4-octanoylamidebenzoyl) -HPI
2-(2-오레오일아미드벤조일)-HPI2- (2-Oleoylamidebenzoyl) -HPI
2-(3-올레오일아미드벤조일)-HPI2- (3-Oleoylamidebenzoyl) -HPI
2-(4-올레오일아미드벤조일)-HPI2- (4-Oleoylamidebenzoyl) -HPI
2-(2-메틸티오벤조일)-HPI2- (2-methylthiobenzoyl) -HPI
2-(3-메틸티오벤조일)-HPI2- (3-methylthiobenzoyl) -HPI
2-(4-메틸티오벤조일)-HPI 융융 195℃2- (4-methylthiobenzoyl) -HPI fusion 195 ° C
2-(3-에틸티오벤조일)-HPI2- (3-ethylthiobenzoyl) -HPI
2-(4-에틸티오벤조일)-HPI2- (4-ethylthiobenzoyl) -HPI
2-(3, 4-비스-(메틸티오)-벤조일)-HPI2- (3, 4-bis- (methylthio) -benzoyl) -HPI
2-(3, 5-비스-(메틸티오)-벤조일)-HPI2- (3, 5-bis- (methylthio) -benzoyl) -HPI
2-(3, 4, 5-트리스-(메틸티오-벤조일)-HPI2- (3, 4, 5-tris- (methylthio-benzoyl) -HPI
2-(4-페닐티오벤 조일)-HPI2- (4-phenylthiobenzyl) -HPI
2-(2-니트로벤조일)-HPI; 융점 188-189℃2- (2-nitrobenzoyl) -HPI; Melting Point 188-189 ℃
2-(3-니트로벤조일)-HPI; 융점 172℃2- (3-nitrobenzoyl) -HPI; Melting point 172 ℃
2-(3, 4-디니트로벤조일)-HPI; 융점 219℃2- (3, 4-dinitrobenzoyl) -HPI; Melting point 219 ℃
2-(3, 5-디니트로벤조일)-HPI; 융점 251-252℃2- (3, 5-dinitrobenzoyl) -HPI; Melting point 251-252 ℃
2-(2-트리플루오로메틸벤조일)-HPI2- (2-trifluoromethylbenzoyl) -HPI
2-(3-트리플루오로메틸벤조일)-HPI; 융점 148-149℃2- (3-trifluoromethylbenzoyl) -HPI; Melting point 148-149 ℃
2-(4-트리플루오로메틸벤조일)-HPI2- (4-trifluoromethylbenzoyl) -HPI
2-(2-시아노벤조일)-HPI2- (2-cyanobenzoyl) -HPI
2-(3-시아노벤조일)-HPI2- (3-cyanobenzoyl) -HPI
2-(4-시아노벤조일)-HPI; 융점 214-215℃2- (4-cyanobenzoyl) -HPI; Melting Point 214-215 ° C
2-(2-메톡시카르보닐벤조일)-HPI2- (2-methoxycarbonylbenzoyl) -HPI
2-(3-메톡시카르보닐벤조일)-HPI2- (3-methoxycarbonylbenzoyl) -HPI
2-(4-메톡시카르보닐벤조일)-HPI; 융점 178℃2- (4-methoxycarbonylbenzoyl) -HPI; Melting point 178 ℃
2-(2-에톡시카르보닐벤조일)-HPI2- (2-ethoxycarbonylbenzoyl) -HPI
2-(3-에톡시카르보닐벤조일)-HPI2- (3-ethoxycarbonylbenzoyl) -HPI
2-(4-에톡시카르보닐벤조일)-HPI2- (4-ethoxycarbonylbenzoyl) -HPI
2-(3, 4-비스-(메톡시카르보닐)-벤조일)-HPI2- (3, 4-bis- (methoxycarbonyl) -benzoyl) -HPI
2-(3, 5-비스-(메톡시카르보닐)-벤조일)-HPI2- (3, 5-bis- (methoxycarbonyl) -benzoyl) -HPI
2-(2-아지도벤조일)-HPI2- (2-azidobenzoyl) -HPI
2-(3-아지도벤조일)-HPI2- (3-azidobenzoyl) -HPI
2-(4-아지도벤조일)-HPI2- (4-azidobenzoyl) -HPI
2-(2-메톡시술포닐벤조일)-HPI2- (2-methoxysulfonylbenzoyl) -HPI
2-(3-메톡시술포닐벤조일)-HPI2- (3-methoxysulfonylbenzoyl) -HPI
2-(4-메톡시술포닐벤조일)-HPI2- (4-methoxysulfonylbenzoyl) -HPI
2-(피릴-3-카르보닐)-HPI; 융점 132-133℃2- (pyryl-3-carbonyl) -HPI; Melting point 132-133 ℃
2-(티에닐-3-카르보닐)-HPI; 융점; 142-143℃2- (thienyl-3-carbonyl) -HPI; Melting point; 142-143 ℃
2-(3-플루오로티에닐-2-카르보닐)-HPI2- (3-fluorothienyl-2-carbonyl) -HPI
2-(4-플루오로티에닐-2-카르보닐)-HPI2- (4-fluorothienyl-2-carbonyl) -HPI
2-(5-플루오로티에닐-2-카르보닐)-HPI2- (5-fluorothienyl-2-carbonyl) -HPI
2-(3-니트로티에닐-2-카르보닐)-HPI2- (3-nitrothienyl-2-carbonyl) -HPI
2-(4-니트로티에닐-2-카르보닐)-HPI2- (4-nitrothienyl-2-carbonyl) -HPI
2-(5-니트로티에닐-2-카르보닐)-HPI 융점 172-173℃2- (5-nitrothienyl-2-carbonyl) -HPI melting point 172-173 ° C
2-(3-디메틸아미노티에닐-2-카르보닐)-HPI2- (3-dimethylaminothienyl-2-carbonyl) -HPI
2-(4-디메틸아미노티에닐-2-카르보닐)-HPI2- (4-dimethylaminothienyl-2-carbonyl) -HPI
2-(3-포름아미드티에닐-2-카르보닐)-HPI2- (3-formamidethienyl-2-carbonyl) -HPI
2-(4-포름아미드티에닐-2-카르보닐)-HPI2- (4-formamidethienyl-2-carbonyl) -HPI
2-(3-메틸-티에닐-2-카르보닐)-HPI2- (3-Methyl-thienyl-2-carbonyl) -HPI
2-(4-메틸-티에닐-2-카르보닐)-HPI2- (4-Methyl-thienyl-2-carbonyl) -HPI
2-(5-메틸-티에닐-2-카르보닐)-HPI 융점 134-136℃2- (5-methyl-thienyl-2-carbonyl) -HPI melting point 134-136 ° C.
2-(2-메틸-티에닐-3-카르보닐)-HPI2- (2-Methyl-thienyl-3-carbonyl) -HPI
2-(4-메틸-티에닐-3-카르보닐)-HPI2- (4-Methyl-thienyl-3-carbonyl) -HPI
2-(5-메틸-티에닐-3-카르보닐)-HPI2- (5-Methyl-thienyl-3-carbonyl) -HPI
2-(듀릴-2-카르보닐)-HPI 120℃2- (duryl-2-carbonyl) -HPI 120 ° C
2-(퓨릴-3-카르보닐)-HPI2- (furyl-3-carbonyl) -HPI
2-(3-플루오로퓨릴-2-카르보닐)-HPI2- (3-fluorofuryl-2-carbonyl) -HPI
2-(4-플루오로퓨릴-2-카르보닐)-HPI2- (4-fluoropuryl-2-carbonyl) -HPI
2-(5-풀루오로퓨릴-2-카르보닐)-HPI2- (5-Pluoropuryl-2-carbonyl) -HPI
2-(5-클로로퓨릴-2-카르보닐)-HPI2- (5-chlorofuryl-2-carbonyl) -HPI
2-(3-메틸-티에닐-2-카르보닐)-HPI2- (3-Methyl-thienyl-2-carbonyl) -HPI
2-(4-메틸-티에닐-2-카르보닐)-HPI2- (4-Methyl-thienyl-2-carbonyl) -HPI
2-(5-메틸-티에닐-2-카르보닐-HPI 융점 134-136℃2- (5-methyl-thienyl-2-carbonyl-HPI melting point 134-136 ° C.
2-(2-메틸-티에닐-3-카르보닐)-HPI2- (2-Methyl-thienyl-3-carbonyl) -HPI
2-(4-메틸-티에닐-3-카르보닐)-HPI2- (4-Methyl-thienyl-3-carbonyl) -HPI
2-(5-메틸-티에닐-3-카르보닐)-HPI2- (5-Methyl-thienyl-3-carbonyl) -HPI
2-(퓨릴-2-카르보닐)-HPI 융점 120℃2- (furyl-2-carbonyl) -HPI melting point 120 ° C
2-(퓨릴-3-카르보닐)-HPI2- (furyl-3-carbonyl) -HPI
2-(3-플루오로퓨릴-2-카르보닐)-HPI2- (3-fluorofuryl-2-carbonyl) -HPI
2-(4-플루오로퓨릴-2-카르보닐)-HPI2- (4-fluoropuryl-2-carbonyl) -HPI
2-(5-플루오로퓨릴-2-카르보닐)-HPI2- (5-fluoropuryl-2-carbonyl) -HPI
2-(5-클로로퓨릴-2-카르보닐)-HPI2- (5-chlorofuryl-2-carbonyl) -HPI
2-(5-브로모퓨릴-2-카르보닐)-HPI 융점 209℃2- (5-bromofuryl-2-carbonyl) -HPI melting point 209 ° C
2-(5-니트로퓨릴-2-카르보닐)-HPI 융점 182℃2- (5-nitrofuryl-2-carbonyl) -HPI melting point 182 ° C
2-(인돌일-2-카르보닐)-HPI2- (indolyl-2-carbonyl) -HPI
2-(인돌일-3-카르보닐)-HPI2- (indolyl-3-carbonyl) -HPI
2-(인돌일-4-카르보닐)-HPI2- (indolyl-4-carbonyl) -HPI
2-(인돌일-5-카르보닐)-HPI 융점 235℃2- (indolyl-5-carbonyl) -HPI melting point 235 ° C
2-(인돌일-6-카르보닐)-HPI2- (indolyl-6-carbonyl) -HPI
2-(인돌일-7-카르보닐)-HPI2- (indolyl-7-carbonyl) -HPI
2-(피라조릴-3-카르보닐)-HPI2- (pyrazoryl-3-carbonyl) -HPI
2-(피라조릴-4-카르보닐)-HPI2- (pyrazoryl-4-carbonyl) -HPI
2-(5-메틸-피라조릴-3-카르보닐)-HPI 융점 201℃2- (5-methyl-pyrazolyl-3-carbonyl) -HPI melting point 201 ° C.
2-(4-메틸-피라조릴-3-카르보닐)-HPI2- (4-Methyl-pyrazolyl-3-carbonyl) -HPI
2-(4-메틸-이미다조릴-2-카르보닐)-HPI2- (4-Methyl-imidazolyl-2-carbonyl) -HPI
2-(5-메틸-이미다조릴-2-카르보닐)-HPI2- (5-Methyl-imidazolyl-2-carbonyl) -HPI
2-(2-메틸-이미다조릴-4-카르보닐)-HPI2- (2-Methyl-imidazolyl-4-carbonyl) -HPI
2-(5-메틸-이미다조릴-4-카르보닐)-HPI2- (5-Methyl-imidazolyl-4-carbonyl) -HPI
2-(이미다조릴-2-카르보닐)-HPI2- (imidazolyl-2-carbonyl) -HPI
2-(이미다조릴-4-카르보닐)-HPI2- (imidazolyl-4-carbonyl) -HPI
2-(치아조릴-2-카르보닐)-HPI2- (thiazolyl-2-carbonyl) -HPI
2-(4-메틸-티아조릴-2-카르보닐)-HPI2- (4-Methyl-thiazolyl-2-carbonyl) -HPI
2-(5-메틸-티아조릴-2-카르보닐)-HPI2- (5-Methyl-thiazolyl-2-carbonyl) -HPI
2-(티아조릴-4-카르보닐)-HPI 융점 154℃2- (thiazolyl-4-carbonyl) -HPI melting point 154 ° C.
2-(2-메틸-티아조릴-4-카르보닐)-HPI2- (2-Methyl-thiazolyl-4-carbonyl) -HPI
2-(5-메틸-티아조릴-4-카르보닐)-HPI2- (5-Methyl-thiazolyl-4-carbonyl) -HPI
2-(티아조릴-5-카르보닐)-HPI2- (thiazolyl-5-carbonyl) -HPI
2-(2-메틸-티아조릴-5-카르보닐)-HPI2- (2-Methyl-thiazolyl-5-carbonyl) -HPI
2-(4-메틸-티아조릴-5-카르보닐)-HPI2- (4-Methyl-thiazolyl-5-carbonyl) -HPI
2-(5-니트로티아조릴-2-카르보닐)-HPI2- (5-nitrothiazolyl-2-carbonyl) -HPI
2-(2, 4-디메틸-티아조릴-5-카르보닐)-HPI 융점 162-163℃2- (2,4-dimethyl-thiazolyl-5-carbonyl) -HPI Melting Point 162-163 ° C
2-(벤즈티아조릴-2-카르보닐)-HPI2- (benzthiazolyl-2-carbonyl) -HPI
2-(벤즈티아조릴-4-카르보닐)-HPI2- (benzthiazolyl-4-carbonyl) -HPI
2-(벤즈티아조릴-5-카르보닐)-HPI2- (benzthiazolyl-5-carbonyl) -HPI
2-(이소티아조릴-3-카르보닐)-HPI2- (isothiazolyl-3-carbonyl) -HPI
2-(4-메틸-이소티아조릴-3-카르보닐)-HPI2- (4-Methyl-isothiazolyl-3-carbonyl) -HPI
2-(5-메틸-이소티아조릴-3-카르보닐)-HPI2- (5-Methyl-isothiazolyl-3-carbonyl) -HPI
2-(이소티아조릴-4-카르보닐)-HPI2- (isothiazolyl-4-carbonyl) -HPI
2-(3-메틸-이소티아조릴-4-카르보닐)-HPI2- (3-Methyl-isothiazolyl-4-carbonyl) -HPI
2-(5-메틸-이소티아조릴-4-카르보닐)-HPI2- (5-Methyl-isothiazolyl-4-carbonyl) -HPI
2-(이소티아조릴-5-카르보닐)-HPI2- (isothiazolyl-5-carbonyl) -HPI
2-(3-메틸-이소티아조릴-5-카르보닐)-HPI2- (3-Methyl-isothiazolyl-5-carbonyl) -HPI
2-(4-메틸-이소티아조릴-5-카르보닐)-HPI2- (4-Methyl-isothiazolyl-5-carbonyl) -HPI
2-(옥사조릴-2-카르보닐)-HPI2- (oxazolyl-2-carbonyl) -HPI
2-(4-메틸-옥사조릴-2-카르보닐)-HPI2- (4-Methyl-oxazolyl-2-carbonyl) -HPI
2-(5-메틸-옥사조릴-2-카르보닐)-HPI2- (5-Methyl-oxazolyl-2-carbonyl) -HPI
2-(옥사조릴-4-카르보닐)-HPI2- (oxazolyl-4-carbonyl) -HPI
2-(2-메틸-옥사조릴-4-카르보닐)-HPI2- (2-Methyl-oxazolyl-4-carbonyl) -HPI
2-(5-메틸-옥사조릴-4-카르보닐)-HPI2- (5-Methyl-oxazolyl-4-carbonyl) -HPI
2-(옥사조릴-5-카르보닐)-HPI2- (oxazolyl-5-carbonyl) -HPI
2-(2-메틸-옥사조릴-5-카르보닐)-HPI2- (2-Methyl-oxazolyl-5-carbonyl) -HPI
2-(4-메틸-옥사조릴-5-카르보닐)-HPI2- (4-Methyl-oxazolyl-5-carbonyl) -HPI
2-(이속사조릴-3-카르보닐)-HPI2- (isoxazolyl-3-carbonyl) -HPI
2-(4-메틸-이속사조릴-3-카르보닐)-HPI2- (4-Methyl-isoxazolyl-3-carbonyl) -HPI
2-(5-메틸-이속사조릴-3-카르보닐)-HPI; 융점 173-174℃2- (5-methyl-isoxazolyl-3-carbonyl) -HPI; Melting Point 173-174 ℃
2-(이속사조릴-4-카르보닐)-HPI2- (isoxazolyl-4-carbonyl) -HPI
2-(3-에틸-이속사조릴-4-카르보닐)-HPI2- (3-ethyl-isoxazolyl-4-carbonyl) -HPI
2-(5-메틸-이속사조릴-4-카르보닐)-HPI2- (5-Methyl-isoxazolyl-4-carbonyl) -HPI
2-(이속사조릴-5-카르보닐)-HPI2- (isoxazolyl-5-carbonyl) -HPI
2-(3-메틸-이속사조릴-5-카르보닐)-HPI2- (3-Methyl-isoxazolyl-5-carbonyl) -HPI
2-(4-메틸-이속사조릴-5-카르보닐)-HPI2- (4-Methyl-isoxazolyl-5-carbonyl) -HPI
2-피콜리노일-HPI 브롬화수소; 융점 163℃2-picolinoyl-HPI hydrogen bromide; Melting point 163 ℃
2-(3-플루오로피콜리노일)-HPI2- (3-fluoropicolinoyl) -HPI
2-(4-플루오로피콜리노일)-HPI2- (4-fluoropicolinoyl) -HPI
2-(5-플루오로피콜리노일)-HPI2- (5-fluoropicolinoyl) -HPI
2-(6-플루오로피콜리노일)-HPI2- (6-fluoropicolinoyl) -HPI
2-(3-디에틸아미노피콜리노일)-HPI2- (3-diethylaminopicolinoyl) -HPI
2-(4-디에틸아미노피콜리노일)-HPI2- (4-diethylaminopicolinoyl) -HPI
2-(5-디에틸아미노피콜리노일)-HPI2- (5-Diethylaminopicolinoyl) -HPI
2-(6-디에틸아미노피콜리노일)-HPI2- (6-Diethylaminopicolinoyl) -HPI
2-(3-포름아미노피콜리노일)-HPI2- (3-formaminopicolinoyl) -HPI
2-(4-포름아미노피콜리노일)-HPI2- (4-formaminopicolinoyl) -HPI
2-(5-포름아미노피콜리노일)-HPI2- (5-formaminopicolinoyl) -HPI
2-(6-포름아미노피콜리노일)-HPI2- (6-formaminopicolinoyl) -HPI
2-니코티노일-HPI 융점 172℃2-nicotinoyl-HPI melting point 172 ° C
2-(2-풀루오로니코티노일)-HPI2- (2-Pluoronicotinoyl) -HPI
2-(4-플루오로니코티노일)-HPI2- (4-fluoronicotinoyl) -HPI
2-(5-플루오로니코티노일)-HPI2- (5-fluoronicotinoyl) -HPI
2-(6-플루오로니코티노일)-HPI2- (6-fluoronicotinoyl) -HPI
2-(2-클로로니코티노일)-HPI2- (2-chloronicotinoyl) -HPI
2-(4-클로로니코티노일)-HPI 융점 158℃2- (4-chloronicotinoyl) -HPI melting point 158 ° C
2-(5-클로로니코티노일)-HPI2- (5-chloronicotinoyl) -HPI
2-(6-클로로니코티노일)-HPI2- (6-chloronicotinoyl) -HPI
2-(2-히드록시니코티노일)-HPI2- (2-hydroxynicotinoyl) -HPI
2-(4-히드록시니코티노일)-HPI2- (4-hydroxynicotinoyl) -HPI
2-(5-히드록시니코티노일)-HPI2- (5-hydroxynicotinoyl) -HPI
2-(6-히드록시니코티노일)-HPI2- (6-hydroxynicotinoyl) -HPI
2-(2-디메틸아미노니코티노일)-HPI2- (2-dimethylaminonicotinoyl) -HPI
2-(4-디메틸아미노니코티노일)-HPI2- (4-dimethylaminonicotinoyl) -HPI
2-(5-디메틸아미노니코티노일)-HPI2- (5-dimethylaminonicotinoyl) -HPI
2-(6-디메틸아미노니코티노일)-HPI2- (6-dimethylaminonicotinoyl) -HPI
2-(2-포름아미도니코티노일)-HPI2- (2-formamidonicotinoyl) -HPI
2-(4-포름아미도니코티노일)-HPI2- (4-formamidonicotinoyl) -HPI
2-(5-포름아미도니코티노일)-HPI2- (5-formamidonicotinoyl) -HPI
2-(6-포름아미도니코티노일)-HPI2- (6-formamidonicotinoyl) -HPI
2-(2-아세트아미도니코티노일)-HPI2- (2-acetamidonicotinoyl) -HPI
2-(4-아세트아미도니코티노일)-HPI2- (4-acetamidonicotinoyl) -HPI
2-(5-아세트아미도니코티노일)-HPI2- (5-acetamidonicotinoyl) -HPI
2-(6-아세트아미도니코티노일)-HPI2- (6-acetamidonicotinoyl) -HPI
2-이소니코티노일-HPI 융점 140-141℃2-isonicotinoyl-HPI melting point 140-141 ° C
2-(2, 6-디클로로이소니코티노일)-HPI 융점 207-208℃2- (2,6-dichloroisonicotinoyl) -HPI Melting Point 207-208 ° C
2-(퀴놀릴-2-카르보닐)-HPI 융점 198-200℃2- (quinolyl-2-carbonyl) -HPI melting point 198-200 ° C
2-(퀴놀릴-3-카르보닐)-HPI2- (quinolyl-3-carbonyl) -HPI
2-(퀴놀릴-4-카르보닐)-HPI2- (quinolyl-4-carbonyl) -HPI
2-(퀴놀릴-5-카르보닐)-HPI2- (quinolyl-5-carbonyl) -HPI
2-(퀴놀릴-6-카르보닐)-HPI2- (quinolyl-6-carbonyl) -HPI
2-(퀴놀릴-7-카르보닐)-HPI2- (quinolyl-7-carbonyl) -HPI
2-(퀴놀릴-8-카르보닐)-HPI2- (quinolyl-8-carbonyl) -HPI
2-(이소퀴놀릴)-1-카르보닐)-HPI 융점 157℃2- (isoquinolyl) -1-carbonyl) -HPI melting point 157 ° C
2-(이소퀴놀릴-3-카르보닐)-HPI2- (isoquinolyl-3-carbonyl) -HPI
2-(피리다지닐-3-카르보닐)-HPI2- (pyridazinyl-3-carbonyl) -HPI
2-(피리다지닐-4-카르보닐)-HPI2- (pyridazinyl-4-carbonyl) -HPI
2-(피리미디닐-2-카르보닐)-HPI2- (pyrimidinyl-2-carbonyl) -HPI
2-(피리미디닐-4-카르보닐)-HPI2- (pyrimidinyl-4-carbonyl) -HPI
2-(피리미디닐-5-카르보닐)-HPI2- (pyrimidinyl-5-carbonyl) -HPI
2-(피라지닐-2-카르보닐)-HPI 융점 153-154℃2- (pyrazinyl-2-carbonyl) -HPI melting point 153-154 ° C
2-(퓨리닐-2-카르보닐)-HPI2- (purinyl-2-carbonyl) -HPI
2-(퓨리닐-2-카르보닐)-HPI2- (purinyl-2-carbonyl) -HPI
2-나리디시닐-HPI (즉 2-(1-에틸-7-메틸-1, 8-나프리딘-4-온-3-카르보닐)-HPI2-Naridicinyl-HPI (ie 2- (1-ethyl-7-methyl-1, 8-napridin-4-one-3-carbonyl) -HPI
2-(디옥사닐-2-카르보닐)-HPI2- (dioxanyl-2-carbonyl) -HPI
2-(4-메틸-피페라지닐-1-카르보닐)-HPI; 염화수소 융점 290℃2- (4-methyl-piperazinyl-1-carbonyl) -HPI; Hydrogen Chloride Melting Point 290 ℃
2-(디히드로퓨릴-2-카르보닐)-HPI2- (dihydrofuryl-2-carbonyl) -HPI
2-(테트라히드로퓨릴-2-카르보닐)-HPI2- (tetrahydrofuryl-2-carbonyl) -HPI
2-(테트라히드로퓨릴-3-카르보닐)-HPI2- (tetrahydrofuryl-3-carbonyl) -HPI
2-(1-메틸-1, 2, 5, 6-테트라히드로피리딜-3-카르보닐)-HPI; 염화수소 융점 211℃2- (1-methyl-1, 2, 5, 6-tetrahydropyridyl-3-carbonyl) -HPI; Hydrogen Chloride Melting Point 211 ℃
2-(1-메틸-1, 4, 5, 6-테트라히드로피리딜-3-카르보닐)-HPI2- (1-Methyl-1, 4, 5, 6-tetrahydropyridyl-3-carbonyl) -HPI
2-(1-메틸피페리딜-2-카르보닐)-HPI2- (1-methylpiperidyl-2-carbonyl) -HPI
2-(1-메틸피페리딜-3-카르보닐)-HPI2- (1-methylpiperidyl-3-carbonyl) -HPI
2-(1-메틸피페리딜-4-카르보닐)-HPI2- (1-methylpiperidyl-4-carbonyl) -HPI
2-(1-에틸피페리딜-2-카르보닐)-HPI2- (1-ethylpiperidyl-2-carbonyl) -HPI
2-(1-에틸피페리딜-3-카르보닐)-HPI2- (1-ethylpiperidyl-3-carbonyl) -HPI
2-(1-에틸피페리딜-4-카르보닐)-HPI2- (1-ethylpiperidyl-4-carbonyl) -HPI
2-(1-벤질피페리딜-2-카르보닐)-HPI2- (1-benzylpiperidyl-2-carbonyl) -HPI
2-(1-벤질피페리딜-3-카르보닐)-HPI2- (1-benzylpiperidyl-3-carbonyl) -HPI
2-(1-벤질피페리딜-4-카르보닐)-HPI2- (1-benzylpiperidyl-4-carbonyl) -HPI
2-(1-포르밀페리딜-3-카르보닐)-HPI2- (1-formylferridyl-3-carbonyl) -HPI
2-(1-포르밀페리딜-4-카르보닐)-HPI 융점 160℃2- (1-formylferridyl-4-carbonyl) -HPI melting point 160 캜
2-(1-아세틸피페리딜-2-카르보닐)-HPI2- (1-acetylpiperidyl-2-carbonyl) -HPI
2-(1-아세틸피페리딜-3-카르보닐)-HPI2- (1-acetylpiperidyl-3-carbonyl) -HPI
2-(1-아세틸피페리딜-4-카르보닐)-HPI2- (1-acetylpiperidyl-4-carbonyl) -HPI
2-(1-헥사노일피페리딜-2-카르보닐)-HPI2- (1-hexanoylpiperidyl-2-carbonyl) -HPI
2-(1-헥사노일피페리딜-3-카르보닐)-HPI2- (1-hexanoylpiperidyl-3-carbonyl) -HPI
2-(1-헥사노일피페리딜-4-카르보닐)-HPI2- (1-hexanoylpiperidyl-4-carbonyl) -HPI
2-(1-옥타노일피페리딜-2-카르보닐)-HPI2- (1-octanoylpiperidyl-2-carbonyl) -HPI
2-(1-옥타노일피페리딜-3-카르보닐)-HPI2- (1-octanoylpiperidyl-3-carbonyl) -HPI
2-(1-옥타노일피페리딜-4-카르보닐)-HPI2- (1-octanoylpiperidyl-4-carbonyl) -HPI
2-(1-올레오일피페리딜-2-카르보닐)-HPI2- (1-Oleoylpiperidyl-2-carbonyl) -HPI
2-(1-올레오일피페리딜-3-카르보닐)-HPI2- (1-Oleoylpiperidyl-3-carbonyl) -HPI
2-(1-올레오일피페리딜-4-카르보닐)-HPI2- (1-Oleoylpiperidyl-4-carbonyl) -HPI
2-(1-메톡시아세틸)-피페리딜-2-카르보닐)-HPI2- (1-methoxyacetyl) -piperidyl-2-carbonyl) -HPI
2-(1-메톡시아세틸)-피페리딜-3-카르보닐)-HPI2- (1-methoxyacetyl) -piperidyl-3-carbonyl) -HPI
2-(1-메톡시아세틸)-피페리딜-4-카르보닐)-HPI2- (1-methoxyacetyl) -piperidyl-4-carbonyl) -HPI
2-(1-에톡시아세틸)-피페리딜-2-카르보닐)-HPI2- (1-ethoxyacetyl) -piperidyl-2-carbonyl) -HPI
2-(1-에톡시아세틸)-피페리딜-3-카르보닐)-HPI2- (1-ethoxyacetyl) -piperidyl-3-carbonyl) -HPI
2-(1-에톡시아세틸)-피페리딜-4-카르보닐)-HPI2- (1-ethoxyacetyl) -piperidyl-4-carbonyl) -HPI
2-(테트라히드로피라닐-2-카르보닐)-HPI2- (tetrahydropyranyl-2-carbonyl) -HPI
2-(테트라히드로피라닐-3-카르보닐)-HPI2- (tetrahydropyranyl-3-carbonyl) -HPI
2-(테트라히드로피라닐-4-카르보닐)-HPI 융점 172℃2- (tetrahydropyranyl-4-carbonyl) -HPI melting point 172 ° C
2-(크로몬-2-카르보닐)-HPI 융점 155-156℃2- (Chlomon-2-carbonyl) -HPI Melting Point
2-(테트라히드로치오피라닐-2-카르보닐)-HPI2- (tetrahydrothiopyranyl-2-carbonyl) -HPI
2-(테트라히드로치오피라닐-3-카르보닐)-HPI2- (tetrahydrothiopyranyl-3-carbonyl) -HPI
2-(테트라히드로치오피리닐-4-카르보닐)-HPI 융점 168℃2- (tetrahydrothiopyridyl-4-carbonyl) -HPI melting point 168 ° C
2-(1, 2, 3-티아디아조릴-4-카르보닐)-HPI2- (1, 2, 3-thiadiazoryl-4-carbonyl) -HPI
2-(2, 1, 3-벤조티아디아조릴-5-카르보닐)-HPI 융점 144℃2- (2, 1, 3-benzothiadiazolyl-5-carbonyl) -HPI melting point 144 캜
[실시예 2]Example 2
포스포러스 트리클로라이드 1ml를 클로로벤젠 50ml에 HPI 6.1g과 5-크로로살리실산 5.5.g을 넣은 용액에 140℃(욕조온도)에서 적가하고 이 반응혼합물을 비등시키고 증발시킨 다음 잔사를 실리카겔상에서 용출제로 클로로포름을 사용하여 크로마토그라피하고 이소프로판올로 재결정시켜 융점이 180°인 2-(5-클로로-2-하이드록시벤조일)-HPI을 얻었다.1 ml of phosphorus trichloride was added dropwise to a solution containing 6.1 g of HPI and 5.5. G of 5-chromosalicylic acid in 50 ml of chlorobenzene at 140 ° C. (bath temperature), and the reaction mixture was boiled and evaporated. Chromatography with chloroform and recrystallization with isopropanol gave 2- (5-chloro-2-hydroxybenzoyl) -HPI having a melting point of 180 °.
[실시예 3]Example 3
HPI 10.1g 이소니코틴산 6.75g 및 사염화실리콘 5.5g을 피리딘 150ml내에서 1시간동안 비등시키고 이 반응혼합물을 얼음에 붓고 클로로포름으로 추출한 다음 물로 씻었다. 클로로포름용액을 무수황산나트륨상에서 건조시키고 에탄올로 재결정시켜 융점 140-141℃인 2-(이소니코티노일)-HPI를 얻었다.6.75 g of HPI 10.1 g isonicotinic acid and 5.5 g of silicon tetrachloride were boiled in 150 ml of pyridine for 1 hour, and the reaction mixture was poured into ice, extracted with chloroform and washed with water. The chloroform solution was dried over anhydrous sodium sulfate and recrystallized with ethanol to give 2- (isonicotinoyl) -HPI having a melting point of 140-141 ° C.
[실시예 4]Example 4
HPI 6.1g과 포름산 1.4g을 톨루엔 100ml내에서 5시간동안 가열하여 생성된 물을 증류 제거시키고 냉각시킨다음 에탄올로 재결정시켜 융검 206℃인 2-포르밀-HPI를 얻었다.6.1 g of HPI and 1.4 g of formic acid were heated in 100 ml of toluene for 5 hours to distill off the resulting water, cool down and recrystallize with ethanol to give 2-formyl-HPI at 206 ° C.
[실시예 5]Example 5
4.04g과 싸이클로헥산-1, 2-트란스-디카복실산무수물 3.4을 각각 20℃에서 메틸렌클로라이드 25ml에서 용해하고 함께 혼합하였다. 이 반응혼합물을 정치한다음 증발시키고 에틸아세테이트/석유에테르로 재결정시켜 융점 208-210℃인 2-(2-트란스-카복시-싸이클로헥실카보닐)-HPI를 얻었다. 같은 방법으로 싸이클로헥산-1, 2-시스-디카복실산무수물을 디옥산내에서 6시간 비등시켜 융점 194-196℃인 2-(2-시스-카복시싸이클로헥실카보닐)-HPI를 얻었다.4.04 g and cyclohexane-1, 2-trans-dicarboxylic anhydride 3.4 were each dissolved in 25 ml of methylene chloride at 20 ° C. and mixed together. The reaction mixture was left to stand and then evaporated and recrystallized from ethyl acetate / petroleum ether to give 2- (2-trans-carboxy-cyclohexylcarbonyl) -HPI having a melting point of 208-210 ° C. Cyclohexane-1, 2-cis-dicarboxylic acid anhydride was boiled in dioxane for 6 hours in the same manner to obtain 2- (2-cis-carboxyhexylcarbonyl) -HPI having a melting point of 194-196 占 폚.
같은 방법으로 싸이클로부탄-1, 2-디카복실산무수물, 싸이클로펜탄-1, 2-디산카실산무수물, 싸이클로헵탄-1, 2-디카복실로무수물, 프탈산무수물 및 석신산 무수물로 2-(2-트란스-카복시싸이클로펜틸-카보닐-HPIIn the same manner, cyclobutane-1, 2-dicarboxylic acid anhydride, cyclopentane-1, 2-dicarboxylic acid anhydride, cycloheptan-1, 2-dicarboxylic anhydride, phthalic anhydride and succinic anhydride Trans-Carboxycyclopentyl-Carbonyl-HPI
2-(2-트란스-카복싸이클로헵틸-카보닐)-HPI;2- (2-trans-carboxycycloheptyl-carbonyl) -HPI;
2-(2-시스-카복시싸이클로부틸-카보닐)-HPI;2- (2-cis-carboxycyclobutyl-carbonyl) -HPI;
2-(2-시스-카복시싸클로펜틸-카보닐)-HPI;2- (2-cis-carboxycyclopentyl-carbonyl) -HPI;
2-(2-시스-카복시싸이클로헵틸-카보닐)-HPI;2- (2-cis-carboxycycloheptyl-carbonyl) -HPI;
2-(2-카복시벤조일)-HPI;2- (2-carboxybenzoyl) -HPI;
2-(3-카복시프로피오닐)-HPI;를 얻었다.2- (3-carboxypropionyl) -HPI; was obtained.
[실시예 6]Example 6
HPI의 (+)-및 (-)-이성체와 상응하는 염화물로부터 실시예 1과 같은 방법으로 다음 화합물들이 얻어졌다.The following compounds were obtained in the same manner as in Example 1 from chlorides corresponding to the (+)-and (-)-isomers of HPI.
(+)-2-아세틸-HPI(+)-2-acetyl-HPI
(-)-2-아세틸-HPI(-)-2-acetyl-HPI
(+)-2-프로피오닐-HPI(+)-2-propionyl-HPI
(-)-2-프로피오닐HPI(-)-2-propionylHPI
(+)-2-이소부티릴-HPI(+)-2-isobutyryl-HPI
(-)-2-이소부티릴-HPI(-)-2-isobutyryl-HPI
(+) -2-트리메틸아세틸-HPI(+)-2-trimethylacetyl-HPI
(-)-2-트리메틸아세틸-HPI(-)-2-trimethylacetyl-HPI
(+)-(3, 3-디메틸-n-부티릴)-HPI(+)-(3, 3-dimethyl-n-butyryl) -HPI
(-)-2-(3, 3-디메틸-n-부티릴)-HPI(-)-2- (3, 3-dimethyl-n-butyryl) -HPI
(+) -2-헵타노일-HPI(+)-2-heptanoyl-HPI
(-)-2-헵타노일-HPI(-)-2-heptanoyl-HPI
(+)-2-(티에닐-2-메르캅토아세틸)-HPI(+)-2- (thienyl-2-mercaptoacetyl) -HPI
(-)-2-(티에닐-2-메르캅토아세틸)-HPI(-)-2- (thienyl-2-mercaptoacetyl) -HPI
(+)-2-시클로프로필-카르보닐-HPI(+)-2-cyclopropyl-carbonyl-HPI
(-)-2-시클로프로필-카르보닐-HPI(-)-2-cyclopropyl-carbonyl-HPI
(±)-2-시클로부틸-카르보닐-HPI(±) -2-cyclobutyl-carbonyl-HPI
(±) -2-시클로펜틸 -카르보닐-HPI(±) -2-cyclopentyl-carbonyl-HPI
(+)-2-시클로헥실-카르보닐-HPI 융점 108-110℃ [α]=+145.2°(+)-2-cyclohexyl-carbonyl-HPI melting point 108-110 ° C. [α] = + 145.2 °
(-)-2-시클로헥실-카르보닐-HPI 융점 107-108℃ [α]=-146.9°(-)-2-cyclohexyl-carbonyl-HPI melting point 107-108 ° C. [α] =-146.9 °
(±)-2-(4-포름아미드시클로헥실-카르보닐)-HPI(±) -2- (4-formamidecyclohexyl-carbonyl) -HPI
(±)-2-시클로헵틸-카르보닐-HPI(±) -2-cycloheptyl-carbonyl-HPI
(±)-2-시클로옥틸-카르보닐-HPI(±) -2-cyclooctyl-carbonyl-HPI
(+)-2-(4-메틸벤조일)-HPI 융점 180-181℃ [α]=+29.2°(+)-2- (4-methylbenzoyl) -HPI melting point 180-181 ° C. [α] = + 29.2 °
(-)-2-(4-메틸벤조일)-HPI 융점 181-182℃ [α]=-28.5°(-)-2- (4-methylbenzoyl) -HPI Melting Point 181-182 ° C [α] =-28.5 °
(+)-2-(4-3보-부닐벤조일)-HPI 융점 181-182℃ [α]=+21.5°(+)-2- (4-3bo-butylbenzoyl) -HPI Melting Point 181-182 ° C [α] = + 21.5 °
(-)-2-(4-3급-부틸벤조일)-HPI 융점 168-169℃ [α]=-20.5°(-)-2- (4-tert-butylbenzoyl) -HPI Melting point 168-169 ° C [α] =-20.5 °
(+)-2-(2-플루오로벤조일)-HPI 융점 155-156℃ [α]=+49.1°(+)-2- (2-fluorobenzoyl) -HPI melting point 155-156 ° C. [α] = + 49.1 °
(-)-2-(2-플루오로벤조일)-HPI 융점 159-161℃ [α]=-49.9°(-)-2- (2-fluorobenzoyl) -HPI Melting point 159-161 ° C. [α] =-49.9 °
(+)-2-(3-플루오로벤조일)-HPI 융점 156-158℃ [α]=-40.2°(+)-2- (3-fluorobenzoyl) -HPI melting point 156-158 ° C [α] = -40.2 °
(-)-2-(3-플루오로벤조일)-HPI 융점 156℃ [α]=-41.6°(-)-2- (3-fluorobenzoyl) -HPI Melting point 156 ° C. [α] =-41.6 °
(+)-2-(4-플루오로벤조일)-HPI 융점 200-201°[α]=+33.5°(+)-2- (4-fluorobenzoyl) -HPI melting point 200-201 ° [α] = + 33.5 °
(-)-2-(4-플루오로벤조일)-HPI 융점 202-203℃ [α]=-32.6°(-)-2- (4-fluorobenzoyl) -HPI Melting Point 202-203 ° C. [α] =-32.6 °
(±)-2-(3-클로로벤조일)-HPI(±) -2- (3-chlorobenzoyl) -HPI
(+)-2-(4-클로로벤조일)-HPI 융점 231-232℃ [α]=+20.4°(+)-2- (4-chlorobenzoyl) -HPI melting point 231-232 ° C [α] = + 20.4 °
(-)-2-(4-클로로벤조일)-HPI 융점 233-234℃ [α]=-20.7°(-)-2- (4-chlorobenzoyl) -HPI Melting point 233-234 ° C. [α] =-20.7 °
(±)-2-(3-히드록시벤조일)-HPI(±) -2- (3-hydroxybenzoyl) -HPI
(±)-2-(4-히드록시벤조일)-HPI(±) -2- (4-hydroxybenzoyl) -HPI
(+)-2-(4-메톡시벤조일)-HPI 융점 215℃ [α]=+19.8°(+)-2- (4-methoxybenzoyl) -HPI melting point 215 ° C. [α] = + 19.8 °
(-)-2-(4-메톡시벤조일)-HPI 융점 216℃ [α]=-18.7°(-)-2- (4-methoxybenzoyl) -HPI Melting Point 216 ° C [α] =-18.7 °
(±)-2-(3-디메틸아미노벤조일)-HPI(±) -2- (3-dimethylaminobenzoyl) -HPI
(±)-2-(4-디메틸아미노벤조일)-HPI(±) -2- (4-dimethylaminobenzoyl) -HPI
(±)-2-(4-디에틸아미노벤조일)-PHI(±) -2- (4-diethylaminobenzoyl) -PHI
(±) -2-(2-포름아미드벤조일)-HPI(±) -2- (2-formamidebenzoyl) -HPI
(±)-2-(3-포름아미드벤조일)-HPI(±) -2- (3-formamidebenzoyl) -HPI
(+)-2-(4-포름아미드벤조일)-HPI 융점 193℃ [α]=+8.6°(+)-2- (4-formamidebenzoyl) -HPI melting point 193 ° C [α] = + 8.6 °
(-)-2-(4-포름아미도벤조일)-HPI 융점 193℃ [α]=-8.4°(-)-2- (4-formamidobenzoyl) -HPI melting point 193 ° C. [α] =-8.4 °
(±)-2-(2-아세트아미도벤조일)-HPI(±) -2- (2-acetamidobenzoyl) -HPI
(±)-2-(3-아세트아미드벤조일)-HPI(±) -2- (3-acetamidebenzoyl) -HPI
(±)-2-(4-아세트아미드벤조일)-HPI(±) -2- (4-acetamidebenzoyl) -HPI
(±)-2-(2-니트로벤조일)-HPI(±) -2- (2-nitrobenzoyl) -HPI
(±)-2-(3-니트로벤조일)-HPI 융점 139℃; [α]=±2.9°()-염기로부터(±) -2- (3-nitrobenzoyl) -HPI melting point 139 ° C .; [α] = ± 2.9 ° ( ) -From base
(+)-2-(4-니트로벤조일)-PHI 융점 223-224℃ [α]=+18.5°(+)-2- (4-nitrobenzoyl) -PHI melting point 223-224 ° C. [α] = + 18.5 °
(-)-2-(4-니트로벤조일)-PHI 융점 223-224℃ [α]=-21.4°(-)-2- (4-nitrobenzoyl) -PHI melting point 223-224 ° C. [α] = -21.4 °
(±)-2-(티에닐-2-카르보닐)-HPI(±) -2- (thienyl-2-carbonyl) -HPI
(±)-2-(티에닐-3-카르보닐)-HPI(±) -2- (thienyl-3-carbonyl) -HPI
(±)-2-(5-메틸-티에닐-2-카르보닐)-HPI(±) -2- (5-methyl-thienyl-2-carbonyl) -HPI
(±)-2-(퓨릴-2-카르보닐)-HPI(±) -2- (furyl-2-carbonyl) -HPI
(±)-2-피코리노일-HPI(±) -2- picolinoyl-HPI
(+)-2-니코티노일-HPI 융점 148℃ [α]=+25.5°(+)-2-nicotinoyl-HPI melting point 148 ° C. [α] = + 25.5 °
(-)-2-니코티노일-HPI 융점 156℃ [α]=-28.4°(-)-2-nicotinoyl-HPI melting point 156 ° C. [α] =-28.4 °
(±)-2-이소니코티노일-HPI(±) -2-isonicotinoyl-HPI
(±)-2-니코티노일-HPI-1'-N-옥사이드(±) -2-nicotinoyl-HPI-1'-N-oxide
(±)-2-(테트라히드로피라닐-4-카르보닐)-HPI(±) -2- (tetrahydropyranyl-4-carbonyl) -HPI
(±)-2-(테트라히드로치오피라닐-4-카르보닐)-HPI(±) -2- (tetrahydrothiopyranyl-4-carbonyl) -HPI
(±)-2-(N-포르밀피페리딜-4-카르보닐)-HPI(±) -2- (N-formylpiperidyl-4-carbonyl) -HPI
등의 화합물을 얻을 수 있다.Compounds, such as these, can be obtained.
[실시예 7]Example 7
3-트리플루오로메틸-벤조일 플루오라이드 3.8g을 클로로포름 50ml에 넣은 것을 클로로포름 50ml에 HPI 4.04g과 트리에틸아민 2.8ml를 넣은 것에 적가하고 20℃로 한시간동안 방치한다음 묽은 염산과 물로 진탕하고 무수황산나트륨상에서 건조시키고 증발시킨다음 에탄올로 재결정시켜 융점 148-149℃인 2-(3-트리플루오로메틸벤조일)-HPI를 얻었다.3.8 g of 3-trifluoromethyl-benzoyl fluoride was added to 50 ml of chloroform, which was added dropwise to 50 ml of chloroform in an amount of 4.04 g of HPI and 2.8 ml of triethylamine. Dry over sodium sulfate, evaporate and recrystallize with ethanol to give 2- (3-trifluoromethylbenzoyl) -HPI having a melting point of 148-149 ° C.
[실시예 8]Example 8
트리에틸아민존재하에 HPI와 P-니트로벤조일브로마이드를 클로로포름내에서 실시예 1과 같이 처리하여 2시간후에 융점 212-213℃인 2-(4-니트로벤조일)-HPI를 얻었다.HPI and P-nitrobenzoylbromide were treated in the chloroform as in Example 1 in the presence of triethylamine to give 2- (4-nitrobenzoyl) -HPI having a melting point of 212-213 ° C after 2 hours.
[실시예 9]Example 9
트리에틸아민존재하에 클로로포름내에서 HPI와 P-니트로벤조일과 요오다이드를 실시예 1과 같이 처리하여 40℃로 2시간후에 융점 212-213℃인 2-(4-니트로벤조일)-HPI를 얻었다.HPI, P-nitrobenzoyl and iodide in chloroform in the presence of triethylamine were treated as in Example 1 to give 2- (4-nitrobenzoyl) -HPI having a melting point of 212-213 ° C after 2 hours at 40 ° C. .
[실시예 10]Example 10
100℃, 250기압에서 1-시아노-2-(4-플루오로벤조일)-1, 2-디하이드로 이소퀴놀린을 라니 니켈상에서 환원시키고 얻어진 N-(1, 2, 3, 4-테트라 하이드로이소퀴놀리닐-1-메틸)-4-플루오로벤즈아마이드를 트리에틸아민 존재하에 클로로포름내에서 클로로아세틸 클로라이드와 반응시켜 얻어질 수 있는 N-(2-클로로아세틸-1, 2, 3, 4-테트라하이드로 이소퀴놀리닐-1-메틸)-4-플루오로벤즈아마이드 8.5g에 무수테트라하이드로푸란 300ml내에서 20% 부틸리디움 헥산용액 12ml를 20℃에서 질소기류하에 적가하였다. 이 반응혼합물을 20℃에서 2시간 교반하고 12시간 더 비등시켰다. 물을 가한후, 용매를 제거시키고 잔사를 클로로포름에 넣고 이 클로로포름용액을 물로 진탕하고 건조시킨 다음 증발시키고 메탄올로 재결정시켜 융점 181-182℃인 2-(4-플루오로벤조일)-HPI를 얻었다. 마찬가지로 (+)-N-(2-클로로아세틸-1, 2, 3, 4-테트라하이드로 이소퀴놀리닐-1-메틸)-4-플루오로벤즈아마이드 8.5g과 부틸리티움으로부터 융점 202-203℃이고 [α]=-32.6℃인 (-)-2-(4-플루오로벤조일)-HPI가 얻어졌다. 같은 방법으로 N-(2-브로모아세틸-1, 2, 3, 4-테트라하이드로이소퀴놀리닐-1-메틸)-4-메틸벤즈아마이드나 N-(2-요오도아세틸-1, 2, 3, 4-테트라하이드로이소퀴놀리닐-1-메틸)-4-메틸벤즈아마이드 또는 N-(2-p-톨루엔설포닐옥시아세틸-1, 2, 3, 4-테트라하이드로이소퀴놀리닐-1-메틸)-4-메틸벤즈아마이드와 부틸리티움으로부터 융점 183-184℃인 2-(4-메틸렌조일)-HPI가 얻어졌다.N- (1, 2, 3, 4-tetrahydroiso) obtained by reducing 1-cyano-2- (4-fluorobenzoyl) -1,2-dihydroisoquinoline on Raney nickel at 100 ° C and 250 atmospheres N- (2-chloroacetyl-1, 2, 3, 4- which can be obtained by reacting quinolinyl-1-methyl) -4-fluorobenzamide with chloroacetyl chloride in chloroform in the presence of triethylamine. To 8.5 g of tetrahydro isoquinolinyl-1-methyl) -4-fluorobenzamide, 12 ml of a 20% butyldium hexane solution in 300 ml of anhydrous tetrahydrofuran was added dropwise at 20 DEG C under nitrogen stream. The reaction mixture was stirred at 20 ° C. for 2 hours and boiled for another 12 hours. After adding water, the solvent was removed and the residue was poured into chloroform, the chloroform solution was shaken with water, dried, evaporated and recrystallized with methanol to obtain 2- (4-fluorobenzoyl) -HPI having a melting point of 181-182 ° C. Likewise melting point 202-203 from 8.5 g of (+)-N- (2-chloroacetyl-1, 2, 3, 4-tetrahydro isoquinolinyl-1-methyl) -4-fluorobenzamide and butylrium (-)-2- (4-fluorobenzoyl) -HPI was obtained, which was ° C and [α] = -32.6 ° C. In the same way N- (2-bromoacetyl-1, 2, 3, 4-tetrahydroisoquinolinyl-1-methyl) -4-methylbenzamide or N- (2-iodoacetyl-1, 2 , 3, 4-tetrahydroisoquinolinyl-1-methyl) -4-methylbenzamide or N- (2-p-toluenesulfonyloxyacetyl-1, 2, 3, 4-tetrahydroisoquinolinyl 2- (4-methylenezoyl) -HPI having a melting point of 183-184 占 폚 was obtained from -1-methyl) -4-methylbenzamide and butylrium.
같은 방법으로 N-(2-클로로아세틸-1, 2, 3, 4-테트라하이드로이소퀴놀리닐-1-메틸)-싸이클로헥실-카복사이드와 부틸리티움으로부터 융점 136-138℃인 2-싸이클로헥실-카보닐-HPI가 얻어졌다.In the same way, N- (2-chloroacetyl-1, 2, 3, 4-tetrahydroisoquinolinyl-1-methyl) -cyclohexyl-carboxide and 2-butyric acid having a melting point of 136-138 ° C Cyclohexyl-carbonyl-HPI was obtained.
[실시예 11]Example 11
니켈-알루미늄 혼합물(1 : 1) 15g을 조금씩 교반하면서 20% 수산화나트륨 200ml에 5분내에 도입시키고 80℃에서 45분간 유지시켰다. 정지시킨후 상등액을 경사시키고 침점을 물과 1, 000ml의 1%(-)-주석산용액으로 4회 씻은 다음 거기에 1N-수산화나트륨 용액을 가하여 pH5로 맞추었다. 이 혼합물을 여러번 진탕시킨후 80℃로 90분간 가열하고 상등액을 경사시킨 다음 고체물질을 물과 메탄올로 여러번 씻었다. 이렇게 얻어진 (-)-주석산-라니니켈 촉매를(±)-나(+)-2-(4-플루오로벤조일)-HPI를 유황으로 탈수소화시켜 얻을 수 있는 2-(4-플루오로벤조일)-4-옥소-2, 3, 6, 7-테트라하이드로-4H-피라지노-[2, 1-a] 이소퀴놀린 0.322mg을 메탄올 40ml에 넣은 용액에 가하고 대기압, 실온에서 수소화시켰다.15 g of a nickel-aluminum mixture (1: 1) was introduced into 200 ml of 20% sodium hydroxide in 5 minutes with slight stirring and held at 80 ° C. for 45 minutes. After stopping, the supernatant was inclined and the needles were washed four times with water and 1,000 ml of 1% (-)-tin acid solution, and then adjusted to pH5 by adding 1N sodium hydroxide solution. The mixture was shaken several times, heated to 80 ° C. for 90 minutes, the supernatant was decanted and the solid was washed several times with water and methanol. 2- (4-fluorobenzoyl) obtained by dehydrogenating (±) -na (+)-2- (4-fluorobenzoyl) -HPI with (±) -tartrate-rannickel catalyst thus obtained with sulfur 0.322 mg of 4-oxo-2, 3, 6, 7-tetrahydro-4H-pyrazino- [2, 1-a] isoquinoline was added to a solution in 40 ml of methanol, and hydrogenated at atmospheric pressure and room temperature.
촉매를 여과해버리고 용매를 증발시킨다음 광학적 순도가 23%이고 융점이 190-193℃ 이며 [α]=7.5°인(-)-2-(4-플루오로벤조일)-HPI를 얻었다.The catalyst was filtered off and the solvent was evaporated to afford (-)-2- (4-fluorobenzoyl) -HPI with an optical purity of 23% and a melting point of 190-193 ° C. with [α] = 7.5 °.
같은 방법으로 2-싸이클로헥실-카보닐-4-옥소-2, 3, 6, 7-테트라하이드로-4H-피라지노-[2, 1-a] 이소퀴놀린으로부터 20% 광학순도로 융점 122-127℃이고 [α]=-29.3°인 (-)-2-싸이클로헥실-카보닐-HPI를 얻었다.Melting point 122-127 with 20% optical purity from 2-cyclohexyl-carbonyl-4-oxo-2, 3, 6, 7-tetrahydro-4H-pyrazino- [2, 1-a] isoquinoline in the same manner (-)-2-cyclohexyl-carbonyl-HPI was obtained which was ° C. and [α] = -29.3 °.
[실시예 12]Example 12
라니니켈 300mg 존재하에 메탄올 40ml내에서 실시예 11과 같은 방법으로 2-(4-플루오로벤조일)-4-옥소-2, 3, 6, 7-테트라하이드로-4H-피라지노[2, 1-a]이소퀴놀린 322mg은 수소화시켜 융점 181-182℃인 2-(4-플루오로벤조일)-HPI라세미체를 얻었다.2- (4-fluorobenzoyl) -4-oxo-2, 3, 6, 7-tetrahydro-4H-pyrazino [2, 1- in the same manner as in Example 11 in 40 ml of methanol in the presence of 300 mg of Ranickel. a] 322 mg of isoquinolines were hydrogenated to obtain 2- (4-fluorobenzoyl) -HPI racemate having a melting point of 181-182 ° C.
같은 방법으로 2-싸이클로헥실카보닐-4-옥소-2, 3, 6, 7-테트라하이드로-4H-피라지노 [2, 1-a] 이소퀴놀린으로부터 융점 136-138℃인 2-싸이클로헥실카보닐-HPI를 얻었다.In the same manner, 2-cyclohexylcarbonyl-4-oxo-2, 3, 6, 7-tetrahydro-4H-pyrazino [2, 1-a] isoquinoline has a melting point of 136-138 ° C. Neil-HPI was obtained.
[실시예 13]Example 13
20℃ 대기압하에서 5% 팔라듐 목탄 12g 존재하에 2-(4-니트로벤조일)-HPI 67.7g을 메탄올 1, 500ml에 넣은 용액을 수소화시키고 촉매를 여과하고 여액을 증발시킨다음 잔사를 에탄올로 재결정시켜 융점 212-213℃인 2-(4-아미노벤조일)-HPI를 얻었다. 염산염의 융점은 165-166℃ (분해)이고 황산염의 융점은 234-235℃이고 이세티오네이트 융점은 233-234℃였다.67.7 g of 2- (4-nitrobenzoyl) -HPI in 1,500 ml of methanol in the presence of 12 g of 5% palladium charcoal at 20 ° C. atmospheric pressure were hydrogenated, the catalyst was filtered off, the filtrate was evaporated and the residue was recrystallized from ethanol to give a melting point. 2- (4-aminobenzoyl) -HPI was obtained at 212-213 ° C. The melting point of the hydrochloride was 165-166 ° C. (decomposition), the melting point of the sulfate was 234-235 ° C. and the isethionate melting point was 233-234 ° C.
다음 화합물들은 상응하는 니트로화합물을 같은 방법으로 수소화시켜 얻어졌다.The following compounds were obtained by hydrogenation of the corresponding nitro compounds in the same manner.
2-(2-아미노-아세틸-HPI2- (2-amino-acetyl-HPI
2-(3-아미노-프로피오닐)-HPI2- (3-amino-propionyl) -HPI
2-(2-아미노-n-부티릴)-HPI2- (2-amino-n-butyryl) -HPI
2-(2-아미노-n-부티릴)-HPI2- (2-amino-n-butyryl) -HPI
2-(2-아미노-n-발레릴)-HPI2- (2-amino-n-valeryl) -HPI
2-(5-아미노-n-발레릴)-HPI2- (5-amino-n-valeryl) -HPI
2-(3-아미노페녹시아세틸)-HPI2- (3-aminophenoxyacetyl) -HPI
2-(4-아미노페녹시아세틸)-HPI2- (4-aminophenoxyacetyl) -HPI
2-(2-아미노시클로프로필-카르보닐)-HPI2- (2-Aminocyclopropyl-carbonyl) -HPI
2-(1-아미노시클로부틸-카르보닐)-HPI2- (1-Aminocyclobutyl-carbonyl) -HPI
2-(2-아미노시클로부틸-카르보닐)-HPI2- (2-Aminocyclobutyl-carbonyl) -HPI
2-(3-아미노시클로부틸-카르보닐)-HPI2- (3-Aminocyclobutyl-carbonyl) -HPI
2-(1-아미노시클로펜틸-카르보닐)-HPI2- (1-aminocyclopentyl-carbonyl) -HPI
2-(2-아미노시클로펜틸-카르보닐)-HPI2- (2-Aminocyclopentyl-carbonyl) -HPI
2-(3-아미노시클로펜틸 -카르보닐) -HPI2- (3-Aminocyclopentyl-carbonyl) -HPI
2-(1-아미노시클로헥실-카르보닐)-HPI2- (1-Aminocyclohexyl-carbonyl) -HPI
2-(2-아미노시클로헥실-카르보닐)-HPI2- (2-Aminocyclohexyl-carbonyl) -HPI
2-(3-아미노시클로헥실-카르보닐)-HPI2- (3-Aminocyclohexyl-carbonyl) -HPI
시스-2-(4-아미노시클로헥실-카르보닐)-HPICis-2- (4-aminocyclohexyl-carbonyl) -HPI
무결정성 : 적외선(IR) 3, 500, 3, 300과 1, 645cm-1 Amorphous: Infrared (IR) 3, 500, 3, 300 and 1, 645 cm -1
트랜스-2-(4-아미노시클로헥실-카르보닐) HPI; 융점 284℃Trans-2- (4-aminocyclohexyl-carbonyl) HPI; Melting point 284 ℃
2-(4-아미노시클로헵틸-카르보닐)-HPI2- (4-Aminocycloheptyl-carbonyl) -HPI
2-(2-아미노벤조일)-HPI 브롬화수소: 융점 279-280℃2- (2-aminobenzoyl) -HPI hydrogen bromide: melting point 279-280 ° C
2-(3-아미노벤조일)-HPI: 융점 161-162℃2- (3-aminobenzoyl) -HPI: Melting point 161-162 ° C
(+)-2-(3-아미노벤조일)-HPI: 융점 164-165℃(+)-2- (3-aminobenzoyl) -HPI: Melting point 164-165 deg.
[α]=+35.9°((-)-니트로이성체로부터)[α] = + 35.9 ° (from (-)-nitrosomer)
(-)-2-(3-아미노벤조일)-HPI: 융점 164-165℃(-)-2- (3-aminobenzoyl) -HPI: Melting point 164-165 ° C
[α]=36.5°((+)-니트로이성체로부터)[α] = 36.5 ° (from (+)-nitrosomer)
(+)-2-(4-아미노벤조일)-HPI: 융점 231-232℃(+)-2- (4-aminobenzoyl) -HPI: Melting point 231-232 ° C
[α]=+23.1°브롬화수소: 융점 193℃(분해) 이세티오네이트 융점 200-210°: [α]=+16.0[α] = + 23.1 ° hydrogen bromide: melting point 193 ° C. (decomposition) isethionate melting point 200-210 °: [α] = + 16.0
(-)-2-(4-아미노벤조일)-HPI: 융점 231-232℃(-)-2- (4-aminobenzoyl) -HPI: Melting point 231-232 ° C
[α]=23.0°브롬화수소: 융점 205℃(분해) 이세티오네이트: 융점 200-210℃ [α]=-16.3°[α] = 23.0 ° hydrogen bromide: melting point 205 ° C. (decomposition) isethionate: melting point 200-210 ° C. [α] =-16.3 °
2-(3, 4-디아미노벤조일)-HPI: 융점 143℃2- (3,4-diaminobenzoyl) -HPI: Melting point 143 ° C.
2-(3, 5-디아미노벤조일)-HPI: 융점 235-236℃2- (3,5-diaminobenzoyl) -HPI: Melting point 235-236 ° C.
2-(2-클로로-4-아미노-벤조일)-HPI; 융점 145℃2- (2-chloro-4-amino-benzoyl) -HPI; Melting point 145 ℃
염화수소 : 181-182℃Hydrogen Chloride: 181-182 ℃
2-(2-클로로-5-아미노-벤조일)-HPI2- (2-Chloro-5-amino-benzoyl) -HPI
2-(3-클로로-4-아미노-벤조일) -HPI2- (3-Chloro-4-amino-benzoyl) -HPI
2-(3-클로로-5-아미노-벤조일)-HPI2- (3-Chloro-5-amino-benzoyl) -HPI
2-(2-아미노-3-클로로벤조일)-HPI2- (2-amino-3-chlorobenzoyl) -HPI
2-(2-아미노-4-클로로벤조일)-HPI2- (2-amino-4-chlorobenzoyl) -HPI
2-(2-아미노-5-클로로벤조일)-HPI2- (2-amino-5-chlorobenzoyl) -HPI
2-(3-아미노-4-클로로벤조일)-HPI: 브롬화수소 융점 208-210℃2- (3-amino-4-chlorobenzoyl) -HPI: hydrogen bromide melting point 208-210 ° C.
2-(3-아미노-티에닐-2-카르보닐)-HPI2- (3-amino-thienyl-2-carbonyl) -HPI
2-(4-아미노-티에닐-2-카르보닐)-HPI2- (4-amino-thienyl-2-carbonyl) -HPI
2-(4-아미노-테트라하이드로티오피라닐-4-카르보닐)-HPI 융점 157-158℃:2- (4-Amino-tetrahydrothiopyranyl-4-carbonyl) -HPI Melting Point 157-158 ° C .:
2-(4-아미노니코티노일)-HPI2- (4-aminonicotinoyl) -HPI
2-(5-아미노니코티노일)-HPI2- (5-aminonicotinoyl) -HPI
[실시예 14]Example 14
클로로포름 100ml에 염화아세틸 2.4g을 넣은 것을 클로로포름 300ml 2-(4-아미노벤조일)-HPI 9.6g과 트리에틸아민 3.1g을 넣은 것에 가하고 이 반응혼합물을 실온에서 2시간 방치했다. 여기에 염화아세틸 2.4g과 트리에틸아민 3.1g을 더 가하고 3시간 비등시킨 다음 묽은 염산과 물로 씻었다. 용매를 증발시키고 아세톤으로 재결정시켜 융점 247-248℃인 2-(4-아세틸아미노벤조일)-HPI를 얻었다.2.4 g of acetyl chloride was added to 100 ml of chloroform, and 9.6 g of chloroform 300 ml 2- (4-aminobenzoyl) -HPI and 3.1 g of triethylamine were added thereto, and the reaction mixture was left at room temperature for 2 hours. 2.4 g of acetyl chloride and 3.1 g of triethylamine were added thereto, and the mixture was boiled for 3 hours, and washed with dilute hydrochloric acid and water. The solvent was evaporated and recrystallized with acetone to give 2- (4-acetylaminobenzoyl) -HPI having a melting point of 247-248 ° C.
유사한 방법으로 적당한 아실화제를 사용하여 다음 화합물들이 얻어졌다:In a similar manner the following compounds were obtained using suitable acylating agents:
2-아세트아미도아세틸-HPI2-acetamidoacetyl-HPI
2-(1-아세트아미도시클로헥실-카르보닐)-HPI2- (1-acetamidocyclohexyl-carbonyl) -HPI
2-(2-아세트아미도시클로헥실-카르보닐)-HPI2- (2-acetamidocyclohexyl-carbonyl) -HPI
2-(3-아세트아미도시클로헥실-카르보닐)-HPI2- (3-acetamidocyclohexyl-carbonyl) -HPI
2-(4-아세트아미도시클로헥실-카르보닐)-HPI2- (4-acetamidocyclohexyl-carbonyl) -HPI
2-(4-프로피온아미도시클로헥실-카르보닐)-HPI2- (4-propionamidocyclohexyl-carbonyl) -HPI
2-(4-펜타노일아미노시클로헥실-카르보닐)-HPI2- (4-pentanoylaminocyclohexyl-carbonyl) -HPI
2-(4-헥사노일아미노시클로헥실-카르보닐)-HPI2- (4-hexanoylaminocyclohexyl-carbonyl) -HPI
2-(4-옥타노일아미노시클로헥실-카르보닐)-HPI2- (4-octanoylaminocyclohexyl-carbonyl) -HPI
2-(4-오레오일아미노시클로헥실-카르보닐)-HPI2- (4-Oleoylaminocyclohexyl-carbonyl) -HPI
2-(2-설파미노아세틸-HPI(클로로설폰산과 함께 )2- (2-sulfaminoacetyl-HPI (with chlorosulfonic acid)
2-(4-설파미노시클로헥실-카르보닐)-HPI2- (4-Sulfaminocyclohexyl-carbonyl) -HPI
2-(3-설파미노벤조일)-HPI2- (3-Sulfaminobenzoyl) -HPI
2-(4-설파미노벤조일)-HPI2- (4-Sulfaminobenzoyl) -HPI
2-(1-설포-피페리딜-4-카르보닐) -HPI2- (1-sulfo-piperidyl-4-carbonyl) -HPI
[실시예 15]Example 15
빙초산 5ml에 2-(4-메틸아미노벤조일)-HPI를 니트로화하여 제조된 2-[4-메틸-니트로스아미노-벤조일]-HPI 3.5g을 넣은 용액을 격렬하게 교반하면서 물 5ml에 아연말 2.7g을 넣은 것에 서서히 가하고 20℃로 2시간 더 교반한 다음 80℃로 가열하고 뜨거울때 여과하였다.A solution of 3.5 g of 2- [4-methyl-nitrosamino-benzoyl] -HPI prepared by nitrating 2- (4-methylaminobenzoyl) -HPI in 5 ml of glacial acetic acid was added to zinc powder in 5 ml of water with vigorous stirring. 2.7 g was added slowly to the mixture and stirred for 2 hours at 20 ° C., then heated to 80 ° C. and filtered when hot.
잔사를 5%염산으르 씻고 합한 여액을 알카리성으로 한 다음, 클로로 포름으로 추출하고 추출액을 물로 씻어 중화시키고 증발시켜 2-[4-(1-메틸하이드라지노)-벤조일]-HPI를 얻었다.The residue was washed with 5% hydrochloric acid, the combined filtrates were alkaline, extracted with chloroform, the extract was washed with water, neutralized and evaporated to afford 2- [4- (1-methylhydrazino) -benzoyl] -HPI.
유사한 방법으로 다음 화합물들이 제조되었다.In a similar manner the following compounds were prepared.
2-[2-(1-메틸하이드라지노)-벤조일]-HPI:2- [2- (1-Methylhydrazino) -benzoyl] -HPI:
2-[3-(1-메틸하이드라지노)-벤조일]-HPI:2- [3- (1-Methylhydrazino) -benzoyl] -HPI:
2-[4-(1-에틸하이드라지노)-벤조일]-HPI:2- [4- (1-ethylhydrazino) -benzoyl] -HPI:
[실시예 16]Example 16
6N-수산화나트륨 수용액 0.8ml이 30% 과산화수소 8ml를 넣은것을 에탄올 20ml에 2-(4-시아노벤조일)-HPI 5g 넣은 것에 가하고 가열하여 산소를 축출시키고 이 온도를 40-50℃로 1시간 동안 유지시킨 다음 반응 혼합물을 냉각시키고 물 5ml로 희석하여 2-(4-카복사미도벤조일)-HPI를 얻었다.0.8 ml of aqueous 6N-sodium hydroxide solution was added with 8 ml of 30% hydrogen peroxide to 5 ml of 2- (4-cyanobenzoyl) -HPI in 20 ml of ethanol, and heated to extract oxygen and the temperature was heated to 40-50 ° C. for 1 hour. The reaction mixture was then cooled and diluted with 5 ml of water to give 2- (4-carboxamidobenzoyl) -HPI.
유사한 방법으로 2-(3-시아노벤조일)-HPI로부터 2-(3-카복사미도벤조일)-HPI를 제조하였다.2- (3-carboxamidobenzoyl) -HPI was prepared from 2- (3-cyanobenzoyl) -HPI in a similar manner.
[실시예 17]Example 17
10% 수산화나트륨 수용액 500ml에 2-(4-메톡시카보닐 벤조일)-HPI 8g을 넣은 혼합물을 20℃에서 12시간 교반하고, 불용물질을 여과한 다음 여액을 염산으로 산성화하여 클로로포름으로 추출하였다. 잔사를 실리카겔상에서 클로로포름과 메탄올로 용출시켜 크로마토그라피하므로써 정제하여 융점 251℃인 2-(4-카복시벤조일)-HPI를 얻었다.A mixture containing 8 g of 2- (4-methoxycarbonyl benzoyl) -HPI in 500 ml of 10% aqueous sodium hydroxide solution was stirred at 20 ° C. for 12 hours, the insolubles were filtered, and the filtrate was acidified with hydrochloric acid and extracted with chloroform. The residue was purified by chromatography on silica gel, eluting with chloroform and methanol to give 2- (4-carboxybenzoyl) -HPI having a melting point of 251 占 폚.
유사한 방법으로 알카리 검화하여 다음 화합물들을 얻었다:Alkali saponification in a similar manner yields the following compounds:
2-(2-카르복시시클로프로필-카르보닐)-HPI2- (2-carboxycyclopropyl-carbonyl) -HPI
2-(2-카르복시시클로부틸-카르보닐)-HPI2- (2-carboxycyclobutyl-carbonyl) -HPI
2-(3-카르복시시클로부틸-카르보닐)-HPI2- (3-carboxycyclobutyl-carbonyl) -HPI
2-(2-카르복시시클로펜틸-카르보닐)-HPI2- (2-carboxycyclopentyl-carbonyl) -HPI
2-(3-카르복시시클로펜틸-카르보닐)-HPI2- (3-carboxycyclopentyl-carbonyl) -HPI
트랜스-2-(2-카르복시시클로헥실-카르보닐)-HPITrans-2- (2-carboxycyclohexyl-carbonyl) -HPI
융점 208-210℃Melting point 208-210 ℃
시스-2-(2-카르복시시클로헥실-카르보닐)-HPICis-2- (2-carboxycyclohexyl-carbonyl) -HPI
융점 194-196℃Melting Point 194-196 ℃
2-(3-카르복시시클로헥실-카르보닐)-HPI2- (3-carboxycyclohexyl-carbonyl) -HPI
2-(4-카르복시시클로헥실-카르보닐)-HPI2- (4-carboxycyclohexyl-carbonyl) -HPI
2-(2-카르복시벤조일)-HPI2- (2-carboxybenzoyl) -HPI
2-(3-카르복시벤조일-HPI2- (3-carboxybenzoyl-HPI
2-(3, 2-디카르복시-벤조일)-HPI2- (3, 2-dicarboxy-benzoyl) -HPI
2-(3, 5-디카르복시-벤조일)-HPI2- (3, 5-dicarboxy-benzoyl) -HPI
[실시예 18]Example 18
메탄올과 물의 10 : 1 혼합물 150ml 2-(4-하이드록시벤조일)-HPI 32g을 넣은 용액을 연황색이 남아 있을 때까지 과량의 에테르성 디아조메탄 용액으로 혼합하고 이 반응혼합물을 증발시켜 잔사를 에테르에 회수하고 묽은 수산화 나트륨 수용액과 물로 씻은 다음 무수황산나트륨상에서 건조시키고 증발시켜 융점 204-205℃인 2-(4-메톡시벤조일)-HPI를 얻었다.A solution of 32 g of a 10: 1 mixture of methanol and water in 32 g 2- (4-hydroxybenzoyl) -HPI was mixed with an excess of etheric diazomethane solution until light yellow remained and the reaction mixture was evaporated to give a residue. Recovered to ether, washed with dilute aqueous sodium hydroxide solution and water, dried over anhydrous sodium sulfate and evaporated to give 2- (4-methoxybenzoyl) -HPI having a melting point of 204-205 占 폚.
[실시예 19]Example 19
보론트리브르마이드 7.5g을-5-10℃에서 메틸렌클로라이드 100ml에 2-(4-메톡시벤조일)-HPI 5.4g을 넣은 용액에 적가하고 이 반응 혼합물을 20℃에서 한시간 교반하고 얼음에 부은다음 유기층을 분리시키고 수층을 염화메틸렌으로 수회 진탕하여 유기층을 합한 다음 무수황산나트륨 상에서 건조시키고, 증발시켰다. 잔사를 에탄올로 재결정시켜 융점 243-245℃인 2-(4-하이드록시벤조일)-HPI를 얻었다.7.5 g of boron tribromide was added dropwise to a solution of 5.4 g of 2- (4-methoxybenzoyl) -HPI in 100 ml of methylene chloride at -5-10 ° C, and the reaction mixture was stirred at 20 ° C for 1 hour and poured into ice. The organic layer was separated and the aqueous layer was shaken several times with methylene chloride, the organic layers combined, dried over anhydrous sodium sulfate, and evaporated. The residue was recrystallized from ethanol to give 2- (4-hydroxybenzoyl) -HPI having a melting point of 243-245 ° C.
[실시예 20]Example 20
2-(4-하이드록시벤조일)-HPI 3.22g, 무수초산 1.02g, 피리딘 100ml를 3시간 비등시키고 즉시 얼음 위에 부은다음 에테르로 추출하고 물로 씻은 후 무수황산나트륨상에서 건조시켜 2-(4-아세톡시벤조일)-HPI를 얻었다.3.22 g of 2- (4-hydroxybenzoyl) -HPI, 1.02 g of acetic anhydride and 100 ml of pyridine are boiled for 3 hours, immediately poured over ice, extracted with ether, washed with water and dried over anhydrous sodium sulfate. Benzoyl) -HPI was obtained.
[실시예 21]Example 21
메탄올 200ml에 2-(4-아미노벤조일)-HPI 4.8g과 33% 포름알데히드 용액 1.5g을 넣은 혼합물을 5% 팔라듐목탄 존재하에 수소화시켰다. 촉매를 여과하고 용매를 증발시킨 다음 잔사를 실리카겔상에서 클로로포름으로 용출시켜 크로마토그라피 하므로써 정제하여 융점 220℃인 2-(4-메틸아미노벤조일)-HPI를 얻었다.A mixture of 4.8 g of 2- (4-aminobenzoyl) -HPI and 1.5 g of 33% formaldehyde solution in 200 ml of methanol was hydrogenated in the presence of 5% palladium charcoal. The catalyst was filtered off, the solvent was evaporated and the residue was purified by chromatography on silica gel, eluting with chloroform to give 2- (4-methylaminobenzoyl) -HPI having a melting point of 220 ° C.
[실시예 22]Example 22
실시예 21과 유사한 방법으로 2-(4-아미노벤조일)-HPI 4.8g과 33% 포름알데히드용액 4g으로부터 융점이 225-226℃인 2-(4-디메틸아미노벤조일)-HPI를 얻었다.In a similar manner to Example 21, 2- (4-dimethylaminobenzoyl) -HPI having a melting point of 225-226 ° C. was obtained from 4.8 g of 2- (4-aminobenzoyl) -HPI and 4 g of 33% formaldehyde solution.
[실시예 23]Example 23
디옥산 100ml에 2-(4-아미노벤조일)-HPI 3.2g을 넣은 것을 2시간동안 습기를 없애고 디메틸설페이트 2.5g과 혼합한 다음 100℃에서 15시간 동안 교반하였다. 냉각시킨다음 여기에 물 5ml 수산화칼륨 1.4g을 넣은 것을 가하고 클로로포름으로 추출하고 증발시켜 융점 225-226℃인 2-(4-디메틸아미노벤조일)-HPI를 얻었다.3.2 g of 2- (4-aminobenzoyl) -HPI was added to 100 ml of dioxane, followed by dehumidification for 2 hours, mixed with 2.5 g of dimethyl sulfate, and stirred at 100 ° C. for 15 hours. After cooling, 5 g of potassium hydroxide (1.4 g) was added thereto, followed by extraction with chloroform and evaporation to obtain 2- (4-dimethylaminobenzoyl) -HPI having a melting point of 225-226 ° C.
[실시예 24]Example 24
2-(4-아미노벤조일)-HPI를 트리플루오로무수초산과 트리에틸아민과 반응시켜 얻을 수 있는 2-(4-트리플루오로아세트아미도벤조일)-HPI 10.4g을 무수 아세톤 300ml 내에서 요오드화메틸 34.2g과 비등될 정도로 가열하고 여기에 분말화된 수산화나트륨 13.4을 가한 다음 5분간 비등시키고 증발건조시켰다. 잔사를 물과 혼합하고 20℃에서 2시간 교반한 다음 클로로포름으로 추출하고 물로 씻은 후 증발시켜 융점 220℃인 2-(4-메틸아미노벤조일)-HPI를 얻었다.10.4 g of 2- (4-trifluoroacetamidobenzoyl) -HPI obtained by reacting 2- (4-aminobenzoyl) -HPI with trifluoroacetic anhydride and triethylamine in iodine in 300 ml of anhydrous acetone It was heated to boiling with 34.2 g of methyl, thereto was added powdered sodium hydroxide 13.4, then boiled for 5 minutes and evaporated to dryness. The residue was mixed with water, stirred at 20 ° C. for 2 hours, extracted with chloroform, washed with water and evaporated to give 2- (4-methylaminobenzoyl) -HPI having a melting point of 220 ° C.
만약 가수분해하기전에 요오드화메틸이 제거되지 않는다면 융점 225-226℃인 2-(4-디메틸아미노벤조일)-HPI가 얻어진다.If methyl iodide is not removed prior to hydrolysis, 2- (4-dimethylaminobenzoyl) -HPI with a melting point of 225-226 ° C. is obtained.
[실시예 25]Example 25
실시예 19와 유사한 방법으로 2-(4-메틸메르캅토벤조일)-HPI와 보론트리브로마이드로부터 2-(4-메르캅토벤조일)-HPI가 얻어졌다. 2-(2-메르캅토벤조일)-HPI와 2-(3-메르캅토벤조일)-HPI도 유사한 방법으로 제조되었다.In a similar manner to Example 19, 2- (4-mercaptobenzoyl) -HPI was obtained from 2- (4-methylmercaptobenzoyl) -HPI and borontribromide. 2- (2-mercaptobenzoyl) -HPI and 2- (3-mercaptobenzoyl) -HPI were prepared in a similar manner.
[실시예 26]Example 26
a) 소디움 브로하이드라이드 1.15g을 에탄올 100ml에 2-(4-옥소싸이클로헥실-카보닐)-HPI 6.5g 넣은 것에 0℃에서 적가하고 20°에서 12시간 교반한 다음 얼음에 부어 이성체 혼합물 상태인 2-(4-하이드록시싸이클로헥실-카보닐)-HPI를 얻었다.a) 1.15 g of sodium brohydride was added dropwise to 100 ml of ethanol in 6.5 g of 2- (4-oxocyclohexyl-carbonyl) -HPI at 0 ° C, stirred at 20 ° C for 12 hours, and poured into ice to give an isomeric mixture. 2- (4-hydroxycyclohexyl-carbonyl) -HPI was obtained.
b) 테트라하이드로푸란에 포다슘 트리스-(sec-부틸)-보로하이드라이드를 넣은 0.5M 용액 24ml를 -70℃의 질소기류하에서 무수테트라하이드로푸란 35ml 2-(4-옥소싸이클로헥실-카보닐)-HP 3.25g을 넣은 용액에 가하고 이 반응혼합물을 35ml의 물과 혼합하고 20℃로 가온한 다음 클로로포름으로 회수시켰다. 실리카겔상에서 클로로포름을 사용하여 정제한 후 융점 162-163℃인 시스-2-(4-하이드록시싸이클로헥실-카보닐)-HPI를 얻었다.b) 24 ml of 0.5M solution containing potassium tris- (sec-butyl) -borohydride in tetrahydrofuran was dissolved in anhydrous tetrahydrofuran 35 ml 2- (4-oxocyclohexyl-carbonyl) under nitrogen stream at -70 ° C. To this solution was added 3.25 g of HP, and the reaction mixture was mixed with 35 ml of water, warmed to 20 DEG C, and recovered with chloroform. Purification using chloroform on silica gel afforded cis-2- (4-hydroxycyclohexyl-carbonyl) -HPI with a melting point of 162-163 ° C.
[실시예 27]Example 27
메탄올 100ml에 2-(4-옥소싸이클로헥실-카보닐)-HPI 6.5g을 넣은 것을 50℃, 100기압에서 라니니켈 2g 존재하에 포화될 정도로 수소화시켰다. 촉매를 여과하고 용매를 증발시켜 이성체혼합물 상태로 2-(4-하이드록시싸이클로헥실-카보닐)-HPI를 얻었다.6.5 g of 2- (4-oxocyclohexyl-carbonyl) -HPI was added to 100 ml of methanol, and the mixture was hydrogenated at 50 ° C. and 100 atm to saturate in the presence of 2 g of nickel nickel. The catalyst was filtered off and the solvent was evaporated to afford 2- (4-hydroxycyclohexyl-carbonyl) -HPI in the form of an isomer mixture.
[실시예 28]Example 28
2-(4-옥소싸이클로헥실-카보닐)-HPI 3.16g을 메탄올 100ml 내에서 10시간동안 수소화시키고 10℃에서 100기압하에 라니니켈 1g 존재하에 암모니아를 포화시켰다. 촉매를 여과하고 용매를 증발시켜 잔사를 에탄올에 용해하였다. 여기에 에탄올에 브롬산을 넣은 것을 가하고 얻어진 생성물을 에테르로 결정화 시켜 융점 285℃인 트란스-2-(4-아미노싸이클로헥실카보닐)-HPI-브롬산염을 얻었다. 여액에 수산화나트륨을 가하고 클로로포름으로 추출한 다음 증발시켜 시스-2-(4-아미노싸이클로헥실카보닐)-HPI를 얻었다.3.16 g of 2- (4-oxocyclohexyl-carbonyl) -HPI were hydrogenated in 100 ml of methanol for 10 hours and saturated with ammonia in the presence of 1 g of Ranickel at 100C at 10 ° C. The catalyst was filtered off and the solvent was evaporated to dissolve the residue in ethanol. After adding bromic acid to ethanol, the obtained product was crystallized with ether to obtain trans-2- (4-aminocyclohexylcarbonyl) -HPI-bromate having a melting point of 285 ° C. Sodium hydroxide was added to the filtrate, extracted with chloroform, and evaporated to afford cis-2- (4-aminocyclohexylcarbonyl) -HPI.
[실시예 29]Example 29
2-(4-옥소싸이클로헥실-카보닐)-HPI와 하이드록실아민으로부터 제조된 융점 194℃인 2-(4-옥시미노싸이클로헥실-카보닐)-HPI 3.1g을 라니니켈 5g 존재하에 실온, 5기압하의 에탄올 100ml 내에서 포화될 때까지 수소화시키고 증발시켜 이성체 혼합물 상태인 2-(4-아미노싸이클로헥실-카보닐)-HPI를 얻었다.3.1 g of 2- (4-oxyminocyclohexyl-carbonyl) -HPI having a melting point of 194 ° C. prepared from 2- (4-oxocyclohexyl-carbonyl) -HPI and hydroxylamine was prepared at room temperature, in the presence of 5 g of rannickel. Hydrogenation and evaporation until saturated in 100 ml of ethanol at 5 atmospheres yielded 2- (4-aminocyclohexyl-carbonyl) -HPI in the form of an isomer mixture.
[실시예 30]Example 30
염화메틸렌에 2-이소니코티노일-HPI 5.5g과 3-클로로퍼벤조산 (50%) 6.3g을 넣은 용액을 20℃에서 하룻밤 정치시키고 포화될 때까지 암모니아를 도입시킨 다음 흡입여과하고 염화메틸렌으로 씻었다.A solution of 5.5 g of 2-isonicotinoyl-HPI and 6.3 g of 3-chloroperbenzoic acid (50%) was added to methylene chloride overnight at 20 ° C, ammonia was introduced until saturated, and then filtered by suction and methylene chloride. Washed.
여액을 증발시키고 에탄올로 재결정시켜 융점 250℃인 2-이소니코티노일-HPI-1'-N-옥사이드를 얻었다.The filtrate was evaporated and recrystallized from ethanol to give 2-isonicotinoyl-HPI-1′-N-oxide having a melting point of 250 ° C.
유사한 방법으로 2-니코티노일-HPI로부터 융점 178℃인 2-니코티노일-HPI-1'-N-옥사이드를 얻었다.In a similar manner, 2-nicotinoyl-HPI-1′-N-oxide having a melting point of 178 ° C. was obtained from 2-nicotinoyl-HPI.
실시예 1에서 언급한 디알킬아미노 화합물로부터 유사한 방법으로 상응하는 N-옥사이드, 예를들면 2-(4-디메틸아미노벤조일)-HPI-N-옥사이드가 얻어질 수 있다.From the dialkylamino compounds mentioned in Example 1 the corresponding N-oxides, for example 2- (4-dimethylaminobenzoyl) -HPI-N-oxide, can be obtained.
[실시예 31]Example 31
2-(4-디메틸아미노벤조일)-HPI 3.2g과 요오드화메틸 5g을 아세토니트릴 600ml내에서 75℃로 하룻밤 가열하였다.3.2 g of 2- (4-dimethylaminobenzoyl) -HPI and 5 g of methyl iodide were heated to 75 ° C. overnight in 600 ml of acetonitrile.
용매를 증발시키고 얻어진 혼합물을 실리카겔상에서 클로로포름과 메탄올로 용출시켜 정제하고 에탄올로 재결정시켜 융점 215-216℃인 2-(4-디메틸아미노벤조일)-HPI의 메티오다이드를 얻었다.The solvent was evaporated and the resulting mixture was purified by elution with chloroform and methanol on silica gel and recrystallized with ethanol to give methoxide of 2- (4-dimethylaminobenzoyl) -HPI having a melting point of 215-216 ° C.
[실시예 32]Example 32
1-아미노-싸이클로헥산-1-카복실산 2.1g을 트리플루오로무수초산 6.3g과 혼합하고 염화메틸렌 20ml에 HPI 2g과 트리에틸아민 2.3g을 넣은 것을 0℃에서 가한다음 30℃ 가온하고 1시간후에 이 반응혼합물을 물에 봇고 유기층을 분리시켜 수산화나트륨 수용액과 물로 씻고 건조시킨다음 증발시키고 벤젠으로 재결정시켜 융점 146℃인 2-(1-아미노싸이클로헥실-1-카보닐)-HPI를 얻었다. 유사한 방법으로 다음 화합물들이 얻어졌다.2.1 g of 1-amino-cyclohexane-1-carboxylic acid was mixed with 6.3 g of trifluoroacetic anhydride, and 2 ml of HPI and 2.3 g of triethylamine were added to 20 ml of methylene chloride at 0 ° C., and warmed at 30 ° C., and after 1 hour The reaction mixture was poured into water, the organic layer was separated, washed with aqueous sodium hydroxide solution and water, dried, evaporated and recrystallized with benzene to give 2- (1-aminocyclohexyl-1-carbonyl) -HPI having a melting point of 146 ° C. In a similar manner the following compounds were obtained.
2-메틸아미노아세틸-HPI2-methylaminoacetyl-HPI
2-에틸아미노아세틸-HPI2-ethylaminoacetyl-HPI
2-(2-메틸아미노-프로피오닐)-HPI2- (2-methylamino-propionyl) -HPI
2-(2-에틸아미노-프로피오닐)-HPI2- (2-ethylamino-propionyl) -HPI
2-(3-메틸아미노-프로피오닐)-HPI2- (3-Methylamino-propionyl) -HPI
2-(3-에틸아미노-프로피오닐)-HPI2- (3-ethylamino-propionyl) -HPI
2-(2-메틸아미노-n-부티릴)-HPI2- (2-methylamino-n-butyryl) -HPI
2-(4-메틸아미노-n-부티릴)-HPI2- (4-methylamino-n-butyryl) -HPI
2-(4-에틸아미노-n-부티릴)-HPI2- (4-ethylamino-n-butyryl) -HPI
2-(2-메틸아미노-n-발레릴)HPI2- (2-methylamino-n-valeryl) HPI
2-(5-메틸아미노-n-발레릴)-HPI2- (5-methylamino-n-valeryl) -HPI
2-(1-메틸아미노시클로부틸-카르보닐)-HPI2- (1-methylaminocyclobutyl-carbonyl) -HPI
2-(2-메틸아미노시클로부틸-카르보닐)-HPI2- (2-Methylaminocyclobutyl-carbonyl) -HPI
2-(3-메틸아미노시클로부틸-카르보닐)-HPI2- (3-Methylaminocyclobutyl-carbonyl) -HPI
2-(1-에틸아미노시클로부틸-카르보닐)-HPI2- (1-ethylaminocyclobutyl-carbonyl) -HPI
2-(2-에틸아미노시클로부틸-카르보닐)-HPI2- (2-ethylaminocyclobutyl-carbonyl) -HPI
2-(3-에틸아미노시클로부틸-카르보닐)-HPI2- (3-ethylaminocyclobutyl-carbonyl) -HPI
2-(1-메틸아미노시클로펜틸-카르보닐)-HPI2- (1-methylaminocyclopentyl-carbonyl) -HPI
2-(2-메틸아미노시클로펜틸-카르보닐)-HPI2- (2-methylaminocyclopentyl-carbonyl) -HPI
2-(3-메틸아미노시클로펜틸-카르보닐)-HPI2- (3-Methylaminocyclopentyl-carbonyl) -HPI
2-(1-에틸아미노시클로펜틸-카르보닐)-HPI2- (1-ethylaminocyclopentyl-carbonyl) -HPI
2-(2-에틸아미노시클로펜틸-카르보닐)-HPI2- (2-ethylaminocyclopentyl-carbonyl) -HPI
2-(3-에틸아미노시클로펜틸-카르보닐)-HPI2- (3-ethylaminocyclopentyl-carbonyl) -HPI
2-(2, 4-디아미노시클로헥실-카르보닐)-HPI2- (2,4-Diaminocyclohexyl-carbonyl) -HPI
2-(3, 4-디아미노시클로헥실-카르보닐)-HPI2- (3,4-Diaminocyclohexyl-carbonyl) -HPI
2-(3, 5-디아미노시클로헥실-카르보닐)-HPI2- (3, 5-Diaminocyclohexyl-carbonyl) -HPI
2-(1-메틸아미노시클로헥실-카르보닐)-HPI2- (1-Methylaminocyclohexyl-carbonyl) -HPI
2-(2-메틸아미노시클로헥실-카르보닐)-HPI2- (2-Methylaminocyclohexyl-carbonyl) -HPI
2-(3-메틸아미노시클로헥실-카르보닐)-HPI2- (3-Methylaminocyclohexyl-carbonyl) -HPI
2-(4-메틸아미노시클로헥실-카르보닐)-HPI2- (4-Methylaminocyclohexyl-carbonyl) -HPI
2-(1-에틸아미노시클로헥실-카르보닐)-HPI2- (1-ethylaminocyclohexyl-carbonyl) -HPI
2-(2-에틸아미노시클로헥실-카르보닐)-HPI2- (2-ethylaminocyclohexyl-carbonyl) -HPI
2-(3-에틸아미노시클로헥실-카르보닐)-HPI2- (3-ethylaminocyclohexyl-carbonyl) -HPI
2-(4-에틸아미노시클로헥실-카르보닐)-HPI2- (4-ethylaminocyclohexyl-carbonyl) -HPI
2-2, 4-비스-(메틸아미노)-시클로헥실-카르보닐-HPI2-2, 4-bis- (methylamino) -cyclohexyl-carbonyl-HPI
2-3, 4-비스-(메틸아미노)-시클로헥실-카르보닐-HPI2-3, 4-bis- (methylamino) -cyclohexyl-carbonyl-HPI
2-3, 5-비스-(메틸아미노)-시클로헥실-카르보닐-HPI2-3, 5-bis- (methylamino) -cyclohexyl-carbonyl-HPI
2-2, 4-비스-(에틸아미노)-시클로헥실-카르보닐-HPI2-2, 4-bis- (ethylamino) -cyclohexyl-carbonyl-HPI
2-3, 4-비스-(에틸아미노)-시클로헥실-카르보닐-HPI2-3, 4-bis- (ethylamino) -cyclohexyl-carbonyl-HPI
2-3, 5-비스-(에틸아미노)-시클로헥실-카르보닐-HPI2-3, 5-bis- (ethylamino) -cyclohexyl-carbonyl-HPI
2-4-메틸아미노시클로헵틸-카르보닐)-HPI2-4-methylaminocycloheptyl-carbonyl) -HPI
2-(4-에틸아미노시클로헵틸-카르보닐)-HPI2- (4-Ethylaminocycloheptyl-carbonyl) -HPI
2-(2-메틸아미노벤조일)-HPI2- (2-methylaminobenzoyl) -HPI
2-(3-메에아미노벤조일-HPI2- (3-Meeaminobenzoyl-HPI
2-(4-메틸아미노벤조일)-HPI 융점 220℃2- (4-methylaminobenzoyl) -HPI melting point 220 ° C
2-(2-에틸아미노벤조일)-HPI2- (2-ethylaminobenzoyl) -HPI
2-(3-에틸아미노벤조일)-HPI2- (3-ethylaminobenzoyl) -HPI
2-(4-에틸아미노벤조일)-HPI2- (4-ethylaminobenzoyl) -HPI
2-[3, 4-비스-(메틸아미노)-벤조일]-HPI2- [3, 4-bis- (methylamino) -benzoyl] -HPI
2-[3, 5-비스-(메틸아미노)-벤조일]-HPI2- [3, 5-bis- (methylamino) -benzoyl] -HPI
2-[3, 4-비스-(에틸아미노)-벤조일]-HPI2- [3, 4-bis- (ethylamino) -benzoyl] -HPI
2-[3, 5-비스-(에틸아미노)-벤조일]-HPI2- [3, 5-bis- (ethylamino) -benzoyl] -HPI
2-(3-아미노피코리노일)-HPI2- (3-aminopicolinoyl) -HPI
2-(4-아미노피코리노일)-HPI2- (4-aminopicolinoyl) -HPI
2-(5-아미노피코리노일)-HPI2- (5-aminopicolinoyl) -HPI
2-(6-아미노피코리노일)-HPI2- (6-aminopicolinoyl) -HPI
2-(3-메틸아미노피코리노일)-HPI2- (3-methylaminopicolinoyl) -HPI
2-(4-메틸아미노피코리노일)-HPI2- (4-Methylaminopicolinoyl) -HPI
2-(5-메틸아미노피코리노일)-HPI2- (5-methylaminopicolinoyl) -HPI
2-(6-메틸아미노피코리노일)-HPI2- (6-methylaminopicolinoyl) -HPI
2-(2-아미노니코티노일)-HPI2- (2-aminonicotinoyl) -HPI
2-(4-아미노니코티노일)-HPI2- (4-aminonicotinoyl) -HPI
2-(5-아미노니코티노일)-HPI2- (5-aminonicotinoyl) -HPI
2-(6-아미노니코티노일)-HPI2- (6-aminonicotinoyl) -HPI
2-(2-메틸아미노니코티노일)-HPI2- (2-methylaminonicotinoyl) -HPI
2-(4-메틸아미노니코티노일)-HPI2- (4-methylaminonicotinoyl) -HPI
2-(5-메틸아미노니코티노일)-HPI2- (5-methylaminonicotinoyl) -HPI
2-(6-메틸아미노니코티노일)-HPI2- (6-methylaminonicotinoyl) -HPI
2-(벤조이미다조릴-2-카르보닐)-HPI2- (benzoimidazolyl-2-carbonyl) -HPI
2-(피롤리닐-2-카르보닐)-HPI2- (pyrrolinyl-2-carbonyl) -HPI
2-(피롤리디닐-2-카르보닐)-HPI2- (pyrrolidinyl-2-carbonyl) -HPI
2-(피롤리디닐-3-카르보닐)-HPI2- (pyrrolidinyl-3-carbonyl) -HPI
2-(1, 2, 3, 4-테트라하이드로피리딜-1-카르보닐)-HPI2- (1, 2, 3, 4-tetrahydropyridyl-1-carbonyl) -HPI
2-(1, 2, 3, 4-테트라하이드로피리딜-2-카르보닐)-HPI2- (1, 2, 3, 4-tetrahydropyridyl-2-carbonyl) -HPI
2-(피페리딜-1-카르보닐)-HPI2- (piperidyl-1-carbonyl) -HPI
2-(피페리딜-2-카르보닐)-HPI2- (piperidyl-2-carbonyl) -HPI
2-(피페리딜-3-카르보닐)-HPI2- (piperidyl-3-carbonyl) -HPI
2-(피페리딜-4-카르보닐)-HPI 모노하이드레이트2- (piperidyl-4-carbonyl) -HPI monohydrate
융점 146-147℃Melting point 146-147 ℃
2-(1, 2, 3, 4-테트라하이드로퀴놀릴-3-카르보닐)-HPI2- (1, 2, 3, 4-tetrahydroquinolyl-3-carbonyl) -HPI
2-(1, 2, 3, 4-테트라하이드퀴놀릴-4-카르보닐)-HPI2- (1, 2, 3, 4-tetrahydroquinolyl-4-carbonyl) -HPI
2-(1, 2, 3, 4-테트라하이드로퀴놀릴-1-카르보닐)-HPI2- (1, 2, 3, 4-tetrahydroquinolyl-1-carbonyl) -HPI
2-(1, 2, 3, 4-테트라하이드로이소퀴놀릴-3-카르보닐)-HPI2- (1, 2, 3, 4-tetrahydroisoquinolyl-3-carbonyl) -HPI
2-(1, 2, 3, 4-테트라하이드로이소퀴놀릴-4-카르보닐)-HPI2- (1, 2, 3, 4-tetrahydroisoquinolyl-4-carbonyl) -HPI
만일 유기상을 수산화나트륨 수용액으로 세척하지 않는다면 트리플루오로아세틸화합물인 2-(1-트리플루오로아세트아미도시클로헥실-카르보닐)-HPI를 얻게 된다.If the organic phase is not washed with an aqueous sodium hydroxide solution, a trifluoroacetyl compound 2- (1-trifluoroacetamidocyclohexyl-carbonyl) -HPI is obtained.
[실시예 33]Example 33
클로로포름 300ml에 4-아미노-테트라하이드로티오피란-4-카복실산의 "로이히 무수물" (이산과 포스겐으로 얻어질 수 있는 1, 3-디옥소-2-옥사-8-티아스피로 [4, 5]] 데칸) 4.2g을 넣은 현탁액에 HPI 4.04g과 초산 1.5g을 가하고 이 반응 혼합물을 24시간 비등시켰다. 이 반응혼합물을 냉각시키고 여과하여 여액을 묽은 수산화나트륨 수용액과 물로 씻고 증발시킨다음 에틸아세테이트와 에테르 및 석유에테르로 재결정시켜 융점 157-158℃인 2-(4-아미노-테트라하이드로티오피란-4-카보닐)-HPI를 얻었다."Lloyd anhydride" of 4-amino-tetrahydrothiopyran-4-carboxylic acid in 300 ml of chloroform (1,3-dioxo-2-oxa-8-thiaspiro, obtainable with diacids and phosgene [4, 5] 4.04 g of HPI and 1.5 g of acetic acid were added to the suspension containing 4.2 g of decane) and the reaction mixture was boiled for 24 hours. The reaction mixture was cooled, filtered and the filtrate was washed with dilute aqueous sodium hydroxide solution and water, evaporated, and then recrystallized with ethyl acetate, ether and petroleum ether to recrystallize 2- (4-amino-tetrahydrothiopyran-4- with a melting point of 157-158 ° C. Carbonyl) -HPI was obtained.
[실시예 34]Example 34
염화메틸렌 50ml 내에 2-(4-옥소싸이클로헥실-카보닐)-HPI 3.26g, 물 0.2ml 및 설피테트라플루오라이드 3.2g을 넣은 것을 오토크레이브 내에서 30℃로 24시간 진탕하고 이 반응 혼합물을 묽은 황산나트륨에 부은다음 증발시켜 2-(4, 4-디플루오로싸이클로헥실-카보닐)-HPI를 얻었다.Into 50 ml of methylene chloride, 3.26 g of 2- (4-oxocyclohexyl-carbonyl) -HPI, 0.2 ml of water and 3.2 g of sulfitetetrafluoride were shaken for 24 hours at 30 ° C. in an autoclave and the reaction mixture was diluted. Poured over sodium sulfate and evaporated to afford 2- (4,4-difluorocyclohexyl-carbonyl) -HPI.
[실시예 35]Example 35
2-(4-메르캅토벤조일)-HPI 3.4g을 수욕상에서 질산 (d=1.2) 40ml와 함께 가열하고 처음의 격렬한 반응이 그친 후에 이 반응혼합물을 증발시켜 2-(4-설포벤조일)-HPI를 얻었다. 유사한 방법으로 상응하는 메르캅토 화합물을 산화시켜 2-(2-설포벤조일)-HPI와 2-(3-설포벤조일)-HPI를 얻었다.3.4 g of 2- (4-mercaptobenzoyl) -HPI were heated with 40 ml of nitric acid (d = 1.2) in a water bath and the reaction mixture was evaporated after the first vigorous reaction ceased, resulting in 2- (4-sulfobenzoyl) -HPI. Got. In a similar manner the corresponding mercapto compound was oxidized to give 2- (2-sulfobenzoyl) -HPI and 2- (3-sulfobenzoyl) -HPI.
[실시예 36]Example 36
실시예 17과 유사한 방법으로 2-(4-아세톡시벤조일)-HPI 8g을 10% 수산화나트륨 수용액 존재하에 검화시켜 융점 243-245℃인 2-(4-하이드록시벤조일)-HPI를 얻었다.In a similar manner as in Example 17, 8 g of 2- (4-acetoxybenzoyl) -HPI was saponified in the presence of 10% aqueous sodium hydroxide solution to give 2- (4-hydroxybenzoyl) -HPI having a melting point of 243-245 ° C.
유사한 방법으로 적당한 아세테이트를 검화하여 다음 화합물들이 얻어졌다.In a similar manner, the appropriate compounds were saponified to afford the following compounds.
2-(2-히드록시-아세틸)-HPI2- (2-hydroxy-acetyl) -HPI
2-(2-히드록시시클로프로필-카르보닐)-HPI2- (2-hydroxycyclopropyl-carbonyl) -HPI
2-(1-히드록시시클로부틸-카르보닐)-HPI2- (1-hydroxycyclobutyl-carbonyl) -HPI
2-(2-히드록시시클로부틸-카르보닐)-HPI2- (2-hydroxycyclobutyl-carbonyl) -HPI
2-(3-히드록시시클로부틸-카르보닐)-HPI2- (3-hydroxycyclobutyl-carbonyl) -HPI
2-(1-히드록시시클로펜틸-카르보닐)-HPI2- (1-hydroxycyclopentyl-carbonyl) -HPI
2-(2-히드록시시클로펜틸-카르보닐)-HPI2- (2-hydroxycyclopentyl-carbonyl) -HPI
2-(3-히드록시시클로펜틸-카르보닐)-HPI2- (3-hydroxycyclopentyl-carbonyl) -HPI
2-(1-히드록시시클로헥실-카르보닐)-HPI2- (1-hydroxycyclohexyl-carbonyl) -HPI
2-(2-히드록시시클로헥실-카르보닐)-HPI2- (2-hydroxycyclohexyl-carbonyl) -HPI
2-(3-히드록시시클로헥실-카르보닐)-HPI2- (3-hydroxycyclohexyl-carbonyl) -HPI
2-(4-히드록시시클로헥실-카르보닐)-HPI2- (4-hydroxycyclohexyl-carbonyl) -HPI
(+)-2-(4-히드록시시클로헥실-카르보닐)-HPI(+)-2- (4-hydroxycyclohexyl-carbonyl) -HPI
(-)-2-(4-히드록시시클로헥실-카르보닐)-HPI(-)-2- (4-hydroxycyclohexyl-carbonyl) -HPI
2-(2, 4-디히드록시시클로헥실-카르보닐)-HPI2- (2,4-Dihydroxycyclohexyl-carbonyl) -HPI
2-(3, 4-시스-디히드록시시클로헥실-카르보닐)-HPI2- (3, 4-cis-dihydroxycyclohexyl-carbonyl) -HPI
하이드레이트 : 융점 100-102℃Hydrate: melting point 100-102 ℃
2-(3, 5-디히드록시시클로헥실-카르보닐-)-HPI2- (3, 5-Dihydroxycyclohexyl-carbonyl-)-HPI
2-(3, 4, 5-트리히드록시시클로헥실-카르보닐)-HPI2- (3, 4, 5-trihydroxycyclohexyl-carbonyl) -HPI
[실시예 37]Example 37
실시예 1과 유사한 방법으로 HPI와 4-(벤질옥시-카보닐아미노)-벤조일 클로라이드로부터 2-(4-벤질옥시카보닐아미노벤조일)-HPI를 제조하였다. 적당히 치환된 산할라이드로 유사하게 다음 화합물들이 제조되었다.2- (4-benzyloxycarbonylaminobenzoyl) -HPI was prepared from HPI and 4- (benzyloxy-carbonylamino) -benzoyl chloride in a similar manner as in Example 1. The following compounds were similarly prepared with suitably substituted acid halides.
2-(1-메톡시아세트 아미도시클로펜틸-카르보닐)-HPI2- (1-methoxyacet amidocyclopentyl-carbonyl) -HPI
2-(1-3급-부톡시 카르보닐아미노시클로펜틸-카르보닐)-HPI2- (1-tert-butoxycarbonylaminocyclopentyl-carbonyl) -HPI
2-(4-벤질옥시카르보닐아미노시클로헥실-카르보닐)-HPI2- (4-benzyloxycarbonylaminocyclohexyl-carbonyl) -HPI
2-4-(3, 5-디메톡시벤질옥시카르보닐)-아미노시클로헥실-카르보닐-HPI2-4- (3, 5-dimethoxybenzyloxycarbonyl) -aminocyclohexyl-carbonyl-HPI
2-(2-메톡시아세트아미드벤조일)-HPI2- (2-methoxyacetamidebenzoyl) -HPI
2-(2-3급 부톡시카르보닐아미노벤조일)-HPI2- (2-tert-butoxycarbonylaminobenzoyl) -HPI
2-(2-벤질옥시카르보닐아미노벤조일)-HPI2- (2-benzyloxycarbonylaminobenzoyl) -HPI
2-2-(3, 5-디메톡시벤질옥시카르보닐)-아미노벤조일-HPI2-2- (3, 5-dimethoxybenzyloxycarbonyl) -aminobenzoyl-HPI
2-(3-메톡시아세트아미도벤조일)-HPI2- (3-methoxyacetamidobenzoyl) -HPI
2-(3-3급-부톡시카르보닐아미노벤조일)-HPI2- (3-tert-butoxycarbonylaminobenzoyl) -HPI
2-(3-벤질옥시카르보닐아미노벤조일)-HPI2- (3-benzyloxycarbonylaminobenzoyl) -HPI
2-3-(3, 5-디메톡시벤질옥시카르보닐)-아미노벤조일-HPI2-3- (3,5-dimethoxybenzyloxycarbonyl) -aminobenzoyl-HPI
2-(4-메톡시아세트아미드벤조일)-HPI 융점 172℃2- (4-methoxyacetamidebenzoyl) -HPI Melting Point 172 ° C
2-(4-3급-부톡시카르보닐아미노벤조일 )-HPI2- (4-tert-butoxycarbonylaminobenzoyl) -HPI
2-4-(3, 5-디메톡시벤질옥시카르보닐)-아미노벤조일)-HPI2-4- (3, 5-dimethoxybenzyloxycarbonyl) -aminobenzoyl) -HPI
2-(1-3급-부톡시카르보닐-피페리딜-3-카르보닐)-HPI2- (l-tert-butoxycarbonyl-piperidyl-3-carbonyl) -HPI
2-(1-벤질옥시카르보닐-피페리딜-3-카르보닐)-HPI2- (1-benzyloxycarbonyl-piperidyl-3-carbonyl) -HPI
2-1-(3, 5-디메톡시벤질옥시카르보닐)-피페리딜-3-카르보닐-HPI2-1- (3, 5-dimethoxybenzyloxycarbonyl) -piperidyl-3-carbonyl-HPI
2-(1-벤질옥시카르보닐-피페리딜-4-카르보닐)-HPI2- (1-benzyloxycarbonyl-piperidyl-4-carbonyl) -HPI
[실시예 38]Example 38
2-(1-벤질옥시카보닐-피페리딜-3-카보닐)-HPI 4.5g을 80% 디옥산 수용액 100ml와 초산 1ml내에서 팔라듐 300mg존재하에 수소화 시킨후에 촉매를 여과하고 여액을 증발시킨후에 잔사를 클로로포름에 취하고 탄산나트륨 수용액과 물로 씻은 다음 증발시켜 2-(피페리딜-3-카보닐)-HPI를 얻었다. 유사한 방법으로 적당한 벤질옥시카보닐아미노아실 유도체를 가수소분해시켜 다음 화합물들이 제조되었다.4.5 g of 2- (1-benzyloxycarbonyl-piperidyl-3-carbonyl) -HPI was hydrogenated in 100 ml of 80% dioxane aqueous solution and 1 ml of acetic acid in the presence of 300 mg of palladium, and then the catalyst was filtered and the filtrate was evaporated. The residue was then taken up in chloroform, washed with aqueous sodium carbonate solution and water and then evaporated to afford 2- (piperidyl-3-carbonyl) -HPI. The following compounds were prepared by hydrolyzing the appropriate benzyloxycarbonylaminoacyl derivatives in a similar manner.
트란스-2-(4-아미노싸이클로헥실-카보닐)-HPI브롬산염 : 융점 284℃Trans-2- (4-aminocyclohexyl-carbonyl) -HPI bromate: Melting point 284 ° C
2-(2-아미노벤조일)-HPI브롬산염 : 융점 279-280℃2- (2-aminobenzoyl) -HPI bromate: melting point 279-280 ° C
2-(3-아미노벤조일)-HPI: 융점 161-162℃2- (3-aminobenzoyl) -HPI: Melting point 161-162 ° C
2-(4-아미노벤조일)-HPI: 융점 212-213℃2- (4-aminobenzoyl) -HPI: Melting point 212-213 ° C
2-(피페리딜-4-카보닐)-HPI 모노아미드레이트 : 융점 146-147℃2- (piperidyl-4-carbonyl) -HPI monoamideate: melting point 146-147 ° C
[실시예 39]Example 39
98%포름산 80ml에 2-(1-tert-부틸옥시카보닐-피페리딜-3-카보닐)-HPI 4.3g을 넣은 용액을 20℃에서 5시간 정치시키고 증발시킨 다음 잔사를 클로로포름 취하고 탄산나트륨수용액과 물로 씻은 다음 증발시켜 2-(피페리딜-3-카보닐)-HPI를 얻었다.A solution containing 4.3 g of 2- (1-tert-butyloxycarbonyl-piperidyl-3-carbonyl) -HPI in 80 ml of 98% formic acid was allowed to stand at 20 ° C. for 5 hours, evaporated, and the residue was chloroform and an aqueous sodium carbonate solution. And washed with water and then evaporated to afford 2- (piperidyl-3-carbonyl) -HPI.
[실시예 40]Example 40
80%디옥산수용액 100ml에 2-[1-(3, 5-디메톡시벤질옥시카보닐)-피페리딜-3-카보닐]-HPI 5.1g을 넣은 용액을 고압의 수은 등으로 2시간 동안 조사시키고 이 반응혼합물을 염산과 혼합하고 에테르로 씻은 다음 수산화나트륨 수용액으로 알카리화한 다음 클로로포름으로 추출하고 추출액을 증발시켜 2-(피페리딜-3-카보닐)-HPI를 얻었다.A solution of 2- [1- (3,5-dimethoxybenzyloxycarbonyl) -piperidyl-3-carbonyl] -HPI was added to 100 ml of 80% aqueous dioxane solution in 5.1 g for 2 hours using high pressure mercury or the like. The reaction mixture was mixed with hydrochloric acid, washed with ether, alkaline with an aqueous sodium hydroxide solution, extracted with chloroform, and the extract was evaporated to give 2- (piperidyl-3-carbonyl) -HPI.
[실시예 41]Example 41
2-(4-아미노벤조일)-HPI 6.4g, 살리실알데히드 2.7g 및 P-톨루엔설포클로라이드 100mg을 톨루엔150ml 내에서 12시간 비등시켜 형성된 물을 제거시키고 이 반응 혼합물을 증발시킨다음 잔사를 에테르와 진탕시키고 벤젠과 석유에테르로 재결정시켜 융점 196-197℃인 2-(4-0-하이드록시벤질리덴아미노-벤조일)-HPI를 얻었다.6.4 g of 2- (4-aminobenzoyl) -HPI, 2.7 g of salicyaldehyde and 100 mg of P-toluenesulfochloride were boiled in 150 ml of toluene for 12 hours to remove the water formed and the reaction mixture was evaporated. Shaking and recrystallization with benzene and petroleum ether gave 2- (4-0-hydroxybenzylideneamino-benzoyl) -HPI having a melting point of 196-197 ° C.
유사한 방법으로 벤즈알데히드를 사용하여 2-(4-벤질리덴아미노-벤조일)-HPI를 얻었다.In a similar manner benzaldehyde was used to obtain 2- (4-benzylideneamino-benzoyl) -HPI.
[실시예 42]Example 42
메탄올 50ml에 2-(4-벤질리덴아미노-벤조일)-HPI 3g을 넣은 것을 백금 1g존재하에 1기압, 20℃에서 3시간 수소화시키고 촉매를 여과시키고 증발시켜 융점 204-205℃인 2-(4-벤질아미노-벤조일)-HPI를 얻었다.3 g of 2- (4-benzylideneamino-benzoyl) -HPI was added to 50 ml of methanol, hydrogenated at 1 atmosphere and 20 ° C for 3 hours in the presence of 1 g of platinum, and the catalyst was filtered and evaporated. -Benzylamino-benzoyl) -HPI was obtained.
유사한 방법으로 적당한 쉬프염기를 수소화시켜 다음 화합물들이 얻어졌다 :In a similar manner the appropriate Schiffbases were hydrogenated to afford the following compounds:
2-(3-벤질아미노-시클로펜틸-카르보닐)-HPI2- (3-benzylamino-cyclopentyl-carbonyl) -HPI
2-(4-벤질아미노-시클로헥실-카르보닐)-HPI2- (4-Benzylamino-cyclohexyl-carbonyl) -HPI
2-(3-벤질아미노-벤조일)-HPI2- (3-benzylamino-benzoyl) -HPI
2-[3-(2-히드록시벤조일)-아미노시클로펜틸-카르보닐-HPI2- [3- (2-hydroxybenzoyl) -aminocyclopentyl-carbonyl-HPI
2-4-(2-히드록시벤조일)-아미노시클로헥실-카르보닐-HPI2-4- (2-hydroxybenzoyl) -aminocyclohexyl-carbonyl-HPI
2-3-(2-히드록시벤조일)-아미노벤조일-HPI2-3- (2-hydroxybenzoyl) -aminobenzoyl-HPI
2-4-(2-히드록시벤조일)-아미노벤조일-HPI 융점 201-202℃2-4- (2-hydroxybenzoyl) -aminobenzoyl-HPI melting point 201-202 ° C
2-[3-(2-히드록시-3-메톡시벤조일)-아미노시클로펜틸-카르보닐]-HPI2- [3- (2-hydroxy-3-methoxybenzoyl) -aminocyclopentyl-carbonyl] -HPI
2-4-(2-히드록시-3-메톡시벤질)-아미노시클로헥실-카르보닐]-HPI2-4- (2-hydroxy-3-methoxybenzyl) -aminocyclohexyl-carbonyl] -HPI
2-[3-(2-히드록시-3-메톡시벤질)-아미노벤조일]-HPI2- [3- (2-hydroxy-3-methoxybenzyl) -aminobenzoyl] -HPI
2-[4-(2-히드록시-3-메톡시벤질)-아미노벤조일]-HPI2- [4- (2-hydroxy-3-methoxybenzyl) -aminobenzoyl] -HPI
2-(3-카르복시메틸아미노시클로펜틸-카르보닐)-HPI2- (3-carboxymethylaminocyclopentyl-carbonyl) -HPI
2-(4-카르복시메틸아미노벤조일)-HPI2- (4-carboxymethylaminobenzoyl) -HPI
2-(3-카르복시메틸아미노벤조일)-HPI2- (3-carboxymethylaminobenzoyl) -HPI
2-(4-카르복시메틸아미노벤조일)-HPI2- (4-carboxymethylaminobenzoyl) -HPI
백금대신에 라니니켈로도 수소화시킬 수 있다. 용매로서 디옥산을 사용하고 반응은 45℃, 1-5기압에서 수행된다.Instead of platinum, it is also possible to hydrogenate with nickel. Dioxane is used as the solvent and the reaction is carried out at 45 DEG C, 1-5 atm.
[실시예 43]Example 43
실시예 38과 유사한 방법으로 2-(4-벤질리덴아미노-벤조일)-HPI를 팔라듐 존재하에 수소화시켜 융점 212-213℃인 2-(4-아미노벤조일)-HPI를 얻었다.In a similar manner as in Example 38, 2- (4-benzylideneamino-benzoyl) -HPI was hydrogenated in the presence of palladium to give 2- (4-aminobenzoyl) -HPI having a melting point of 212-213 ° C.
[실시예 44]Example 44
2-(4-아미노벤조일)-HPI 3.21g, 6N-염산 5ml, 소디움니트라이트 0.7g으로부터 디아조니움 용액을 제조하고 2N-수산화나트륨 수용액 15ml 살리실산 1.38g을 넣은 용액에 5-10℃에서 용액이 알카리성이 되도록 주의하면서 물 4ml를 유입시켰다. 30분 후에 얻어진 생성물을 염산으로 침전시키고 여과하여 물과 소량의 에탄올로 씻고 건조시켜 오렌지-황색 분말상태인 융점 241-244℃의 2-4-(3-카복시-4-하이드록시페닐아조)-벤조일]-HPI를 얻었다. 유사한 방법으로 아니솔과 디미틸아닐린을 사용하여 다음 화합물들이 얻어진다.A diazonium solution was prepared from 3.21 g of 2- (4-aminobenzoyl) -HPI, 5 ml of 6N-hydrochloric acid, and 0.7 g of sodium nitrite, and the solution was added to a solution containing 15 ml of 1 N salicylic acid in 15 ml of 2N-sodium hydroxide solution at 5-10 ° C. 4 ml of water was introduced while being careful to make this alkaline. After 30 minutes, the obtained product was precipitated with hydrochloric acid, filtered, washed with water and a small amount of ethanol and dried to give an orange-yellow powder of 2-4- (3-carboxy-4-hydroxyphenylazo) at a melting point of 241-244 ° C. Benzoyl] -HPI was obtained. In a similar manner the following compounds are obtained using anisole and dimitaniline.
2-[4-(4-메톡시페닐아조-벤조일]-HPI와 2-[4-(4-디메틸아미노페닐아조)-벤조일]-HPI,2- [4- (4-methoxyphenylazo-benzoyl] -HPI and 2- [4- (4-dimethylaminophenylazo) -benzoyl] -HPI,
[실시예 45]Example 45
3.7N소디움비설파이트용액 300ml를 신나밀알데히드와 90℃에서 30분간 가열하고 여기에 디옥산 1리터에 2-(4-아미노벤조일)-HPI 111.7g을 넣은 것을 가한다음 이 반응혼합물을 90℃로 12시간 가열시키고 냉각한 후 클로로포름으로 추출하여 수층을 농축시키고 에탄올을 가하여 원하는 목적물을 침전시켜 융점 221-222℃(분해 )인 2-[4-(1, 3-디설포-3-페닐프로필아미노)-벤조일]-HPI의 디소디움염을 얻었다.300 ml of a 3.7 N sodium bisulfite solution was heated with cinnamilaldehyde at 90 ° C. for 30 minutes, and 11.7 g of 2- (4-aminobenzoyl) -HPI was added to 1 liter of dioxane, and the reaction mixture was heated to 90 ° C. After heating and cooling for 12 hours, the mixture was extracted with chloroform, the aqueous layer was concentrated, ethanol was added to precipitate the desired product, and 2- [4- (1,3-disulfo-3-phenylpropylamino) having a melting point of 221-222 DEG C (decomposition) was obtained. Disodium salt of) -benzoyl] -HPI was obtained.
[실시예 46]Example 46
실시예 24와 유사한 방법으로 2-(4-아미노벤조일)-HPI와 알릴요오다이드로부터 2-(4-알릴아미노-벤조일)-HPI를 얻었다:In a similar manner to Example 24, 2- (4-allylamino-benzoyl) -HPI was obtained from 2- (4-aminobenzoyl) -HPI and allyliodide:
유사한 방법으로 다음 화합물들이 얻어졌다.In a similar manner the following compounds were obtained.
2-(3-알릴아미노싸이클로펜틸-카보닐)-HPI:2- (3-allylaminocyclopentyl-carbonyl) -HPI:
2-(4-알릴아미노싸이클로헥실-카보닐)-HPI:2- (4-allylaminocyclohexyl-carbonyl) -HPI:
2-(3-알릴아미노벤조일) -HPI:2- (3-allylaminobenzoyl) -HPI:
[실시예 47]Example 47
실시예 5와 유사한 방법으로 적당한 아미노화합물과 석신산 무수물, 말레산 무수물 또는 프탈산 무수물로부터 다음 화합물들이 얻어졌다:In a similar manner to Example 5, the following compounds were obtained from suitable amino compounds and succinic anhydrides, maleic anhydride or phthalic anhydride:
2-(4-석시닐아미노-벤조일)-HPI:2- (4-succinylamino-benzoyl) -HPI:
2-(4-말레이노일아미노-벤조일)-HPI:2- (4-Malaynoylamino-benzoyl) -HPI:
2-(4-프탈로일아미노-벤조일) -HPI:2- (4-phthaloylamino-benzoyl) -HPI:
2-(1-석시닐-피페리디닐-4-카보닐)-HPI:2- (1-Succinyl-piperidinyl-4-carbonyl) -HPI:
2-(1-프탈로일-피페리딜-4-카보닐)-HPI:2- (1-phthaloyl-piperidyl-4-carbonyl) -HPI:
[실시예 48]Example 48
2-(3-싸이클로헥실-1-카보닐)-HPI 4.8g과 오스미움테트록사이드 4g을 피리딘 60ml내에서 20℃로 하룻밤 교반하고, 물 100ml와 피리딘 85ml에 소디움비설파이트 7g을 넣는 용액을 여기에 가한다음 30분간 교반하고 염화메틸렌으로 추출하고 건조증발시켜 융점 100-102℃인 2-(3, 4-시스-디하이드록시싸이클로헥실-1-카보닐)-HPI 수화물을 얻었다.4.8 g of 2- (3-cyclohexyl-1-carbonyl) -HPI and 4 g of osmium tetraoxide were stirred overnight at 20 ° C. in 60 ml of pyridine, and a solution of 7 g of sodium bisulfite was added to 100 ml of water and 85 ml of pyridine. It was stirred for 30 minutes, extracted with methylene chloride and evaporated to dryness to obtain 2- (3,4-cis-dihydroxycyclohexyl-1-carbonyl) -HPI hydrate having a melting point of 100-102 ° C.
[실시에 49][49]
2-(3-싸이클로헥실-1-카보닐)-HPI 3.1g을 산화백금 300mg존재하에 20℃, 대기압에서 반응이 그칠때가지 메탄올 100m내에서 수소화시키고 이 반응 혼합물을 여과하여 여액을 증발시켜 융점 136-138℃인 2-싸이클로헥실카보닐-HPI를 얻었다.3.1 g of 2- (3-cyclohexyl-1-carbonyl) -HPI was hydrogenated in 100 m of methanol at 20 ° C. at atmospheric pressure in the presence of 300 mg of platinum oxide, and the reaction mixture was filtered to evaporate the filtrate to evaporate the melting point. 2-cyclohexylcarbonyl-HPI was obtained at 136-138 ° C.
[실시예 50]Example 50
초산 20ml에 2-(테트라하이드로티오피란-4-카보닐)-HPI 3.3g과 30%과산화수소 수용액 1.05ml를 넣은 용액을 20℃에서 하룻밤 방치시키고 증발시킨 다음 클로로포름과 물로 회수시켜 이성체 혼합물 상태인 융점 175-180℃의 2-(테트라하이드로티오피란-4-카보닐)-HPI-S-디옥사이드를 얻었다.A solution containing 3.3 g of 2- (tetrahydrothiopyran-4-carbonyl) -HPI and 1.05 ml of 30% aqueous hydrogen peroxide solution in 20 ml of acetic acid was left at 20 ° C. overnight, evaporated, and recovered with chloroform and water. 2- (tetrahydrothiopyran-4-carbonyl) -HPI-S-dioxide was obtained at 175-180 ° C.
[실시예 51]Example 51
2-(테트라하이드로티오피란-4-카보닐)-HPI 3.3g과 30% 과산화수소 2.5ml를 초산 25ml내에서 60℃로 2시간 가열하고 증발시킨 다음 클로로포름과 물로 회수하고 에탄올로 재결정시켜 융점 253-255℃인 2-(테트라하이드로티오피란-4-카보닐)-HPI-S. S.-디옥사이드를 얻었다.3.3 g of 2- (tetrahydrothiopyran-4-carbonyl) -HPI and 2.5 ml of 30% hydrogen peroxide were heated in 60 ml of acetic acid at 60 ° C. for 2 hours, evaporated, recovered with chloroform and water, and recrystallized from ethanol to give a melting point 253-. 2- (tetrahydrothiopyran-4-carbonyl) -HPI-S at 255 ° C. S.-dioxide was obtained.
[실시예 52]Example 52
테트라하이드로푸란에 포타슘트리-sec-부틸보로하이드라이드를 넣은 0.5M용액 35ml를 -70℃로 질소가스하에서 무수테트라하이드로푸란 50ml에 2-(4-옥소싸이클로헥 실-카보닐)-HPI 4.9g을 넣은 용액에 서서히 가하고 3시간후에 이 반응혼합물을 물 50ml와 혼합하고 실온까지 가온한 다음 염산으로 산성화하고 클로로포름으로 추출하였다. 이 클로로포름 추출액을 크로마토그라피(실리카겔/클로로포름)로 정제 하고 이소프포판을/디에틸에테르로 재결정시켜 융점 162-163℃ 시스-2-(4-하이드록시싸이클로헥실-카보닐)-HPI를 얻었다. 일반식(Ⅰ)의 활성물질은 문헌에 기술된 공지방법에 따라처리하여 다음 실시예에 나타난 바와같은 제약조정물을 얻을 수 있다.35 ml of 0.5 M solution with potassium tri-sec-butylborohydride in tetrahydrofuran was added to 50 ml of anhydrous tetrahydrofuran under nitrogen gas at -70 ° C. in 2- (4-oxocyclohexyl-carbonyl) -HPI 4.9 The solution was slowly added to the solution, and after 3 hours, the reaction mixture was mixed with 50 ml of water, warmed to room temperature, acidified with hydrochloric acid, and extracted with chloroform. This chloroform extract was purified by chromatography (silica gel / chloroform), and the recrystallized isopofane with / diethyl ether to obtain a melting point of 162-163 ° C cis-2- (4-hydroxycyclohexyl-carbonyl) -HPI. The active substance of formula (I) can be treated according to the known method described in the literature to obtain a pharmaceutical adjustment as shown in the following examples.
[실시예 53]Example 53
촌충(성충)구제용 정제Tablets for tapeworms
a)활성물질로서 2-싸이클로헥실카보닐-HPI500mg을 함유한정제는 2-싸이클로헥실카보닐-HPI 5kg, 락토스 3kg, 옥수수전분 1.8kg 및 마그네슘스테아레이트 0.2 kg으로된 분말혼합물로부터 제조되었다.a) A tablet containing 500 mg of 2-cyclohexylcarbonyl-HPI as the active substance was prepared from a powder mixture of 5 kg 2-cyclohexylcarbonyl-HPI, 3 kg lactose, 1.8 kg corn starch and 0.2 kg magnesium stearate.
b) 또한 실시예 53)에 기술된 혼합물은 2-싸이를로헥실카보닐-HPI 50mg, 250mg 및, 1, 000kg 함유한 정제제조에도 사용될 수 있다.b) The mixtures described in Example 53) can also be used for the preparation of tablets containing 50 mg, 250 mg of 2-cyclohexylcarbonyl-HPI and 1, 000 kg.
활성물질로서 2-싸이클로헥실카보닐-HPI 250mg 및 5mg 함유한 정제는 의약으로 사용하는 것이 좋으나 이런 모든 정제는 수의약품으로 사용될 수 있다.Tablets containing 250 mg and 5 mg 2-cyclohexylcarbonyl-HPI as the active substance are recommended for use as a medicament, but all such tablets can be used as veterinary medicine.
[실시예 54]Example 54
촌충포충과 주혈흡충 구제용 정제Tablets for removing tapeworms and schistosomiasis
발포정Effervescent tablet
저작 당의정Authoritarian
[실시예 55]Example 55
인간의 촌충구제용 당의정Dragee for human tapeworm
당의정의 제피는 탈크, 삭카로스, 이산화티탄, 탄산칼슘, 폴리비닐 피롤리돈, 메틸셀룰로스, 글리세롤, 마그네슘옥사이드와 락커로 구성되어 있고 이 제제는 활성 성분으로서 2-싸이클로헥실카보닐 HPI 500mg을 함유한 당의정에도 사용될 수 있다.Dragee coating consists of talc, saccharose, titanium dioxide, calcium carbonate, polyvinyl pyrrolidone, methylcellulose, glycerol, magnesium oxide and lacquer, which contains 500 mg of 2-cyclohexylcarbonyl HPI as active ingredient Can also be used for one party.
[실시예 56]Example 56
인간의 촌충구제용 시럽Human tapeworm syrup
이 시럽은 다음 성분으로 구성된 현탁제로부터 얻어진다 :This syrup is obtained from a suspension consisting of the following components:
이 혼합물을 착색제 및 향료와 섞고 증류수로 100ℓ가 되도록 한다.The mixture is mixed with colorants and flavorings and brought to 100 l with distilled water.
[실시예 57]Example 57
인간과 동물의 촌충과 주혈흡충 구제용 캅셀Capsule for controlling tapeworm and schistosomiasis in humans and animals
적당한 크기의 캅셀에 2-싸이클로헥실카보닐-HPI 5, 000mg과 탈크 250mg 및 마그네슘스테아레이트 150mg을 충진시킨다. 같은 방법으로 2-싸이클로헥실카보닐-HPI 1, 000mg 과, 10, 000mg을 함유한 캅셀을 생산한다.An appropriately sized capsule is filled with 5,000 mg of 2-cyclohexylcarbonyl-HPI, 250 mg of talc and 150 mg of magnesium stearate. In the same manner, a capsule containing 1,000 mg of 2-cyclohexylcarbonyl-HPI and 10,000 mg is produced.
[실시예 58]Example 58
인간과 동물용 주사액Human and Animal Injections
유제 또는 수제 현탁액으로 피하투여하기 위한 15mg앰플을 물 6ml와 프로필렌 글리콜 4ml 2-싸이클로헥실카보닐-HPI 500mg을 넣은 용액을 용해제와 함께 충진시키고 가열 멸균시킨 다음 여기에 보존제를 넣는다. 유사한 방법으로 2-싸이클로헥실카보닐-HPI 100mg(작은 동물용)과 2-싸이클로헥실카보닐-HPI 1,000mg(큰 동물용)을 함유한 앰플도 생산된다.A 15 mg ampoule for subcutaneous administration into an emulsion or a homemade suspension is filled with a solution containing 6 ml of water and 500 mg of propylene glycol 4 ml 2-cyclohexylcarbonyl-HPI together with the solubilizer, heat sterilized and then a preservative. Similarly, ampoules containing 100 mg of 2-cyclohexylcarbonyl-HPI (for small animals) and 1,000 mg of 2-cyclohexylcarbonyl-HPI (for large animals) are also produced.
[실시예 59]Example 59
환제(pellet)Pellet
등량의 2-싸이클로헥실카보닐-HPI와 락토스 및 소디움카복시 메틸셀룰로스로 분말 혼합물을 만들고 공지방법으로 처리하여 평균입자 크기가 1.5mm 인 균일한 과립제를 만든다.A powder mixture is prepared from an equivalent amount of 2-cyclohexylcarbonyl-HPI with lactose and sodium carboxy methylcellulose and treated by known methods to produce uniform granules with an average particle size of 1.5 mm.
[실시예 60]Example 60
약제가 첨가된 사료를 얻기위해 담체로서 사료와 혼합하기에 적당하도록한 동물용 예비혼합물 :Animal premixes adapted to be mixed with feed as a carrier to obtain feed with added agent:
a) 큰 동물용에 적당한 25% 예비혼합물;a) 25% premix suitable for large animals;
2-싸이클로헥실카보닐-HPI 25kg을 밀을 분쇄시켜 얻은 미세한겨거나 락토스 75kg과 혼합한다.25 kg of 2-cyclohexylcarbonyl-HPI are mixed with 75 kg of fine bran or lactose obtained by milling wheat.
b) 작은 동물용에 알맞는 5% 예비 혼합물;b) 5% premix suitable for small animals;
2-싸이클로헥실카보닐-HPI 5kg을 실시예 60 a)와 같이 처리한다.5 kg 2-cyclohexylcarbonyl-HPI is treated as in Example 60 a).
c) 소과동물의 장에 있는 모니에지아 유형을 구제하기 위해 실시예 60 a)이 따라 제조한 예비혼합물을 사용하는 실시예 적당히 약제를 넣은 사료를 만들기 위하여 실시예 60 a)에서 제조한 예비혼합물 1kg을 통상의 사료농축물 9과 섞는다.c) Examples of using premixes prepared according to Example 60 a) to control the moniezia type in the bovine of bovine animals Premixes prepared in Example 60 a) to make a suitable medicated feed. Mix 1 kg with conventional feed concentrate 9.
2-싸이클로헥실카보닐-HPI 10, 000mg을 함유한 이 사료 400g을 성숙한 가축의 모니에지아 감염을 구제하기 위해 투여한다.400 g of this feed containing 10,000 mg of 2-cyclohexylcarbonyl-HPI is administered to control Monygia infection in mature livestock.
실시예 53-60에 기술한 것과 유사한 방법으로 2-싸이클로헥실카보닐-HPI대신에 일반식(Ⅰ)의 다른활성물질이나 생리학상 허용되는 그의 염을 약제조성물 생산에 사용할 수 있다.Instead of 2-cyclohexylcarbonyl-HPI, other active substances of formula (I) or physiologically acceptable salts thereof can be used for the production of pharmaceutical compositions in a manner similar to that described in Examples 53-60.
Claims (1)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR7404234A KR800000089B1 (en) | 1973-12-17 | 1974-12-10 | Method for preparing 2-acyl-4-oxo-hexahydro-4H-pyrazino [2, 1-a] isoquinoline derivative |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE2362539A DE2362539C2 (en) | 1973-12-17 | 1973-12-17 | 2-Acyl-4-oxo-1,2,3,6,7,11b-hexahydro-4H-pyrazino [2,1-a] isoquinolines, processes for their preparation and pharmaceuticals containing these compounds |
| KR7404234A KR800000089B1 (en) | 1973-12-17 | 1974-12-10 | Method for preparing 2-acyl-4-oxo-hexahydro-4H-pyrazino [2, 1-a] isoquinoline derivative |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| KR800000089B1 true KR800000089B1 (en) | 1980-01-30 |
Family
ID=25766249
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR7404234A Expired KR800000089B1 (en) | 1973-12-17 | 1974-12-10 | Method for preparing 2-acyl-4-oxo-hexahydro-4H-pyrazino [2, 1-a] isoquinoline derivative |
Country Status (1)
| Country | Link |
|---|---|
| KR (1) | KR800000089B1 (en) |
-
1974
- 1974-12-10 KR KR7404234A patent/KR800000089B1/en not_active Expired
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US4001411A (en) | 2-acyl-4-oxo-pyrazino-isoquinoline derivatives and process for the preparation thereof | |
| EP0163965B1 (en) | Pyridazinones, their preparation and use, medicaments containing pyridazinones | |
| US9693975B2 (en) | Bicyclic analgesic compounds | |
| KR20000075719A (en) | Heteroaryl-Hexanoic Acid Amide Derivative, Their Preparation and Their Use as Selective Inhibitor of MIP-1-Alpha Binding to its CCR1 Receptor | |
| DE4339868A1 (en) | imidazopyridazines | |
| DE4432860A1 (en) | imidazopyridines | |
| BRPI0719187A2 (en) | Heterocyclic Compounds Useful as Anabolic Agents for Breeding Animals | |
| CN116600807A (en) | Anthelmintic compounds containing thienopyridine structures | |
| NO133669B (en) | ||
| EP0125636B1 (en) | Pyridazinones, their preparation and use, medicines containing these pyridazinones | |
| CH620680A5 (en) | ||
| US4051243A (en) | Ring substituted pyrazino-isoquinoline derivatives and their preparation | |
| US4141978A (en) | 2-Acyl-4-oxo-pyrazino-isoquinoline derivatives and process for the preparation thereof | |
| US4196291A (en) | 2-Acyl-4-oxo-pyrazino-isoquinoline derivatives and process for the preparation thereof | |
| US5500430A (en) | Amidic derivatives of glutamic, aspartic and 2-amino adipic acids, a process for preparing same, and anti-gastrin composition containing the derivatives | |
| US4420476A (en) | Benzofuro[3,2-c]pyrazol-3-amine derivatives | |
| US4162319A (en) | Ring substituted pyrazino-isoquinoline derivatives and their preparation | |
| DE19528418A1 (en) | Endothelin receptor antagonists | |
| DE2457971A1 (en) | PROCESS FOR THE PREPARATION OF 2-ACYL4-OXO-PYRAZINO-ISOCHINOLINE DERIVATIVES | |
| Gadekar et al. | Synthesis and biological activity of pyridoxine analogs | |
| NO823824L (en) | PROCEDURE FOR PREPARING BENZYLIDE DERIVATIVES | |
| JPH037670B2 (en) | ||
| DE4218159C2 (en) | 4,4,4-trifluoroacetoacetic acid amides, process for their preparation and pharmaceuticals | |
| RU2833552C1 (en) | Anthelmintic compounds containing quinoline structure | |
| KR800000031B1 (en) | Preparation of Substituted 4-oxo- and 4-thioxo-hexahydro-4H-pyrazino- [2.1-a] isoquinoline derivatives |












